US8114637B2	NNP	O
-	:	O
Packaging	NN	O
cells	NNS	O
for	IN	O
recombinant	JJ	O
adenovirus	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
application	NN	O
is	VBZ	O
a	DT	O
divisional	JJ	O
of	IN	O
co-pending	JJ	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
11/384,850	CD	O
,	,	O
filed	VBN	O
Mar	NNP	O
.	.	O
20	CD	O
,	,	O
2006	CD	O
now	RB	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,816,104	CD	O
,	,	O
which	WDT	O
application	NN	O
is	VBZ	O
a	DT	O
continuation	NN	O
of	IN	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
No	NNP	O
.	.	O
PCT/EP2004/052428	NNP	O
,	,	O
filed	VBD	O
on	IN	O
Oct.	NNP	O
4	CD	O
,	,	O
2004	CD	O
,	,	O
designating	VBG	O
the	DT	O
United	NNP	O
States	NNPS	O
of	IN	O
America	NNP	O
,	,	O
and	CC	O
published	VBN	O
,	,	O
in	IN	O
English	NNP	O
,	,	O
as	IN	O
PCT	NNP	O
International	NNP	O
Publication	NNP	O
No	NNP	O
.	.	O
WO	$	O
2005/033320	CD	O
A1	NNP	O
on	IN	O
Apr	NNP	O
.	.	O
14	CD	O
,	,	O
2005	CD	O
,	,	O
which	WDT	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
claims	VBZ	O
priority	NN	O
under	IN	O
the	DT	O
Article	NNP	O
8	CD	O
of	IN	O
the	DT	O
Patent	NNP	O
Cooperation	NNP	O
Treaty	NNP	O
to	TO	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
No	NNP	O
.	.	O
PCT/EP03/50679	NNP	O
,	,	O
filed	VBD	O
on	IN	O
Oct.	NNP	O
2	CD	O
,	,	O
2003	CD	O
,	,	O
the	DT	O
contents	NNS	O
of	IN	O
the	DT	O
entirety	NN	O
of	IN	O
each	DT	O
of	IN	O
which	WDT	O
are	VBP	O
hereby	RB	O
incorporated	VBN	O
herein	NN	O
by	IN	O
this	DT	O
reference	NN	O
.	.	O
TECHNICAL	NNP	O
FIELD	NNP	O
The	DT	O
invention	NN	O
relates	VBZ	O
to	TO	O
the	DT	O
field	NN	O
of	IN	O
biotechnology	NN	O
and	CC	O
molecular	JJ	O
and	CC	O
cell	NN	O
biology	NN	O
;	:	O
more	RBR	O
in	IN	O
particular	JJ	O
,	,	O
to	TO	O
packaging	VBG	O
cells	NNS	O
and	CC	O
use	NN	O
thereof	NN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
batches	NNS	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
.	.	O
BACKGROUND	NNP	O
Replication-deficient	NNP	O
recombinant	NN	O
adenoviruses	NNS	O
are	VBP	O
useful	JJ	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
in	IN	O
gene	NN	O
therapy	NN	O
and	CC	O
for	IN	O
vaccination	NN	O
purposes	NNS	O
.	.	O
They	PRP	O
usually	RB	O
lack	VBP	O
the	DT	O
E1-region	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
and	CC	O
are	VBP	O
,	,	O
therefore	RB	O
,	,	O
propagated	VBD	O
on	IN	O
complementing	VBG	O
cells	NNS	O
providing	VBG	O
the	DT	O
E1	NNP	O
sequences	NNS	O
.	.	O
The	DT	O
packaging	NN	O
cells	NNS	O
provide	VBP	O
all	DT	O
information	NN	O
required	VBN	O
for	IN	O
replication	NN	O
of	IN	O
a	DT	O
vector	NN	O
that	WDT	O
is	VBZ	O
packaged	VBN	O
in	IN	O
the	DT	O
cells	NNS	O
to	TO	O
form	VB	O
recombinant	JJ	O
viral	JJ	O
particles	NNS	O
.	.	O
An	DT	O
example	NN	O
of	IN	O
a	DT	O
packaging	NN	O
cell	NN	O
is	VBZ	O
a	DT	O
293	CD	O
cell	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
nucleotides	IN	O
1-4344	CD	O
of	IN	O
the	DT	O
adenovirus	NN	O
5	CD	O
genome	NN	O
(	(	O
Louis	NNP	B
et	RB	I
al.	RB	I
,	,	I
1997	CD	I
)	)	O
,	,	O
which	WDT	O
include	VBP	O
the	DT	O
5′	CD	O
inverted	JJ	O
terminal	JJ	O
repeat	NN	O
(	(	O
ITR	NNP	O
)	)	O
,	,	O
the	DT	O
packaging	NN	O
signal	NN	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
and	CC	O
the	DT	O
pIX	NN	O
coding	VBG	O
sequences	NNS	O
.	.	O
Overlap	NNP	O
between	IN	O
the	DT	O
adenoviral	JJ	O
sequences	NNS	O
in	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
and	CC	O
the	DT	O
vector	NN	O
may	MD	O
lead	VB	O
to	TO	O
homologous	JJ	O
recombination	NN	O
between	IN	O
these	DT	O
sequences	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
replication-competent	JJ	O
adenovirus	NN	O
(	(	O
RCA	NNP	O
)	)	O
(	(	O
Lochmuller	NNP	B
et	RB	I
al.	RB	I
,	,	I
1994	CD	I
)	)	O
.	.	O
This	DT	O
problem	NN	O
has	VBZ	O
been	VBN	O
solved	VBN	O
by	IN	O
using	VBG	O
a	DT	O
packaging	NN	O
system	NN	O
consisting	VBG	O
of	IN	O
a	DT	O
cell	NN	O
line	NN	O
and	CC	O
a	DT	O
vector	NN	O
that	WDT	O
are	VBP	O
matched	VBN	O
to	TO	O
each	DT	O
other	JJ	O
by	IN	O
lacking	VBG	O
such	JJ	O
overlapping	JJ	O
sequences	NNS	O
(	(	O
Fallaux	NNP	B
et	RB	I
al.	RB	I
,	,	I
1998	CD	I
;	:	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
)	)	O
.	.	O
One	CD	O
example	NN	O
of	IN	O
a	DT	O
particularly	RB	O
useful	JJ	O
cell	NN	O
line	NN	O
in	IN	O
such	JJ	O
applications	NNS	O
is	VBZ	O
the	DT	O
PER.C6®	NNP	O
cell	NN	O
line	NN	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
;	:	O
Nichols	NNP	B
et	FW	I
al.	NN	I
,	,	I
2002	CD	I
)	)	O
.	.	O
Recently	RB	O
,	,	O
it	PRP	O
was	VBD	O
reported	VBN	O
that	IN	O
upon	NN	O
use	NN	O
of	IN	O
PER.C6®	NNP	O
cells	NNS	O
in	IN	O
conjunction	NN	O
with	IN	O
a	DT	O
vector	NN	O
that	WDT	O
still	RB	O
contained	VBD	O
177	CD	O
by	IN	O
sequence	NN	O
homology	NN	O
with	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
PER.C6®	NNP	O
,	,	O
a	DT	O
single	JJ	O
cross-over	JJ	O
event	NN	O
could	MD	O
result	VB	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
helper-dependent	JJ	O
replication-competent	JJ	O
virus	NN	O
at	IN	O
a	DT	O
low	JJ	O
frequency	NN	O
(	(	O
Murakami	NNP	B
et	RB	I
al.	RB	I
,	,	I
2002	CD	I
)	)	O
.	.	O
The	DT	O
generated	JJ	O
atypical	JJ	O
RCA	NNP	O
was	VBD	O
termed	VBN	O
“	JJ	O
helper-dependent	JJ	O
E1-containing	JJ	O
particle	NN	O
”	NNP	O
(	(	O
HDEP	NNP	O
)	)	O
.	.	O
As	IN	O
expected	VBN	O
,	,	O
the	DT	O
emergence	NN	O
of	IN	O
this	DT	O
type	NN	O
of	IN	O
particle	NN	O
was	VBD	O
circumvented	VBN	O
when	WRB	O
a	DT	O
vector	NN	O
was	VBD	O
used	VBN	O
that	IN	O
lacked	VBD	O
the	DT	O
sequence	NN	O
overlap	NN	O
with	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
PER.C6®	NNP	O
cells	NNS	O
(	(	O
Murakami	NNP	B
et	RB	I
al.	RB	I
,	,	I
2002	CD	I
)	)	O
.	.	O
However	RB	O
,	,	O
it	PRP	O
now	RB	O
unexpectedly	RB	O
appears	VBZ	O
that	IN	O
using	VBG	O
the	DT	O
system	NN	O
of	IN	O
matched	JJ	O
vector	NN	O
and	CC	O
PER.C6®	NNP	O
cells	NNS	O
,	,	O
some	DT	O
batches	NNS	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
are	VBP	O
contaminated	VBN	O
at	IN	O
a	DT	O
very	RB	O
low	JJ	O
frequency	NN	O
with	IN	O
particles	NNS	O
that	WDT	O
can	MD	O
cause	VB	O
cytopathological	JJ	O
effect	NN	O
(	(	O
CPE	NNP	O
)	)	O
in	IN	O
cells	NNS	O
lacking	VBG	O
E1	NNP	O
sequences	NNS	O
.	.	O
The	DT	O
particle	NN	O
is	VBZ	O
helper-dependent	JJ	O
and	CC	O
contains	VBZ	O
E1-sequences	NNS	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
is	VBZ	O
also	RB	O
an	DT	O
HDEP	NNP	O
.	.	O
This	DT	O
HDEP	NNP	O
is	VBZ	O
generated	VBN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
substantial	JJ	O
homology	NN	O
between	IN	O
vector	NN	O
and	CC	O
packaging	NN	O
cell	NN	O
(	(	O
see	VB	O
Murakami	NNP	B
et	FW	I
al.	NN	I
,	,	I
2004	CD	I
)	)	O
.	.	O
While	IN	O
RCA	NNP	O
is	VBZ	O
recognized	VBN	O
by	IN	O
the	DT	O
regulatory	JJ	O
authorities	NNS	O
as	IN	O
a	DT	O
potential	JJ	O
problem	NN	O
and	CC	O
detection	NN	O
of	IN	O
RCA	NNP	O
in	IN	O
batches	NNS	O
for	IN	O
clinical	JJ	O
use	NN	O
is	VBZ	O
mandatory	JJ	O
(	(	O
USDHHS	NNP	O
,	,	O
FDA	NNP	O
,	,	O
CBER	NNP	O
.	.	O
Guidance	NN	O
for	IN	O
Industry	NNP	O
,	,	O
Guidance	NNP	O
for	IN	O
human	JJ	O
somatic	JJ	O
cell	NN	O
therapy	NN	O
and	CC	O
gene	NN	O
therapy	NN	O
,	,	O
March	NNP	O
1998	CD	O
)	)	O
,	,	O
the	DT	O
safety	NN	O
aspects	NNS	O
of	IN	O
HDEP	NNP	O
are	VBP	O
unclear	JJ	O
.	.	O
HDEP	NNP	O
is	VBZ	O
replication	JJ	O
deficient	NN	O
since	IN	O
it	PRP	O
lacks	VBZ	O
the	DT	O
necessary	JJ	O
viral	JJ	O
genes	NNS	O
for	IN	O
autonomous	JJ	O
replication	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
HDEP	NNP	O
will	MD	O
not	RB	O
disseminate	VB	O
in	IN	O
a	DT	O
host	NN	O
.	.	O
The	DT	O
theoretical	JJ	O
possibility	NN	O
that	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
recombinant	JJ	O
vector	NN	O
or	CC	O
wild-type	JJ	O
adenovirus	NN	O
in	IN	O
the	DT	O
same	JJ	O
cell	NN	O
may	MD	O
cause	VB	O
rescue	NN	O
and	CC	O
spread	NN	O
of	IN	O
HDEP	NNP	O
can	MD	O
not	RB	O
,	,	O
however	RB	O
,	,	O
be	VB	O
completely	RB	O
excluded	VBN	O
.	.	O
Hence	RB	O
,	,	O
at	IN	O
least	JJS	O
a	DT	O
latent	JJ	O
need	NN	O
exists	NNS	O
for	IN	O
means	NNS	O
and	CC	O
methods	NNS	O
for	IN	O
preventing	VBG	O
generation	NN	O
of	IN	O
E1-containing	JJ	O
particles	NNS	O
during	IN	O
the	DT	O
preparation	NN	O
of	IN	O
batches	NNS	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
particles	NNS	O
.	.	O
To	TO	O
this	DT	O
purpose	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
new	JJ	O
cell	NN	O
lines	NNS	O
,	,	O
methods	NNS	O
for	IN	O
preparing	VBG	O
new	JJ	O
cell	NN	O
lines	NNS	O
,	,	O
and	CC	O
the	DT	O
use	NN	O
thereof	NN	O
to	TO	O
make	VB	O
batches	NNS	O
of	IN	O
RCA-free	JJ	O
and	CC	O
HDEP-free	JJ	O
recombinant	NN	O
adenovirus	NN	O
vectors	NNS	O
.	.	O
SUMMARY	NN	O
OF	IN	O
THE	NNP	O
INVENTION	NNP	O
Described	NNP	O
herein	NN	O
are	VBP	O
methods	NNS	O
of	IN	O
generating	VBG	O
a	DT	O
packaging	NN	O
cell	NN	O
comprising	VBG	O
adenoviral	JJ	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
,	,	O
wherein	VBP	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
separated	VBN	O
from	IN	O
each	DT	O
other	JJ	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cell	NN	O
.	.	O
To	TO	O
this	DT	O
purpose	NN	O
,	,	O
at	IN	O
least	JJS	O
three	CD	O
embodiments	NNS	O
are	VBP	O
provided	VBN	O
.	.	O
In	IN	O
a	DT	O
first	JJ	O
embodiment	NN	O
,	,	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
a	DT	O
precursor	NN	O
cell	NN	O
at	IN	O
different	JJ	O
moments	NNS	O
in	IN	O
time	NN	O
,	,	O
reducing	VBG	O
the	DT	O
chance	NN	O
that	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
are	VBP	O
co-integrated	VBN	O
on	IN	O
the	DT	O
same	JJ	O
chromosomal	JJ	O
location	NN	O
.	.	O
In	IN	O
a	DT	O
second	JJ	O
embodiment	NN	O
,	,	O
the	DT	O
chances	NNS	O
of	IN	O
co-integration	NN	O
into	IN	O
the	DT	O
same	JJ	O
locus	NN	O
are	VBP	O
reduced	VBN	O
by	IN	O
introducing	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
into	IN	O
a	DT	O
precursor	NN	O
cell	NN	O
on	IN	O
two	CD	O
different	JJ	O
molecules	NNS	O
that	WDT	O
lack	VBP	O
overlapping	VBG	O
sequences	NNS	O
that	WDT	O
could	MD	O
otherwise	RB	O
lead	VB	O
to	TO	O
homologous	JJ	O
recombination	NN	O
between	IN	O
these	DT	O
sequences	NNS	O
.	.	O
In	IN	O
a	DT	O
third	JJ	O
embodiment	NN	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
introduced	VBN	O
by	IN	O
virtue	NN	O
of	IN	O
one	CD	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
whereon	IN	O
these	DT	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
a	DT	O
given	VBN	O
distance	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
clear	JJ	O
that	IN	O
in	IN	O
the	DT	O
third	JJ	O
embodiment	NN	O
,	,	O
instead	RB	O
of	IN	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
,	,	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
can	MD	O
also	RB	O
be	VB	O
introduced	VBN	O
,	,	O
which	WDT	O
would	MD	O
satisfy	VB	O
the	DT	O
criterion	NN	O
that	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
a	DT	O
given	VBN	O
distance	NN	O
,	,	O
in	IN	O
case	NN	O
these	DT	O
two	CD	O
or	CC	O
more	JJR	O
molecules	NNS	O
would	MD	O
form	VB	O
one	CD	O
molecule	NN	O
,	,	O
e.g.	NN	O
,	,	O
by	IN	O
ligation	NN	O
,	,	O
recombination	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
The	DT	O
resulting	VBG	O
packaging	NN	O
cells	NNS	O
are	VBP	O
characterized	VBN	O
in	IN	O
that	DT	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
present	JJ	O
at	IN	O
a	DT	O
distance	NN	O
from	IN	O
each	DT	O
other	JJ	O
and	CC	O
,	,	O
hence	RB	O
,	,	O
the	DT	O
chances	NNS	O
are	VBP	O
reduced	VBN	O
of	IN	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
together	RB	O
being	VBG	O
incorporated	VBN	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
that	WDT	O
is	VBZ	O
propagated	VBN	O
on	IN	O
such	JJ	O
packaging	NN	O
cells	NNS	O
.	.	O
Provided	VBN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
preparing	VBG	O
a	DT	O
cell	NN	O
capable	JJ	O
of	IN	O
complementing	VBG	O
E1-deficient	JJ	O
adenoviral	JJ	O
vectors	NNS	O
without	IN	O
generating	VBG	O
helper-dependent	JJ	O
E1-containing	JJ	O
particles	NNS	O
,	,	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
a	DT	O
)	)	O
introducing	NN	O
into	IN	O
a	DT	O
precursor	NN	O
or	CC	O
ancestor	NN	O
of	IN	O
the	DT	O
cell	NN	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
(	(	O
s	PRP	O
)	)	O
coding	VBG	O
for	IN	O
E1A	NNP	O
gene	NN	O
functions	NNS	O
and	CC	O
E1B	NNP	O
gene	NN	O
functions	NNS	O
,	,	O
or	CC	O
if	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
already	RB	O
comprises	VBZ	O
one	CD	O
of	IN	O
E1A	NNP	O
or	CC	O
E1B	NNP	O
gene	NN	O
functions	NNS	O
,	,	O
the	DT	O
other	JJ	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
gene	NN	O
functions	NNS	O
;	:	O
and	CC	O
b	NN	O
)	)	O
selecting	NN	O
or	CC	O
identifying	VBG	O
cells	NNS	O
having	VBG	O
obtained	VBN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
in	IN	O
a	DT	O
chromosomal	JJ	O
configuration	NN	O
that	WDT	O
prevents	VBZ	O
the	DT	O
formation	NN	O
of	IN	O
helper-dependent	JJ	O
E1-containing	JJ	O
particles	NNS	O
when	WRB	O
the	DT	O
cells	NNS	O
are	VBP	O
used	VBN	O
to	TO	O
complement	VB	O
a	DT	O
recombinant	JJ	O
adenoviral	JJ	O
vector	NN	O
deficient	NN	O
for	IN	O
one	CD	O
or	CC	O
more	JJR	O
E1	JJ	O
gene	NN	O
functions	NNS	O
,	,	O
the	DT	O
vector	NN	O
lacking	VBG	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
that	WDT	O
have	VBP	O
substantial	JJ	O
overlap	NN	O
with	IN	O
the	DT	O
chromosomally	RB	O
located	VBN	O
E1	NNP	O
sequence	NN	O
that	WDT	O
otherwise	RB	O
could	MD	O
give	VB	O
rise	NN	O
to	TO	O
homologous	JJ	O
recombination	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
provided	VBN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
preparing	VBG	O
a	DT	O
cell	NN	O
having	VBG	O
adenovirus	JJ	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	NN	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
wherein	WP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
comprising	VBG	O
those	DT	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
a	DT	O
precursor	NN	O
cell	NN	O
,	,	O
the	DT	O
method	NN	O
characterized	VBN	O
in	IN	O
that	DT	O
:	:	O
a	DT	O
)	)	O
at	IN	O
least	JJS	O
two	CD	O
nucleic	JJ	O
acid	NNS	O
molecules	VBZ	O
together	RB	O
comprising	VBG	O
those	DT	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
,	,	O
wherein	NN	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
present	JJ	O
on	IN	O
different	JJ	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
,	,	O
which	WDT	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
on	IN	O
a	DT	O
different	JJ	O
moment	NN	O
in	IN	O
time	NN	O
,	,	O
and	CC	O
wherein	VBD	O
the	DT	O
precursor	NN	O
cell	NN	O
is	VBZ	O
not	RB	O
a	DT	O
baby	NN	O
rat	NN	O
kidney	NN	O
cell	NN	O
;	:	O
or	CC	O
b	VB	O
)	)	O
a	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
comprising	VBG	O
the	DT	O
E1A	NNP	O
coding	NN	O
sequence	NN	O
and	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
comprising	VBG	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
,	,	O
wherein	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
lack	VBP	O
substantial	JJ	O
overlap	NN	O
that	WDT	O
could	MD	O
otherwise	RB	O
lead	VB	O
to	TO	O
homologous	JJ	O
recombination	NN	O
between	IN	O
the	DT	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
;	:	O
or	CC	O
c	VB	O
)	)	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
on	IN	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
or	CC	O
on	IN	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
when	WRB	O
these	DT	O
would	MD	O
form	VB	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
.	.	O
Preferably	RB	O
,	,	O
in	IN	O
embodiment	JJ	O
c	NN	O
)	)	O
,	,	O
the	DT	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
more	JJR	O
preferably	RB	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
or	CC	O
more	JJR	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
separating	NN	O
sequences	NNS	O
are	VBP	O
non-E1	JJ	O
sequences	NNS	O
so	RB	O
that	IN	O
integration	NN	O
of	IN	O
both	DT	O
expression	NN	O
cassettes	NNS	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
together	RB	O
in	IN	O
a	DT	O
single	JJ	O
virus	NN	O
genome	NN	O
is	VBZ	O
rendered	VBN	O
very	RB	O
unlikely	JJ	O
or	CC	O
impossible	JJ	O
.	.	O
Alternatively	RB	O
,	,	O
when	WRB	O
the	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
0	CD	O
to	TO	O
15	CD	O
kb	NNS	O
,	,	O
a	DT	O
screen	NN	O
for	IN	O
the	DT	O
absence	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
of	IN	O
the	DT	O
E1-sequences	NNS	O
in	IN	O
the	DT	O
generated	JJ	O
cells	NNS	O
may	MD	O
be	VB	O
used	VBN	O
to	TO	O
select	VB	O
for	IN	O
cells	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
upon	IN	O
propagation	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
in	IN	O
the	DT	O
generated	JJ	O
cells	NNS	O
is	VBZ	O
decreased	VBN	O
or	CC	O
absent	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
cells	NNS	O
obtainable	JJ	O
by	IN	O
the	DT	O
method	NN	O
described	VBD	O
herein	NN	O
.	.	O
Further	RB	O
provided	VBN	O
is	VBZ	O
a	DT	O
cell	NN	O
comprising	VBG	O
adenovirus	JJ	O
E1A	NNP	O
and	CC	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
coding	NN	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
cell	NN	O
lacks	VBZ	O
stretches	NNS	O
of	IN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
,	,	O
wherein	JJ	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
less	JJR	O
than	IN	O
4	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
cell	NN	O
lacks	VBZ	O
stretches	NNS	O
of	IN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
,	,	O
wherein	JJ	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
less	JJR	O
than	IN	O
10	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
,	,	O
more	JJR	O
preferably	RB	O
,	,	O
the	DT	O
cell	NN	O
lacks	VBZ	O
stretches	NNS	O
of	IN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
,	,	O
wherein	JJ	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
less	JJR	O
than	IN	O
34.5	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
Also	RB	O
provided	VBN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
providing	VBG	O
or	CC	O
generating	VBG	O
a	DT	O
cell	NN	O
comprising	VBG	O
adenoviral	JJ	O
E1	NNP	O
sequences	NNS	O
,	,	O
wherein	VBP	O
E1	NNP	O
sequences	NNS	O
include	VBP	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
method	NN	O
includes	VBZ	O
a	DT	O
step	NN	O
of	IN	O
selecting	VBG	O
cells	NNS	O
lacking	VBG	O
inverted	JJ	O
repeats	NNS	O
comprising	VBG	O
E1	NNP	O
sequences	NNS	O
.	.	O
Further	RB	O
provided	VBN	O
is	VBZ	O
a	DT	O
cell	NN	O
comprising	VBG	O
adenovirus	JJ	O
E1	NNP	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
wherein	VBP	O
the	DT	O
E1	NNP	O
sequences	NNS	O
include	VBP	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
In	IN	O
one	CD	O
embodiment	NN	O
thereof	NN	O
,	,	O
the	DT	O
cell	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
two	CD	O
copies	NNS	O
of	IN	O
the	DT	O
adenovirus	NN	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
which	WDT	O
copies	VBZ	O
may	MD	O
be	VB	O
on	IN	O
the	DT	O
same	JJ	O
chromosome	NN	O
.	.	O
In	IN	O
another	DT	O
embodiment	NN	O
thereof	NN	O
,	,	O
the	DT	O
cell	NN	O
comprises	VBZ	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
and	CC	O
further	RB	O
lacks	NNS	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
encoding	NN	O
(	(	O
functional	JJ	O
)	)	O
pIX	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
.	.	O
Also	RB	O
provided	VBN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
generating	VBG	O
a	DT	O
batch	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
having	VBG	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
E1	NNP	O
region	NN	O
,	,	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
a	DT	O
)	)	O
introducing	VBG	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
into	IN	O
a	DT	O
cell	NN	O
comprising	VBG	O
E1	NNP	O
sequences	NNS	O
of	IN	O
an	DT	O
adenovirus	NN	O
capable	JJ	O
of	IN	O
complementing	VBG	O
the	DT	O
deleted	JJ	O
E1	NNP	O
sequences	NNS	O
of	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
;	:	O
b	NN	O
)	)	O
culturing	VBG	O
the	DT	O
cell	NN	O
and	CC	O
harvesting	VBG	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
,	,	O
the	DT	O
method	NN	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
cell	NN	O
is	VBZ	O
a	DT	O
cell	NN	O
described	VBN	O
herein	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
clear	JJ	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
that	IN	O
instead	RB	O
of	IN	O
introducing	VBG	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
possible	JJ	O
to	TO	O
start	VB	O
the	DT	O
generation	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
by	IN	O
using	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
fragments	NNS	O
capable	JJ	O
of	IN	O
forming	VBG	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
and	CC	O
which	WDT	O
will	MD	O
,	,	O
after	IN	O
replication	NN	O
and	CC	O
packaging	NN	O
in	IN	O
that	DT	O
cell	NN	O
,	,	O
form	VB	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
.	.	O
Hence	NNP	O
,	,	O
for	IN	O
this	DT	O
embodiment	NN	O
,	,	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
may	MD	O
also	RB	O
be	VB	O
a	DT	O
genome	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
.	.	O
In	IN	O
a	DT	O
preferred	JJ	O
embodiment	NN	O
,	,	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
lacks	VBZ	O
substantial	JJ	O
sequence	NN	O
overlap	NN	O
with	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
present	NN	O
in	IN	O
the	DT	O
cell	NN	O
,	,	O
which	WDT	O
could	MD	O
otherwise	RB	O
lead	VB	O
to	TO	O
homologous	JJ	O
recombination	NN	O
.	.	O
In	IN	O
yet	RB	O
another	DT	O
embodiment	NN	O
,	,	O
provided	VBN	O
is	VBZ	O
a	DT	O
packaging	NN	O
system	NN	O
comprising	VBG	O
a	DT	O
packaging	NN	O
cell	NN	O
comprising	VBG	O
E1	NNP	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
and	CC	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
vector	NN	O
with	IN	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
E1	NNP	O
region	NN	O
,	,	O
wherein	VBP	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
vector	NN	O
lacks	VBZ	O
substantial	JJ	O
overlap	NN	O
with	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
packaging	NN	O
cell	NN	O
is	VBZ	O
a	DT	O
cell	NN	O
according	VBG	O
to	TO	O
the	DT	O
invention	NN	O
.	.	O
BRIEF	JJ	O
DESCRIPTION	NNP	O
OF	IN	O
THE	NNP	O
FIGURES	NNP	O
FIG	NNP	O
.	.	O
1	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pIG.E1A	NN	O
.	.	O
FIG	NNP	O
.	.	O
2	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pIG.E1AB21	NN	O
.	.	O
FIG	NNP	O
.	.	O
3	CD	O
is	VBZ	O
an	DT	O
illustration	NN	O
of	IN	O
a	DT	O
map	NN	O
of	IN	O
pE1B	NN	O
.	.	O
FIG	NNP	O
.	.	O
4	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pCC.E1A	NN	O
.	.	O
FIG	NNP	O
.	.	O
5	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pCC.E1AB21	NN	O
.	.	O
FIG	NNP	O
.	.	O
6	CD	O
is	VBZ	O
an	DT	O
illustration	NN	O
of	IN	O
a	DT	O
map	NN	O
of	IN	O
pCC101	NN	O
.	.	O
FIG	NNP	O
.	.	O
7	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pCC105	NN	O
.	.	O
FIG	NNP	O
.	.	O
8	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pCC.55Kcol	NN	O
.	.	O
FIG	NNP	O
.	.	O
9	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pIG.E1B	NN	O
.	.	O
FIG	NNP	O
.	.	O
10	CD	O
is	VBZ	O
an	DT	O
illustration	NN	O
of	IN	O
a	DT	O
map	NN	O
of	IN	O
pCC.E1Bcol	NN	O
.	.	O
FIG	NNP	O
.	.	O
11	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pEC.E1B	NN	O
.	.	O
FIG	NNP	O
.	.	O
12	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pSC.55K	NN	O
.	.	O
FIG	NNP	O
.	.	O
13	CD	O
is	VBZ	O
an	DT	O
example	NN	O
of	IN	O
the	DT	O
design	NN	O
of	IN	O
large	JJ	O
molecules	NNS	O
suitable	JJ	O
for	IN	O
the	DT	O
transformation	NN	O
of	IN	O
primary	JJ	O
cells	NNS	O
.	.	O
Panel	NNP	O
I	PRP	O
is	VBZ	O
a	DT	O
schematic	JJ	O
presentation	NN	O
of	IN	O
single	JJ	O
cosmid	NN	O
vector	NN	O
with	IN	O
coding	VBG	O
regions	NNS	O
for	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
proteins	NNS	O
(	(	O
A	DT	O
and	CC	O
B	NNP	O
,	,	O
respectively	RB	O
)	)	O
flanked	VBN	O
by	IN	O
spacer	NN	O
DNA	NNP	O
.	.	O
RE	NNP	O
represents	VBZ	O
a	DT	O
restriction	NN	O
enzyme	NN	O
recognition	NN	O
site	NN	O
not	RB	O
present	JJ	O
in	IN	O
the	DT	O
spacer	NN	O
DNA	NNP	O
or	CC	O
E1	NNP	O
sequences	NNS	O
.	.	O
Panel	NNP	O
II	NNP	O
is	VBZ	O
a	DT	O
schematic	JJ	O
representation	NN	O
of	IN	O
two	CD	O
separate	JJ	O
nucleic	NNS	O
acids	NNS	O
(	(	O
e.g.	NN	O
,	,	O
plasmids	NNS	O
or	CC	O
cosmid	JJ	O
vector	NN	O
)	)	O
having	VBG	O
either	CC	O
E1A	NNP	O
(	(	O
A	NNP	O
)	)	O
or	CC	O
E1B	NNP	O
(	(	O
B	NNP	O
)	)	O
coding	VBG	O
regions	NNS	O
flanked	VBN	O
by	IN	O
spacer	NN	O
DNA	NNP	O
.	.	O
Panel	NNP	O
III	NNP	O
illustrates	VBZ	O
a	DT	O
situation	NN	O
that	WDT	O
may	MD	O
occur	VB	O
after	IN	O
transformation	NN	O
and	CC	O
integration	NN	O
into	IN	O
host	NN	O
cell	NN	O
genome	NN	O
of	IN	O
a	DT	O
primary	JJ	O
cell	NN	O
with	IN	O
the	DT	O
molecule	NN	O
from	IN	O
Panel	NNP	O
I	PRP	O
or	CC	O
with	IN	O
the	DT	O
two	CD	O
molecules	NNS	O
of	IN	O
Panel	NNP	O
II	NNP	O
.	.	O
In	IN	O
the	DT	O
host	NN	O
genome	NN	O
,	,	O
the	DT	O
insert	NN	O
consists	VBZ	O
of	IN	O
an	DT	O
E1A	NNP	O
region	NN	O
and	CC	O
an	DT	O
E1B	NNP	O
region	NN	O
that	WDT	O
are	VBP	O
separated	VBN	O
by	IN	O
spacer	NN	O
DNA	NNP	O
and	CC	O
a	DT	O
second	JJ	O
copy	NN	O
of	IN	O
that	DT	O
fragment	NN	O
(	(	O
those	DT	O
fragments	NNS	O
)	)	O
in	IN	O
inverted	JJ	O
orientation	NN	O
.	.	O
J	NNP	O
represents	VBZ	O
the	DT	O
junction	NN	O
between	IN	O
inverted	VBN	O
repeat	NN	O
.	.	O
If	IN	O
a	DT	O
part	NN	O
of	IN	O
these	DT	O
sequences	NNS	O
(	(	O
indicated	VBN	O
by	IN	O
arrows	NNS	O
)	)	O
recombine	VBP	O
in	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
,	,	O
the	DT	O
genome	JJ	O
becomes	NNS	O
too	RB	O
large	JJ	O
to	TO	O
be	VB	O
packaged	VBN	O
.	.	O
ITR	NNP	O
is	VBZ	O
the	DT	O
inverted	JJ	O
terminal	JJ	O
repeat	NN	O
,	,	O
Φ	JJ	O
represents	VBZ	O
the	DT	O
packaging	NN	O
signal	NN	O
,	,	O
and	CC	O
FI	NNP	O
is	VBZ	O
the	DT	O
fragment	NN	O
inserted	VBD	O
into	IN	O
recombinant	JJ	O
virus	NN	O
,	,	O
here	RB	O
including	VBG	O
inverted	VBN	O
repeat	NN	O
sequences	NNS	O
.	.	O
Although	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
inverted	JJ	O
repeat	NN	O
may	MD	O
help	VB	O
in	IN	O
the	DT	O
subsequently	RB	O
necessary	JJ	O
step	NN	O
of	IN	O
deleting	VBG	O
other	JJ	O
sequences	NNS	O
from	IN	O
the	DT	O
virus	NN	O
genome	NN	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
inverted	JJ	O
repeat	NN	O
sequence	NN	O
results	NNS	O
in	IN	O
a	DT	O
minor-imaged	JJ	O
duplication	NN	O
of	IN	O
the	DT	O
left	JJ	O
end	NN	O
of	IN	O
the	DT	O
recombined	JJ	O
virus	NN	O
during	IN	O
replication	NN	O
of	IN	O
the	DT	O
virus	NN	O
genome	NN	O
and	CC	O
generates	VBZ	O
a	DT	O
genome	NN	O
(	(	O
duplicated	JJ	O
fragment	NN	O
,	,	O
DF	NNP	O
)	)	O
that	WDT	O
again	RB	O
is	VBZ	O
too	RB	O
large	JJ	O
to	TO	O
be	VB	O
packaged	VBN	O
due	JJ	O
to	TO	O
the	DT	O
spacer	NN	O
DNA	NNP	O
.	.	O
FIG	NNP	O
.	.	O
14	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pIG.E1A.E1B	NN	O
.	.	O
FIG	NNP	O
.	.	O
15	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pCC200	NN	O
.	.	O
FIG	NNP	O
.	.	O
16	CD	O
is	VBZ	O
an	DT	O
illustration	NN	O
of	IN	O
a	DT	O
map	NN	O
of	IN	O
pCC205	NN	O
.	.	O
FIG	NNP	O
.	.	O
17	CD	O
is	VBZ	O
a	DT	O
map	NN	O
of	IN	O
pdys44	NN	O
.	.	O
FIG	NNP	O
.	.	O
18	CD	O
depicts	VBZ	O
a	DT	O
map	NN	O
of	IN	O
p44-1.ccE1A	NN	O
.	.	O
FIG	NNP	O
.	.	O
19	CD	O
depicts	NNS	O
Western	JJ	O
blots	NNS	O
of	IN	O
protein	NN	O
lysates	NNS	O
from	IN	O
generated	VBN	O
cell	NN	O
lines	NNS	O
.	.	O
Lane	NNP	O
1	CD	O
,	,	O
HER01-B-71	NNP	O
;	:	O
Lane	NNP	O
2	CD	O
,	,	O
HER01-H-86	NNP	O
;	:	O
Lane	NNP	O
3	CD	O
,	,	O
HER01-H-87	NNP	O
;	:	O
Lane	NNP	O
4	CD	O
,	,	O
HER01-H-88	NNP	O
;	:	O
Lane	NNP	O
5	CD	O
,	,	O
HER01-H-89	NNP	O
;	:	O
Lane	NNP	O
6	CD	O
,	,	O
HER01-B-90	NNP	O
;	:	O
Lane	NNP	O
7	CD	O
,	,	O
HER01	NNP	O
pn06	NN	O
cells	NNS	O
;	:	O
and	CC	O
Lane	NNP	O
8	CD	O
,	,	O
PER.C6	NNP	O
cells	NNS	O
.	.	O
FIG	NNP	O
.	.	O
20	CD	O
is	VBZ	O
a	DT	O
demonstration	NN	O
of	IN	O
complementation	NN	O
of	IN	O
E1-deleted	JJ	O
adenovirus	NN	O
vectors	NNS	O
with	IN	O
transformed	VBN	O
cell	NN	O
clones	NNS	O
.	.	O
−	NN	O
:	:	O
negative	JJ	O
control	NN	O
;	:	O
MOF	NNP	O
:	:	O
mean	NN	O
of	IN	O
fluorescence	NN	O
;	:	O
B-71	NNP	O
,	,	O
B-90	NNP	O
,	,	O
H-86	NNP	O
,	,	O
H-87	NNP	O
,	,	O
H-88	NNP	O
,	,	O
H-89	NNP	O
:	:	O
generated	VBD	O
transformed	JJ	O
cell	NN	O
clones	NNS	O
.	.	O
FIG	NNP	O
.	.	O
21	CD	O
is	VBZ	O
a	DT	O
schematic	JJ	O
overview	NN	O
of	IN	O
the	DT	O
Ad5.E1	NNP	O
constructs	NNS	O
used	VBN	O
for	IN	O
the	DT	O
transfection	NN	O
in	IN	O
Example	NNP	O
3	CD	O
.	.	O
The	DT	O
restriction	NN	O
sites	VBZ	O
used	VBN	O
to	TO	O
digest	VB	O
the	DT	O
genomic	JJ	O
DNA	NN	O
and	CC	O
to	TO	O
generate	VB	O
the	DT	O
probe	NN	O
fragments	NNS	O
are	VBP	O
indicated	VBN	O
.	.	O
The	DT	O
E1A	NNP	O
and	CC	O
the	DT	O
E1B	NNP	O
DNA	NNP	O
fragment	NN	O
are	VBP	O
fictively	RB	O
linked	VBN	O
with	IN	O
nucleotide	JJ	O
numbering	VBG	O
starting	VBG	O
at	IN	O
the	DT	O
5′	CD	O
end	NN	O
of	IN	O
the	DT	O
E1A-containing	JJ	O
fragment	NN	O
.	.	O
FIG	NNP	O
.	.	O
22	CD	O
depicts	VBZ	O
a	DT	O
schematic	JJ	O
presentation	NN	O
of	IN	O
some	DT	O
embodiments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
not	RB	O
to	TO	O
scale	VB	O
)	)	O
.	.	O
Regulating	VBG	O
sequences	NNS	O
(	(	O
such	JJ	O
as	IN	O
promoters	NNS	O
and	CC	O
polyA	JJ	O
signals	NNS	O
)	)	O
are	VBP	O
not	RB	O
depicted	VBN	O
.	.	O
DETAILED	JJ	O
DESCRIPTION	NNP	O
OF	IN	O
THE	NNP	O
INVENTION	NNP	O
A	NNP	O
replication-competent	JJ	O
adenovirus	NN	O
(	(	O
RCA	NNP	O
)	)	O
is	VBZ	O
an	DT	O
adenoviral	JJ	O
particle	NN	O
that	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
replication	NN	O
in	IN	O
cells	NNS	O
without	IN	O
the	DT	O
need	NN	O
for	IN	O
helper	JJR	O
adenovirus	NN	O
.	.	O
An	DT	O
“	JJ	O
HDEP	NNP	O
”	NNP	O
(	(	O
helper-dependent	JJ	O
E1-containing	NNP	O
particle	NN	O
)	)	O
as	IN	O
used	VBN	O
herein	NN	O
is	VBZ	O
defined	VBN	O
as	IN	O
a	DT	O
viral	JJ	O
particle	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
E1A	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	VBG	O
sequences	NNS	O
from	IN	O
an	DT	O
adenovirus	NN	O
,	,	O
the	DT	O
particle	NN	O
not	RB	O
being	VBG	O
able	JJ	O
to	TO	O
replicate	VB	O
in	IN	O
a	DT	O
cell	NN	O
lacking	VBG	O
functional	JJ	O
E1A	NNP	O
and/or	NN	O
E1B-55K	NNP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
“	NNP	O
helper	NN	O
virus.	NN	O
”	VBZ	O
A	DT	O
helper	JJ	O
virus	NN	O
may	MD	O
be	VB	O
wild-type	JJ	O
or	CC	O
mutant	JJ	O
adenovirus	NN	O
or	CC	O
any	DT	O
adenoviral	JJ	O
vector	NN	O
providing	VBG	O
the	DT	O
functions	NNS	O
missing	VBG	O
in	IN	O
HDEP	NNP	O
and	CC	O
can	MD	O
,	,	O
therefore	RB	O
,	,	O
be	VB	O
provided	VBN	O
by	IN	O
the	DT	O
(	(	O
E1-defective	JJ	O
)	)	O
desired	VBD	O
product	NN	O
recombinant	NN	O
adenovirus	NN	O
propagated	VBN	O
on	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
.	.	O
The	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
55K	CD	O
sequences	NNS	O
are	VBP	O
required	VBN	O
for	IN	O
propagation	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
.	.	O
The	DT	O
HDEP	NNP	O
usually	RB	O
further	RB	O
contains	VBZ	O
E1B-19K	JJ	O
coding	NN	O
sequences	NNS	O
.	.	O
The	DT	O
E1	NNP	O
sequences	NNS	O
present	JJ	O
in	IN	O
HDEP	NNP	O
should	MD	O
be	VB	O
able	JJ	O
to	TO	O
complement	VB	O
the	DT	O
recombinant	JJ	O
E1-defective	JJ	O
adenovirus	NN	O
,	,	O
which	WDT	O
can	MD	O
serve	VB	O
as	IN	O
a	DT	O
helper	NN	O
virus	NN	O
for	IN	O
HDEP	NNP	O
.	.	O
HDEP	NNP	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
homologous	JJ	O
recombination	NN	O
on	IN	O
overlap	NN	O
between	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
a	DT	O
packaging	NN	O
cell	NN	O
and	CC	O
a	DT	O
vector	NN	O
(	(	O
Murakami	NNP	B
et	RB	I
al.	RB	I
,	,	I
2002	CD	I
)	)	O
,	,	O
but	CC	O
as	RB	O
now	RB	O
unexpectedly	RB	O
appears	VBZ	O
from	IN	O
several	JJ	O
studies	NNS	O
,	,	O
it	PRP	O
can	MD	O
also	RB	O
be	VB	O
generated	VBN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
substantial	JJ	O
homology/overlap	NN	O
between	IN	O
sequences	NNS	O
in	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
and	CC	O
vector	NN	O
,	,	O
i.e.	FW	O
,	,	O
by	IN	O
a	DT	O
process	NN	O
referred	VBD	O
to	TO	O
herein	VB	O
as	IN	O
non-homologous	JJ	O
recombination	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Murakami	NNP	B
et	FW	I
al.	NN	I
,	,	I
2004	CD	I
,	,	O
for	IN	O
possible	JJ	O
structures	NNS	O
of	IN	O
HDEP	NNP	O
)	)	O
.	.	O
“	JJ	O
Substantial	NNP	O
overlap	NN	O
”	NN	O
as	IN	O
used	VBN	O
herein	NN	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
defined	VBD	O
as	IN	O
sufficient	JJ	O
overlap	NN	O
for	IN	O
homologous	JJ	O
recombination	NN	O
.	.	O
In	IN	O
any	DT	O
case	NN	O
,	,	O
in	IN	O
embodiments	NNS	O
where	WRB	O
the	DT	O
invention	NN	O
refers	NNS	O
to	TO	O
“	VB	O
absence	NN	O
of	IN	O
substantial	JJ	O
overlap	NN	O
,	,	O
”	VB	O
this	DT	O
condition	NN	O
is	VBZ	O
considered	VBN	O
to	TO	O
be	VB	O
fulfilled	VBN	O
if	IN	O
an	DT	O
overlap	JJ	O
exists	NNS	O
of	IN	O
no	DT	O
more	JJR	O
than	IN	O
50	CD	O
nucleotides	NNS	O
(	(	O
“	JJ	O
nt	RB	O
”	NN	O
)	)	O
,	,	O
preferably	RB	O
less	JJR	O
than	IN	O
40	CD	O
nt	NNS	O
,	,	O
more	JJR	O
preferably	RB	O
less	JJR	O
than	IN	O
30	CD	O
nt	NN	O
,	,	O
still	RB	O
more	RBR	O
preferably	RB	O
less	JJR	O
than	IN	O
20	CD	O
nt	NN	O
,	,	O
even	RB	O
still	RB	O
more	RBR	O
preferably	RB	O
less	JJR	O
than	IN	O
10	CD	O
nt	NNS	O
,	,	O
and	CC	O
most	JJS	O
preferably	RB	O
no	DT	O
overlap	NN	O
at	IN	O
all	DT	O
.	.	O
Although	IN	O
the	DT	O
mechanism	NN	O
of	IN	O
the	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
is	VBZ	O
not	RB	O
fully	RB	O
understood	VBN	O
at	IN	O
present	JJ	O
,	,	O
it	PRP	O
is	VBZ	O
clear	JJ	O
that	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
therein	RB	O
originate	VBP	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
.	.	O
The	DT	O
presence	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
in	IN	O
recombinant	JJ	O
adenovirus	NN	O
batches	NNS	O
is	VBZ	O
unwanted	JJ	O
,	,	O
being	VBG	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
RCA	NNP	O
or	CC	O
HDEP	NNP	O
.	.	O
Provided	VBN	O
is	VBZ	O
methods	NNS	O
and	CC	O
means	VBZ	O
that	IN	O
minimize	VB	O
the	DT	O
chance	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
.	.	O
Thereto	NNP	O
,	,	O
methods	NNS	O
for	IN	O
preparing	VBG	O
cells	NNS	O
and	CC	O
the	DT	O
resulting	JJ	O
cells	NNS	O
are	VBP	O
provided	VBN	O
,	,	O
wherein	VBZ	O
the	DT	O
cells	NNS	O
have	VBP	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
in	IN	O
a	DT	O
chromosomal	JJ	O
configuration	NN	O
that	WDT	O
prevents	VBZ	O
the	DT	O
introduction	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
together	RB	O
into	IN	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
and	CC	O
,	,	O
hence	RB	O
,	,	O
the	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
when	WRB	O
the	DT	O
cells	NNS	O
are	VBP	O
used	VBN	O
for	IN	O
the	DT	O
complementation	NN	O
of	IN	O
E1-deficient	NNP	O
recombinant	JJ	O
adenoviral	JJ	O
vectors	NNS	O
,	,	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
substantial	JJ	O
sequence	NN	O
overlap	NN	O
between	IN	O
the	DT	O
vector	NN	O
and	CC	O
the	DT	O
chromosomally	RB	O
located	VBN	O
E1	NNP	O
sequences	NNS	O
of	IN	O
the	DT	O
complementing	VBG	O
cells	NNS	O
hereof	NN	O
.	.	O
To	TO	O
this	DT	O
purpose	NN	O
,	,	O
the	DT	O
chromosomal	JJ	O
conformation	NN	O
of	IN	O
the	DT	O
cells	NNS	O
according	VBG	O
to	TO	O
one	CD	O
embodiment	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
such	JJ	O
that	IN	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
separated	VBN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
novel	JJ	O
cells	NNS	O
.	.	O
Since	IN	O
inverted	VBN	O
repeats	NNS	O
are	VBP	O
believed	VBN	O
to	TO	O
contribute	VB	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
by	IN	O
stimulating	VBG	O
the	DT	O
deletion	NN	O
of	IN	O
adenovirus	NN	O
sequences	NNS	O
,	,	O
in	IN	O
another	DT	O
embodiment	NN	O
,	,	O
provided	VBN	O
is	VBZ	O
cells	NNS	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
in	IN	O
inverted	JJ	O
repeat	NN	O
conformation	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cells	NNS	O
.	.	O
The	DT	O
cells	NNS	O
hereof	VBP	O
comprise	NN	O
adenovirus	NN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
and	CC	O
preferably	RB	O
,	,	O
they	PRP	O
comprise	VBP	O
the	DT	O
coding	NN	O
sequences	NNS	O
for	IN	O
all	DT	O
functional	JJ	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
(	(	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
)	)	O
proteins	VBZ	O
in	IN	O
their	PRP$	O
genome	NN	O
.	.	O
E1A	NN	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
proteins	NNS	O
may	MD	O
be	VB	O
of	IN	O
the	DT	O
same	JJ	O
or	CC	O
optionally	RB	O
be	VB	O
of	IN	O
different	JJ	O
serotype	NN	O
described	VBD	O
herein	NN	O
.	.	O
Preferably	RB	O
in	IN	O
these	DT	O
embodiments	NNS	O
,	,	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
are	VBP	O
regulated	VBN	O
by	IN	O
a	DT	O
promoter	NN	O
different	JJ	O
from	IN	O
an	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
promoter	NN	O
,	,	O
respectively	RB	O
.	.	O
Cells	NNS	O
A	DT	O
recombinant	JJ	O
adenovirus	NN	O
may	MD	O
be	VB	O
able	JJ	O
to	TO	O
take	VB	O
up	RP	O
>	RB	O
20	CD	O
kb	NN	O
of	IN	O
DNA	NN	O
from	IN	O
the	DT	O
cell	NN	O
line	NN	O
in	IN	O
which	WDT	O
it	PRP	O
is	VBZ	O
propagated	VBN	O
,	,	O
and	CC	O
the	DT	O
maximum	JJ	O
genome	JJ	O
length	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
allowing	VBG	O
efficient	JJ	O
packaging	NN	O
is	VBZ	O
approximately	RB	O
38	CD	O
kb	NNS	O
(	(	O
for	IN	O
an	DT	O
adenovirus	JJ	O
type	NN	O
5-based	JJ	O
vector	NN	O
;	:	O
this	DT	O
figure	NN	O
may	MD	O
depend	VB	O
somewhat	RB	O
on	IN	O
the	DT	O
serotype	NN	O
)	)	O
.	.	O
This	DT	O
feature	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
prepare	VB	O
novel	JJ	O
complementing	VBG	O
cells	NNS	O
described	VBN	O
herein	RB	O
,	,	O
the	DT	O
cells	NNS	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
and	CC	O
the	DT	O
cells	NNS	O
characterized	VBN	O
in	IN	O
that	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
and	CC	O
more	JJR	O
preferably	RB	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
This	DT	O
means	VBZ	O
that	IN	O
the	DT	O
genome	NN	O
of	IN	O
such	JJ	O
cells	NNS	O
lacks	VBZ	O
stretches	NNS	O
of	IN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
wherein	NN	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
less	JJR	O
than	IN	O
4	CD	O
,	,	O
10	CD	O
or	CC	O
34.5	CD	O
kb	NNS	O
,	,	O
respectively	RB	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
FIG	NNP	O
.	.	O
22	CD	O
for	IN	O
a	DT	O
schematic	JJ	O
representation	NN	O
)	)	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
clear	JJ	O
that	IN	O
wherever	VBZ	O
the	DT	O
invention	NN	O
mentions	NNS	O
that	WDT	O
two	CD	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
a	DT	O
given	VBN	O
distance	NN	O
in	IN	O
a	DT	O
genome	NN	O
of	IN	O
a	DT	O
cell	NN	O
,	,	O
this	DT	O
requirement	NN	O
is	VBZ	O
deemed	VBN	O
to	TO	O
be	VB	O
fulfilled	VBN	O
as	RB	O
well	RB	O
when	WRB	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
present	JJ	O
on	IN	O
separate	JJ	O
chromosomes	NNS	O
.	.	O
Hence	NNP	O
,	,	O
the	DT	O
embodiment	NN	O
where	WRB	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
on	IN	O
different	JJ	O
chromosomes	NNS	O
is	VBZ	O
expressly	RB	O
included	VBN	O
within	IN	O
the	DT	O
meaning	NN	O
“	NN	O
at	IN	O
least	JJS	O
x	JJ	O
kb	JJ	O
apart	RB	O
”	VBZ	O
or	CC	O
“	NNP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
x	JJ	O
kb	NN	O
”	NN	O
in	IN	O
the	DT	O
genome	NN	O
,	,	O
as	IN	O
used	VBN	O
herein	NN	O
.	.	O
Such	JJ	O
an	DT	O
embodiment	NN	O
can	MD	O
be	VB	O
easily	RB	O
checked	VBN	O
by	IN	O
methods	NNS	O
known	VBN	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
by	IN	O
fluorescent	NN	O
in	IN	O
situ	JJ	O
hybridization	NN	O
(	(	O
FISH	NNP	O
)	)	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
locate	VB	O
the	DT	O
chromosome	NN	O
and/or	JJ	O
chromosome	NN	O
location	NN	O
where	WRB	O
a	DT	O
given	VBN	O
sequence	NN	O
is	VBZ	O
present	JJ	O
.	.	O
The	DT	O
cells	NNS	O
hereof	VBP	O
comprise	NN	O
adenovirus	NN	O
sequences	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
and	CC	O
preferably	RB	O
,	,	O
those	DT	O
adenovirus	JJ	O
sequences	NNS	O
encode	VBP	O
all	DT	O
E1	NNP	O
proteins	NNS	O
but	CC	O
lack	NN	O
sequences	NNS	O
encoding	VBG	O
pIX	NN	O
,	,	O
or	CC	O
a	DT	O
part	NN	O
thereof	NN	O
(	(	O
i.e.	JJ	O
,	,	O
such	JJ	O
cells	NNS	O
preferably	RB	O
do	VBP	O
not	RB	O
contain	VB	O
sequences	NNS	O
from	IN	O
the	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
pIX	NN	O
;	:	O
for	IN	O
cells	NNS	O
with	IN	O
Ad5	NNP	O
E1	NNP	O
sequences	NNS	O
,	,	O
this	DT	O
means	VBZ	O
that	IN	O
they	PRP	O
preferably	RB	O
do	VBP	O
not	RB	O
contain	VB	O
nt	JJ	O
3609-4031	CD	O
of	IN	O
wt	NN	O
Ad5	NNP	O
or	CC	O
parts	NNS	O
thereof	NN	O
)	)	O
,	,	O
and	CC	O
more	JJR	O
preferably	RB	O
,	,	O
they	PRP	O
also	RB	O
have	VBP	O
deletions	NNS	O
in	IN	O
the	DT	O
pIX	NN	O
promoter	NN	O
(	(	O
for	IN	O
cells	NNS	O
with	IN	O
Ad5	NNP	O
E1	NNP	O
sequence	NN	O
,	,	O
preferably	RB	O
no	DT	O
sequences	NNS	O
of	IN	O
the	DT	O
pIX	NN	O
promoter	NN	O
downstream	NN	O
from	IN	O
nt	JJ	O
3550	CD	O
,	,	O
more	RBR	O
preferably	RB	O
3525	CD	O
)	)	O
in	IN	O
order	NN	O
to	TO	O
prevent	VB	O
significant	JJ	O
overlap	NN	O
with	IN	O
adenovirus	NN	O
vectors	NNS	O
having	VBG	O
pIX	NN	O
under	IN	O
control	NN	O
of	IN	O
its	PRP$	O
own	JJ	O
promoter	NN	O
.	.	O
The	DT	O
absence	NN	O
of	IN	O
pIX	JJ	O
sequences	NNS	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cells	NNS	O
aids	NNS	O
in	IN	O
preventing	VBG	O
overlap	NN	O
between	IN	O
the	DT	O
genome	NN	O
and	CC	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
vector	NN	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
,	,	O
the	DT	O
contents	NNS	O
of	IN	O
which	WDT	O
are	VBP	O
incorporated	VBN	O
by	IN	O
this	DT	O
reference	NN	O
)	)	O
.	.	O
The	DT	O
cells	NNS	O
described	VBD	O
herein	NN	O
may	MD	O
be	VB	O
derived	VBN	O
from	IN	O
immortalized	JJ	O
cells	NNS	O
such	JJ	O
as	IN	O
A549	NNP	O
,	,	O
Hela	NNP	O
and	CC	O
the	DT	O
like	JJ	O
,	,	O
in	IN	O
which	WDT	O
case	NN	O
a	DT	O
selection	NN	O
marker	NN	O
is	VBZ	O
required	VBN	O
to	TO	O
establish	VB	O
the	DT	O
cells	NNS	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
cells	NNS	O
described	VBN	O
herein	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
primary	JJ	O
cells	NNS	O
,	,	O
in	IN	O
which	WDT	O
case	NN	O
,	,	O
selection	NN	O
is	VBZ	O
provided	VBN	O
by	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
transforming	NN	O
activity	NN	O
(	(	O
see	VB	O
examples	NNS	O
)	)	O
.	.	O
In	IN	O
preferred	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
cells	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
retina	NN	O
cells	NNS	O
.	.	O
They	PRP	O
may	MD	O
be	VB	O
cells	NNS	O
of	IN	O
any	DT	O
origin	NN	O
,	,	O
including	VBG	O
of	IN	O
human	JJ	O
origin	NN	O
.	.	O
For	IN	O
the	DT	O
propagation	NN	O
of	IN	O
human	JJ	O
adenovirus	NN	O
,	,	O
cells	NNS	O
of	IN	O
human	JJ	O
origin	NN	O
are	VBP	O
preferred	VBN	O
.	.	O
The	DT	O
cells	NNS	O
may	MD	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
also	RB	O
be	VB	O
of	IN	O
bovine	JJ	O
origin	NN	O
for	IN	O
the	DT	O
propagation	NN	O
of	IN	O
recombinant	JJ	O
bovine	NN	O
adenovirus	NN	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,379,944	CD	O
)	)	O
.	.	O
The	DT	O
origin	NN	O
of	IN	O
the	DT	O
cells	NNS	O
may	MD	O
be	VB	O
chosen	VBN	O
by	IN	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
to	TO	O
be	VB	O
compatible	JJ	O
with	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
of	IN	O
choice	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
cells	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
primary	JJ	O
human	JJ	O
retina	NN	O
cells	NNS	O
(	(	O
also	RB	O
referred	VBN	O
to	TO	O
as	IN	O
HER	NNP	O
cells	NNS	O
)	)	O
.	.	O
Immortalization	NN	O
of	IN	O
such	JJ	O
cells	NNS	O
with	IN	O
adenoviral	JJ	O
E1	NNP	O
sequences	NNS	O
has	VBZ	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
been	VBN	O
described	VBN	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
,	,	O
in	IN	O
Byrd	NNP	B
et	CC	I
al.	NN	I
,	,	I
1982	CD	I
,	,	I
1988	CD	I
,	,	O
and	CC	O
Gallimore	NNP	B
et	VBP	I
al.	NN	I
,	,	I
1986	CD	I
.	.	O
Primary	NNP	O
HER	NNP	O
cells	NNS	O
can	MD	O
be	VB	O
isolated	VBN	O
from	IN	O
fetuses	NNS	O
(	(	O
Byrd	NNP	B
et	RB	I
al.	RB	I
,	,	I
1982	CD	I
,	,	I
1988	CD	I
)	)	O
.	.	O
In	IN	O
other	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
cells	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
primary	JJ	O
human	JJ	O
embryonic	JJ	O
kidney	NN	O
cells	NNS	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Graham	NNP	B
et	FW	I
al.	NN	I
,	,	I
1977	CD	I
)	)	O
.	.	O
In	IN	O
yet	RB	O
other	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
cells	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
primary	JJ	O
amniocytes	NNS	O
,	,	O
such	JJ	O
as	IN	O
human	JJ	O
primary	NN	O
amniocytes	NNS	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,558,948	CD	O
for	IN	O
methods	NNS	O
of	IN	O
immortalizing	VBG	O
primary	JJ	O
amniocytes	NNS	O
with	IN	O
adenovirus	JJ	O
E1	NNP	O
sequences	NNS	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
Cells	NNP	O
The	DT	O
cells	NNS	O
described	VBD	O
herein	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
introducing	VBG	O
adenovirus	NN	O
E1A	NNP	O
and	CC	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
coding	NN	O
sequences	NNS	O
into	IN	O
a	DT	O
precursor	NN	O
or	CC	O
ancestor	NN	O
cell	NN	O
(	(	O
hence	NN	O
,	,	O
the	DT	O
cells	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
the	DT	O
precursor	NN	O
or	CC	O
ancestor	NN	O
cell	NN	O
by	IN	O
introduction	NN	O
of	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
therein	RB	O
)	)	O
.	.	O
Described	NNP	O
herein	NN	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
to	TO	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cells	NNS	O
in	IN	O
an	DT	O
unlinked	JJ	O
manner	NN	O
.	.	O
“	NN	O
Unlinked	VBD	O
”	NNP	O
as	IN	O
used	VBN	O
in	IN	O
this	DT	O
connotation	NN	O
,	,	O
is	VBZ	O
meant	VBN	O
to	TO	O
refer	VB	O
to	TO	O
a	DT	O
configuration	NN	O
that	WDT	O
is	VBZ	O
different	JJ	O
from	IN	O
the	DT	O
natural	JJ	O
configuration	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
as	IN	O
found	VBN	O
in	IN	O
an	DT	O
adenovirus	NN	O
,	,	O
i.e.	FW	O
,	,	O
directly	RB	O
adjacent	JJ	O
to	TO	O
each	DT	O
other	JJ	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
FIG	NNP	O
.	.	O
14	CD	O
where	WRB	O
the	DT	O
natural	JJ	O
,	,	O
i.e.	FW	O
,	,	O
“	FW	O
linked	VBN	O
,	,	O
”	JJ	O
configuration	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
is	VBZ	O
shown	VBN	O
as	IN	O
present	NN	O
in	IN	O
plasmid	JJ	O
pIG.E1A.E1B	NN	O
)	)	O
.	.	O
It	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
noted	VBN	O
that	IN	O
prior	JJ	O
hereto	NN	O
,	,	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
that	WDT	O
wished	VBD	O
to	TO	O
obtain	VB	O
a	DT	O
packaging	NN	O
cell	NN	O
comprising	VBG	O
in	IN	O
its	PRP$	O
genome	NN	O
adenovirus	NN	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
would	MD	O
not	RB	O
contemplate	VB	O
introducing	VBG	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
sequence	NN	O
in	IN	O
an	DT	O
unlinked	JJ	O
manner	NN	O
,	,	O
because	IN	O
:	:	O
a	DT	O
)	)	O
it	PRP	O
is	VBZ	O
more	RBR	O
work	NN	O
and	CC	O
hence	RB	O
less	RBR	O
convenient	JJ	O
,	,	O
and	CC	O
b	NN	O
)	)	O
both	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
are	VBP	O
required	VBN	O
for	IN	O
immortalization	NN	O
.	.	O
Previous	JJ	O
studies	NNS	O
,	,	O
that	WDT	O
were	VBD	O
done	VBN	O
to	TO	O
gain	VB	O
insight	NN	O
into	IN	O
the	DT	O
transforming	VBG	O
capabilities	NNS	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
proteins	NNS	O
,	,	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
introduction	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
can	MD	O
lead	VB	O
to	TO	O
established	VBN	O
clones	NNS	O
(	(	O
van	JJ	B
den	NN	I
Elsen	NNP	I
et	CC	I
al.	NN	I
,	,	I
1982	CD	I
;	:	O
Gallimore	NNP	B
et	FW	I
al.	NN	I
,	,	I
1986	CD	I
;	:	O
Jochemsen	NNP	B
et	FW	I
al.	NN	I
,	,	I
1987	CD	I
;	:	O
Rao	NNP	B
et	FW	I
al.	NN	I
,	,	I
1992	CD	I
;	:	O
Nevels	NNP	B
et	FW	I
al.	NN	I
,	,	I
2001	CD	I
)	)	O
.	.	O
However	RB	O
,	,	O
the	DT	O
simultaneous	JJ	O
introduction	NN	O
of	IN	O
these	DT	O
plasmids	NNS	O
,	,	O
and/or	VBP	O
the	DT	O
overlap	NN	O
between	IN	O
the	DT	O
introduced	JJ	O
sequences	NNS	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
the	DT	O
plasmid	NN	O
sequences	NNS	O
,	,	O
the	DT	O
regulatory	JJ	O
sequences	NNS	O
such	JJ	O
as	IN	O
promoter	NN	O
and/or	NN	O
polyadenylation	NN	O
signal	NN	O
,	,	O
and	CC	O
the	DT	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
overlapping	VBG	O
sequence	NN	O
likely	JJ	O
results	NNS	O
in	IN	O
the	DT	O
co-integration	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
in	IN	O
the	DT	O
same	JJ	O
locus	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
Indeed	RB	O
such	JJ	O
co-integration	NN	O
was	VBD	O
observed	VBN	O
by	IN	O
van	NN	B
den	NN	I
Elsen	NNP	I
et	CC	I
al	NN	I
.	.	I
(	(	I
1982	CD	I
)	)	I
.	.	O
In	IN	O
one	CD	O
case	NN	O
(	(	O
Jochemsen	NNP	B
et	RB	I
al.	RB	I
,	,	I
1987	CD	I
)	)	O
,	,	O
baby	JJ	O
rat	NN	O
kidney	NN	O
(	(	O
BRK	NNP	O
)	)	O
cells	NNS	O
were	VBD	O
first	RB	O
transfected	VBN	O
with	IN	O
E1A	NNP	O
and	CC	O
picked	VBD	O
clones	NNS	O
were	VBD	O
then	RB	O
transfected	VBN	O
with	IN	O
an	DT	O
E1B	NNP	O
plasmid	NN	O
to	TO	O
study	VB	O
the	DT	O
influence	NN	O
of	IN	O
E1B	NNP	O
expression	NN	O
on	IN	O
E1A	NNP	O
expression	NN	O
.	.	O
Obviously	RB	O
,	,	O
this	DT	O
study	NN	O
was	VBD	O
done	VBN	O
on	IN	O
a	DT	O
specific	JJ	O
type	NN	O
of	IN	O
cells	NNS	O
and	CC	O
for	IN	O
a	DT	O
reason	NN	O
unrelated	JJ	O
to	TO	O
the	DT	O
invention	NN	O
described	VBN	O
in	IN	O
this	DT	O
application	NN	O
.	.	O
Prior	NNP	O
hereto	NN	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
reason	NN	O
to	TO	O
separately	RB	O
transfect	VB	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
for	IN	O
the	DT	O
purpose	NN	O
of	IN	O
generating	VBG	O
a	DT	O
packaging	NN	O
cell	NN	O
.	.	O
The	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
substantial	JJ	O
overlap	NN	O
between	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
and	CC	O
the	DT	O
packaging	NN	O
cell	NN	O
was	VBD	O
hitherto	JJ	O
not	RB	O
described	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
would	MD	O
,	,	O
in	IN	O
fact	NN	O
,	,	O
be	VB	O
dissuaded	VBN	O
to	TO	O
use	VB	O
this	DT	O
method	NN	O
for	IN	O
obtaining	VBG	O
other	JJ	O
than	IN	O
BRK-derived	NNP	O
cells	NNS	O
,	,	O
such	JJ	O
as	IN	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
human	JJ	O
cells	NNS	O
,	,	O
since	IN	O
Gallimore	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1986	CD	I
)	)	I
had	VBD	O
described	VBN	O
that	IN	O
human	JJ	O
cells	NNS	O
were	VBD	O
only	RB	O
rarely	RB	O
morphologically	RB	O
transformed	VBN	O
by	IN	O
expressing	VBG	O
E1A	NNP	O
only	RB	O
and	CC	O
most	JJS	O
clones	NNS	O
died	VBD	O
in	IN	O
situ	NN	O
or	CC	O
immediately	RB	O
after	IN	O
isolation	NN	O
.	.	O
The	DT	O
sole	JJ	O
case	NN	O
where	WRB	O
an	DT	O
Ad12	NNP	O
(	(	O
subgroup	VB	O
A	DT	O
)	)	O
E1A-expressing	NN	O
plasmid	NN	O
resulted	VBD	O
in	IN	O
a	DT	O
clone	NN	O
was	VBD	O
identified	VBN	O
114	CD	O
days	NNS	O
post-transfection	NN	O
and	CC	O
could	MD	O
only	RB	O
be	VB	O
picked	VBN	O
after	IN	O
the	DT	O
clone	NN	O
had	VBD	O
overgrown	VBN	O
the	DT	O
dish	NN	O
.	.	O
Clearly	RB	O
,	,	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
would	MD	O
not	RB	O
be	VB	O
motivated	VBN	O
to	TO	O
introduce	VB	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
gene	NN	O
into	IN	O
precursor	NN	O
cells	NNS	O
on	IN	O
a	DT	O
separate	JJ	O
moment	NN	O
in	IN	O
time	NN	O
based	VBN	O
on	IN	O
the	DT	O
prior	JJ	O
art	NN	O
.	.	O
It	PRP	O
is	VBZ	O
the	DT	O
merit	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
provide	VB	O
such	JJ	O
methods	NNS	O
for	IN	O
obtaining	VBG	O
cells	NNS	O
that	WDT	O
have	VBP	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
separated	VBN	O
in	IN	O
their	PRP$	O
genome	NN	O
.	.	O
In	IN	O
certain	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
cells	NNS	O
hereof	NN	O
are	VBP	O
preferably	RB	O
not	RB	O
baby	JJ	O
rat	NN	O
kidney	NN	O
(	(	O
BRK	NNP	O
)	)	O
cells	NNS	O
.	.	O
The	DT	O
cells	NNS	O
hereof	NN	O
may	MD	O
be	VB	O
human	JJ	O
cells	NNS	O
.	.	O
Such	JJ	O
cells	NNS	O
may	MD	O
be	VB	O
derived	VBN	O
from	IN	O
HER	NNP	O
cells	NNS	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
clear	JJ	O
that	IN	O
the	DT	O
cells	NNS	O
wherein	VBP	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
according	VBG	O
to	TO	O
the	DT	O
invention	NN	O
,	,	O
before	IN	O
introducing	NN	O
,	,	O
are	VBP	O
preferably	RB	O
free	JJ	O
from	IN	O
adenovirus	JJ	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
and	CC	O
,	,	O
only	RB	O
upon	IN	O
introduction	NN	O
of	IN	O
the	DT	O
sequences	NNS	O
,	,	O
will	MD	O
obtain	VB	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
,	,	O
thereby	RB	O
becoming	VBG	O
immortalized	VBN	O
and	CC	O
capable	JJ	O
of	IN	O
packaging	VBG	O
recombinant	JJ	O
adenovirus	NN	O
with	IN	O
deletions	NNS	O
in	IN	O
the	DT	O
E1	NNP	O
region	NN	O
.	.	O
For	IN	O
instance	NN	O
,	,	O
WO	NNP	O
03/031633	CD	O
describes	VBZ	O
the	DT	O
introduction	NN	O
of	IN	O
Ad11	NNP	O
E1B-55k	NNP	O
into	IN	O
293	CD	O
cells	NNS	O
:	:	O
this	DT	O
will	MD	O
clearly	RB	O
not	RB	O
lead	VB	O
to	TO	O
the	DT	O
advantages	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
since	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
as	IN	O
already	RB	O
present	JJ	O
in	IN	O
293	CD	O
remain	NN	O
in	IN	O
the	DT	O
original	JJ	O
configuration	NN	O
and	CC	O
will	MD	O
have	VB	O
an	DT	O
E1B	NNP	O
ORF	NNP	O
less	JJR	O
than	IN	O
4	CD	O
kb	JJ	O
apart	RB	O
from	IN	O
the	DT	O
E1A	NNP	O
ORF	NNP	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
generating	VBG	O
cells	NNS	O
having	VBG	O
adenovirus	NN	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	NN	O
sequences	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
resulting	VBG	O
cells	NNS	O
from	IN	O
the	DT	O
methods	NNS	O
,	,	O
so	IN	O
that	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
sufficiently	RB	O
separated	VBN	O
from	IN	O
each	DT	O
other	JJ	O
to	TO	O
prevent	VB	O
the	DT	O
simultaneous	JJ	O
introduction	NN	O
of	IN	O
all	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cells	NNS	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
a	DT	O
single	JJ	O
adenovirus	NN	O
particle	NN	O
.	.	O
According	VBG	O
to	TO	O
a	DT	O
first	JJ	O
embodiment	NN	O
for	IN	O
generating	VBG	O
cells	NNS	O
hereof	NN	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separately	RB	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
,	,	O
by	IN	O
placing	VBG	O
them	PRP	O
on	IN	O
separate	JJ	O
molecules	NNS	O
that	WDT	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
cell	NN	O
on	IN	O
a	DT	O
different	JJ	O
moment	NN	O
in	IN	O
time	NN	O
,	,	O
and	CC	O
the	DT	O
precursor	NN	O
cells	NNS	O
are	VBP	O
not	RB	O
BRK	NNP	O
cells	NNS	O
.	.	O
In	IN	O
one	CD	O
embodiment	NN	O
hereof	NN	O
,	,	O
first	RB	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B-21K	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
,	,	O
while	IN	O
the	DT	O
E1B-55K	NNP	O
coding	NN	O
sequence	NN	O
is	VBZ	O
introduced	VBN	O
at	IN	O
a	DT	O
later	JJ	O
moment	NN	O
in	IN	O
time	NN	O
.	.	O
According	VBG	O
to	TO	O
a	DT	O
second	JJ	O
embodiment	NN	O
for	IN	O
generating	VBG	O
cells	NNS	O
,	,	O
at	IN	O
least	JJS	O
two	CD	O
nucleic	JJ	O
acid	NNS	O
molecules	VBZ	O
together	RB	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
at	IN	O
least	JJS	O
two	CD	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
lack	VBP	O
substantial	JJ	O
overlapping	NN	O
sequences	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
believed	VBN	O
that	IN	O
the	DT	O
presence	NN	O
of	IN	O
such	JJ	O
overlapping	JJ	O
sequences	NNS	O
would	MD	O
enhance	VB	O
the	DT	O
possibility	NN	O
of	IN	O
at	IN	O
least	JJS	O
some	DT	O
way	NN	O
of	IN	O
interaction	NN	O
between	IN	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
and	CC	O
the	DT	O
subsequent	JJ	O
co-integration	NN	O
of	IN	O
the	DT	O
sequences	NNS	O
on	IN	O
the	DT	O
molecules	NNS	O
into	IN	O
the	DT	O
same	JJ	O
locus	NN	O
of	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
into	IN	O
which	WDT	O
the	DT	O
molecules	NNS	O
are	VBP	O
introduced	VBN	O
,	,	O
whereas	IN	O
it	PRP	O
is	VBZ	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
circumvent	VB	O
this	DT	O
.	.	O
In	IN	O
one	CD	O
embodiment	NN	O
hereof	NN	O
,	,	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
regions	NNS	O
are	VBP	O
placed	VBN	O
under	IN	O
control	NN	O
of	IN	O
different	JJ	O
heterologous	JJ	O
regulatory	JJ	O
sequences	NNS	O
,	,	O
such	JJ	O
as	IN	O
promoters	NNS	O
and	CC	O
polyadenylation	NN	O
sequences	NNS	O
.	.	O
In	IN	O
another	DT	O
embodiment	NN	O
hereof	NN	O
,	,	O
the	DT	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
sequences	NNS	O
,	,	O
which	WDT	O
are	VBP	O
overlapping	VBG	O
,	,	O
are	VBP	O
separated	VBN	O
and	CC	O
all	DT	O
overlap	VBP	O
between	IN	O
these	DT	O
coding	VBG	O
sequences	NNS	O
is	VBZ	O
removed	VBN	O
by	IN	O
genetic	JJ	O
engineering	NN	O
using	VBG	O
knowledge	NN	O
of	IN	O
the	DT	O
redundancy	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
code	NN	O
,	,	O
according	VBG	O
to	TO	O
methods	NNS	O
known	VBN	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
thereby	RB	O
allowing	VBG	O
the	DT	O
introduction	NN	O
of	IN	O
these	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
independently	RB	O
and	CC	O
unlinked	JJ	O
from	IN	O
each	DT	O
other	JJ	O
.	.	O
Introduction	NN	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
regions	NNS	O
in	IN	O
this	DT	O
embodiment	NN	O
may	MD	O
be	VB	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
by	IN	O
co-transfection	NN	O
of	IN	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
,	,	O
but	CC	O
obviously	RB	O
,	,	O
the	DT	O
first	JJ	O
and	CC	O
second	JJ	O
embodiments	NNS	O
may	MD	O
also	RB	O
be	VB	O
combined	VBN	O
,	,	O
i.e.	FW	O
,	,	O
introduction	NN	O
of	IN	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
comprising	VBG	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
together	RB	O
comprising	VBG	O
E1A	NNP	O
and	CC	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
wherein	NN	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
lack	VBP	O
substantial	JJ	O
overlap	NN	O
with	IN	O
respect	NN	O
to	TO	O
each	DT	O
other	JJ	O
,	,	O
and	CC	O
wherein	NN	O
at	IN	O
least	JJS	O
two	CD	O
molecules	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
a	DT	O
precursor	NN	O
cell	NN	O
on	IN	O
a	DT	O
different	JJ	O
moment	NN	O
in	IN	O
time	NN	O
.	.	O
In	IN	O
a	DT	O
third	JJ	O
embodiment	NN	O
,	,	O
the	DT	O
sequences	NNS	O
encoding	VBG	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
unlinked	VBN	O
by	IN	O
placing	VBG	O
them	PRP	O
on	IN	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
,	,	O
wherein	NN	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
(	(	O
obviously	RB	O
,	,	O
this	DT	O
may	MD	O
as	RB	O
well	RB	O
be	VB	O
both	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
)	)	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
6	CD	O
kb	NN	O
,	,	O
more	JJR	O
preferably	RB	O
at	IN	O
least	JJS	O
8	CD	O
kb	NN	O
,	,	O
still	RB	O
more	RBR	O
preferably	RB	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
even	RB	O
still	RB	O
more	RBR	O
preferably	RB	O
at	IN	O
least	JJS	O
15	CD	O
kb	NN	O
,	,	O
and	CC	O
most	JJS	O
preferably	RB	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
,	,	O
herein	RB	O
referred	VBD	O
to	TO	O
as	IN	O
“	JJ	O
spacer	NN	O
”	NN	O
or	CC	O
“	NN	O
stuffer	VBP	O
”	JJ	O
nucleic	JJ	O
acid	NN	O
.	.	O
The	DT	O
spacer	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
may	MD	O
advantageously	RB	O
have	VB	O
the	DT	O
characteristics	NNS	O
as	IN	O
described	JJ	O
infra	NN	O
for	IN	O
spacer	NN	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
in	IN	O
particular	JJ	O
,	,	O
the	DT	O
sequence	NN	O
lacks	VBZ	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
may	MD	O
be	VB	O
built	VBN	O
up	RP	O
at	IN	O
least	JJS	O
in	IN	O
part	NN	O
of	IN	O
intron	NN	O
sequences	NNS	O
,	,	O
and	CC	O
may	MD	O
comprise	VB	O
regulatory	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
E1A	NNP	O
and/or	NN	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
immediately	RB	O
clear	JJ	O
to	TO	O
the	DT	O
skilled	JJ	O
person	NN	O
that	IN	O
in	IN	O
an	DT	O
equivalent	JJ	O
variant	NN	O
of	IN	O
the	DT	O
third	JJ	O
embodiment	NN	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
may	MD	O
be	VB	O
present	JJ	O
on	IN	O
different	JJ	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
instead	RB	O
of	IN	O
on	IN	O
one	CD	O
molecule	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
FIG	NNP	O
.	.	O
13	CD	O
I	PRP	O
,	,	O
II	NNP	O
,	,	O
and	CC	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
Example	NNP	O
3	CD	O
)	)	O
,	,	O
as	RB	O
long	RB	O
as	IN	O
the	DT	O
sequences	NNS	O
are	VBP	O
still	RB	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
the	DT	O
indicated	JJ	O
distance	NN	O
when	WRB	O
different	JJ	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
would	MD	O
form	VB	O
a	DT	O
single	JJ	O
molecule	NN	O
,	,	O
e.g.	NN	O
,	,	O
by	IN	O
(	(	O
homologous	JJ	O
)	)	O
recombination	NN	O
or	CC	O
ligation	NN	O
or	CC	O
end-to-end	JJ	O
joining	NN	O
.	.	O
The	DT	O
idea	NN	O
is	VBZ	O
that	IN	O
also	RB	O
in	IN	O
such	JJ	O
a	DT	O
case	NN	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
will	MD	O
still	RB	O
be	VB	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
6	CD	O
kb	NN	O
,	,	O
more	JJR	O
preferably	RB	O
at	IN	O
least	JJS	O
8	CD	O
kb	NN	O
,	,	O
still	RB	O
more	RBR	O
preferably	RB	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
even	RB	O
still	RB	O
more	RBR	O
preferably	RB	O
at	IN	O
least	JJS	O
15	CD	O
kb	NN	O
,	,	O
and	CC	O
most	JJS	O
preferably	RB	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NNS	O
,	,	O
when	WRB	O
integrating	VBG	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Example	NNP	O
3	CD	O
and	CC	O
FIG	NNP	O
.	.	O
21	CD	O
)	)	O
.	.	O
In	IN	O
other	JJ	O
words	NNS	O
,	,	O
the	DT	O
third	JJ	O
embodiment	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
,	,	O
therefore	RB	O
,	,	O
be	VB	O
performed	VBN	O
by	IN	O
introducing	VBG	O
into	IN	O
a	DT	O
precursor	NN	O
cell	NN	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
(	(	O
“	JJ	O
molecule	NN	O
A	NNP	O
”	NN	O
)	)	O
comprising	VBG	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
at	IN	O
least	JJS	O
two	CD	O
of	IN	O
these	DT	O
three	CD	O
coding	VBG	O
sequences	NNS	O
being	VBG	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
(	(	O
embodiment	JJ	O
3a	CD	O
)	)	O
,	,	O
or	CC	O
equally	RB	O
well	RB	O
by	IN	O
introducing	VBG	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
that	WDT	O
when	WRB	O
these	DT	O
would	MD	O
form	VB	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
,	,	O
would	MD	O
form	VB	O
“	NNP	O
molecule	NN	O
A	NNP	O
”	NNP	O
(	(	O
embodiment	JJ	O
3b	CD	O
)	)	O
.	.	O
In	IN	O
certain	JJ	O
aspects	NNS	O
of	IN	O
the	DT	O
third	JJ	O
embodiment	NN	O
,	,	O
there	EX	O
are	VBP	O
no	DT	O
substantially	RB	O
overlapping	VBG	O
sequences	NNS	O
between	IN	O
the	DT	O
spacer	NN	O
nucleic	JJ	O
acids	NNS	O
flanking	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
,	,	O
nor	CC	O
in	IN	O
the	DT	O
regulatory	JJ	O
sequences	NNS	O
for	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
reduce	VB	O
the	DT	O
chance	NN	O
of	IN	O
interaction	NN	O
and	CC	O
possible	JJ	O
homologous	JJ	O
recombination	NN	O
between	IN	O
these	DT	O
separated	VBN	O
sequences	NNS	O
.	.	O
Recombinant	JJ	O
Molecules	NNP	O
Encoding	NNP	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
provided	VBN	O
is	VBZ	O
a	DT	O
recombinant	JJ	O
molecule	NN	O
comprising	VBG	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
encoding	VBG	O
the	DT	O
adenoviral	JJ	O
E1A	NNP	O
proteins	NNS	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
adenoviral	JJ	O
E1B	NNP	O
protein	NN	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
encoding	VBG	O
E1A	NNP	O
proteins	NNS	O
and	CC	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
encoding	VBG	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
protein	NN	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
more	JJR	O
preferably	RB	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
.	.	O
Such	JJ	O
a	DT	O
molecule	NN	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
method	NN	O
described	VBD	O
herein	NN	O
to	TO	O
generate	VB	O
the	DT	O
cells	NNS	O
described	VBD	O
herein	NN	O
.	.	O
Such	JJ	O
a	DT	O
molecule	NN	O
may	MD	O
take	VB	O
various	JJ	O
forms	NNS	O
known	VBN	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
plasmid	NN	O
,	,	O
cosmid	NN	O
,	,	O
bacterial	JJ	O
artificial	JJ	O
chromosome	NN	O
,	,	O
YAC	NNP	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
an	DT	O
equivalent	JJ	O
embodiment	NN	O
,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
possible	JJ	O
to	TO	O
have	VB	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
protein-encoding	JJ	O
nucleic	JJ	O
acid	NN	O
initially	RB	O
present	JJ	O
as	IN	O
separate	JJ	O
molecules	NNS	O
.	.	O
Such	JJ	O
molecules	NNS	O
may	MD	O
optionally	RB	O
be	VB	O
capable	JJ	O
of	IN	O
forming	VBG	O
a	DT	O
single	JJ	O
molecule	NN	O
by	IN	O
homologous	JJ	O
recombination	NN	O
,	,	O
ligation	NN	O
,	,	O
site-specific	JJ	O
recombination	NN	O
,	,	O
end-to-end	JJ	O
joining	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
It	PRP	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
an	DT	O
aspect	JJ	O
hereof	NN	O
to	TO	O
provide	VB	O
a	DT	O
set	NN	O
of	IN	O
at	IN	O
least	JJS	O
two	CD	O
nucleic	JJ	O
acid	NN	O
molecules	NNS	O
comprising	VBG	O
:	:	O
a	DT	O
)	)	O
a	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
encoding	VBG	O
the	DT	O
E1A	NNP	O
proteins	NNS	O
of	IN	O
an	DT	O
adenovirus	NN	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
has	VBZ	O
at	IN	O
least	JJS	O
5	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
17	CD	O
kb	NN	O
of	IN	O
spacer	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
on	IN	O
both	DT	O
sides	NNS	O
of	IN	O
the	DT	O
E1A	NNP	O
coding	NN	O
sequence	NN	O
,	,	O
the	DT	O
spacer	NN	O
nucleic	RB	O
acid	VBZ	O
not	RB	O
encoding	VBG	O
an	DT	O
E1B	NNP	O
protein	NN	O
;	:	O
and	CC	O
b	NN	O
)	)	O
a	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
encoding	VBG	O
an	DT	O
E1B	NNP	O
protein	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
has	VBZ	O
at	IN	O
least	JJS	O
5	CD	O
kb	NN	O
,	,	O
preferably	RB	O
at	IN	O
least	JJS	O
17	CD	O
kb	NN	O
of	IN	O
spacer	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
on	IN	O
both	DT	O
sides	NNS	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequence	NN	O
,	,	O
the	DT	O
spacer	NN	O
nucleic	RB	O
acid	VBZ	O
not	RB	O
encoding	VBG	O
an	DT	O
E1A	NNP	O
protein	NN	O
.	.	O
The	DT	O
spacer	NN	O
nucleic	JJ	O
acid	NN	O
may	MD	O
be	VB	O
any	DT	O
other	JJ	O
nucleic	JJ	O
acid	NN	O
and	CC	O
preferably	NN	O
is	VBZ	O
chosen	VBN	O
such	JJ	O
that	IN	O
it	PRP	O
is	VBZ	O
inert	JJ	O
,	,	O
i.e.	FW	O
,	,	O
does	VBZ	O
not	RB	O
contain	VB	O
coding	VBG	O
sequences	NNS	O
,	,	O
preferably	RB	O
no	DT	O
known	JJ	O
regulatory	JJ	O
elements	NNS	O
,	,	O
no	DT	O
highly	RB	O
repeated	VBN	O
regions	NNS	O
that	WDT	O
may	MD	O
lead	VB	O
to	TO	O
chromosomal	JJ	O
instability	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
spacer	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
flanking	VBG	O
E1A	NNP	O
encoding	VBG	O
sequences	NNS	O
does	VBZ	O
not	RB	O
contain	VB	O
substantial	JJ	O
homology	NN	O
with	IN	O
the	DT	O
spacer	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
flanking	VBG	O
an	DT	O
E1B	NNP	O
protein	NN	O
encoding	VBG	O
sequence	NN	O
.	.	O
The	DT	O
spacer	NN	O
fragment	NN	O
may	MD	O
include	VB	O
regulatory	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
E1A	NNP	O
or	CC	O
E1B	NNP	O
expression	NN	O
cassettes	NNS	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
heterologous	JJ	O
promoter	NN	O
and/or	NN	O
polyadenylation	NN	O
site	NN	O
.	.	O
The	DT	O
propagation	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
molecules	NNS	O
in	IN	O
a	DT	O
host	NN	O
can	MD	O
usually	RB	O
conveniently	RB	O
be	VB	O
performed	VBN	O
when	WRB	O
the	DT	O
molecules	NNS	O
are	VBP	O
in	IN	O
circular	JJ	O
form	NN	O
.	.	O
In	IN	O
certain	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
recombinant	JJ	O
molecules	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
in	IN	O
a	DT	O
linear	JJ	O
form	NN	O
.	.	O
This	DT	O
may	MD	O
aid	VB	O
in	IN	O
the	DT	O
transfection	NN	O
of	IN	O
the	DT	O
precursor	NN	O
cell	NN	O
lines	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
generally	RB	O
more	RBR	O
efficient	JJ	O
when	WRB	O
linear	JJ	O
molecules	NNS	O
are	VBP	O
used	VBN	O
.	.	O
Linearization	NN	O
may	MD	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
be	VB	O
effected	VBN	O
by	IN	O
digestion	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
molecule	NN	O
with	IN	O
one	CD	O
or	CC	O
more	JJR	O
convenient	JJ	O
restriction	NN	O
enzymes	RB	O
,	,	O
as	IN	O
known	VBN	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Cell	NNP	O
Lines	NNP	O
Lacking	NNP	O
E1	NNP	O
Sequences	NNP	O
in	IN	O
Inverted	NNP	O
Repeat	NNP	O
Orientation	NNP	O
Whatever	NNP	O
the	DT	O
mechanism	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
substantial	JJ	O
overlap	NN	O
between	IN	O
packaging	VBG	O
cell	NN	O
and	CC	O
recombinant	JJ	O
adenovirus	NN	O
,	,	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
first	JJ	O
step	NN	O
in	IN	O
this	DT	O
process	NN	O
is	VBZ	O
an	DT	O
integration	NN	O
event	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
into	IN	O
the	DT	O
virus	NN	O
genome	NN	O
.	.	O
To	TO	O
accommodate	VB	O
for	IN	O
these	DT	O
extra	JJ	O
sequences	NNS	O
,	,	O
the	DT	O
virus	NN	O
must	MD	O
subsequently	RB	O
delete	VB	O
adenovirus	NN	O
sequences	NNS	O
(	(	O
Murakami	NNP	B
et	RB	I
al.	RB	I
,	,	I
2002	CD	I
)	)	O
.	.	O
This	DT	O
step	NN	O
may	MD	O
be	VB	O
more	RBR	O
efficient	JJ	O
when	WRB	O
inverted	VBN	O
repeats	NNS	O
are	VBP	O
present	JJ	O
(	(	O
Steinwaerder	NNP	B
et	VBZ	I
al.	RB	I
,	,	I
1999	CD	I
)	)	O
.	.	O
The	DT	O
PER.C6®	NNP	O
cell	NN	O
line	NN	O
contains	VBZ	O
in	IN	O
its	PRP$	O
genome	JJ	O
several	JJ	O
repeats	NNS	O
of	IN	O
the	DT	O
pIG.E1A.E1B	NN	O
plasmid	NN	O
that	WDT	O
was	VBD	O
used	VBN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
the	DT	O
cell	NN	O
line	NN	O
,	,	O
some	DT	O
of	IN	O
which	WDT	O
repeats	NNS	O
are	VBP	O
in	IN	O
inverted	JJ	O
orientation	NN	O
with	IN	O
respect	NN	O
to	TO	O
each	DT	O
other	JJ	O
.	.	O
Hence	NNP	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
of	IN	O
the	DT	O
E1	NNP	O
region	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
PER.C6®	NNP	O
cells	NNS	O
may	MD	O
influence	VB	O
the	DT	O
frequency	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
.	.	O
It	PRP	O
should	MD	O
be	VB	O
noted	VBN	O
that	IN	O
the	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
particles	NNS	O
could	MD	O
also	RB	O
occur	VB	O
in	IN	O
other	JJ	O
adenovirus	JJ	O
packaging	NN	O
cell	NN	O
lines	NNS	O
,	,	O
but	CC	O
in	IN	O
such	JJ	O
cell	NN	O
lines	NNS	O
goes	VBZ	O
undetected	JJ	O
due	JJ	O
to	TO	O
the	DT	O
appearance	NN	O
of	IN	O
classical	JJ	O
RCA	NNP	O
.	.	O
The	DT	O
absence	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
in	IN	O
inverted	JJ	O
repeat	NN	O
orientation	NN	O
in	IN	O
packaging	NN	O
cell	NN	O
lines	NNS	O
will	MD	O
likely	RB	O
result	VB	O
in	IN	O
a	DT	O
lower	JJR	O
frequency	NN	O
or	CC	O
even	RB	O
complete	JJ	O
absence	NN	O
of	IN	O
generation	NN	O
of	IN	O
HDEP	NNP	O
when	WRB	O
recombinant	JJ	O
adenovirus	NN	O
is	VBZ	O
propagated	VBN	O
on	IN	O
such	JJ	O
packaging	NN	O
cells	NNS	O
.	.	O
When	WRB	O
new	JJ	O
cell	NN	O
lines	NNS	O
comprising	VBG	O
E1	NNP	O
regions	NNS	O
in	IN	O
their	PRP$	O
genome	NN	O
are	VBP	O
generated	VBN	O
or	CC	O
chosen	VBN	O
,	,	O
it	PRP	O
may	MD	O
,	,	O
therefore	VB	O
,	,	O
be	VB	O
desirable	JJ	O
to	TO	O
select	VB	O
clones	NNS	O
that	WDT	O
lack	VBP	O
inverted	JJ	O
repeats	NNS	O
,	,	O
but	CC	O
rather	RB	O
have	VBP	O
only	RB	O
direct	JJ	O
repeats	NNS	O
,	,	O
or	CC	O
even	RB	O
a	DT	O
single	JJ	O
integration	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
an	DT	O
aspect	JJ	O
hereof	NN	O
to	TO	O
provide	VB	O
cells	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
method	NN	O
for	IN	O
providing	VBG	O
or	CC	O
generating	VBG	O
cells	NNS	O
comprising	VBG	O
adenoviral	JJ	O
E1	NNP	O
sequences	NNS	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
method	NN	O
includes	VBZ	O
a	DT	O
step	NN	O
of	IN	O
selecting	VBG	O
cells	NNS	O
lacking	VBG	O
inverted	JJ	O
repeats	NNS	O
comprising	VBG	O
the	DT	O
E1	NNP	O
sequences	NNS	O
.	.	O
Provided	VBN	O
is	VBZ	O
a	DT	O
cell	NN	O
comprising	VBG	O
adenovirus	JJ	O
E1	NNP	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
wherein	VBP	O
the	DT	O
E1	NNP	O
sequences	NNS	O
include	VBP	O
at	IN	O
least	JJS	O
one	CD	O
functional	JJ	O
copy	NN	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
E1	NNP	O
sequences	NNS	O
or	CC	O
part	NN	O
thereof	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
In	IN	O
this	DT	O
embodiment	NN	O
,	,	O
the	DT	O
cell	NN	O
is	VBZ	O
not	RB	O
a	DT	O
293	CD	O
cell	NN	O
or	CC	O
a	DT	O
derivative	JJ	O
thereof	NN	O
.	.	O
If	IN	O
inverted	VBN	O
repeats	NNS	O
are	VBP	O
present	JJ	O
,	,	O
preferably	RB	O
such	JJ	O
inverted	JJ	O
repeats	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
within	IN	O
10	CD	O
kb	NNS	O
in	IN	O
the	DT	O
cell	NN	O
and	CC	O
,	,	O
for	IN	O
the	DT	O
disclosure	NN	O
herein	NN	O
,	,	O
inverted	VBD	O
repeats	NNS	O
with	IN	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
of	IN	O
non-E1	JJ	O
intervening	NN	O
sequence	NN	O
are	VBP	O
not	RB	O
further	RB	O
considered	VBN	O
inverted	JJ	O
repeats	NNS	O
.	.	O
The	DT	O
rationale	NN	O
is	VBZ	O
that	IN	O
when	WRB	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
E1	NNP	O
sequence	NN	O
is	VBZ	O
integrated	VBN	O
somewhere	RB	O
on	IN	O
a	DT	O
chromosome	NN	O
and	CC	O
an	DT	O
inverted	JJ	O
copy	NN	O
would	MD	O
be	VB	O
integrated	VBN	O
on	IN	O
the	DT	O
same	JJ	O
chromosome	NN	O
but	CC	O
at	IN	O
a	DT	O
distance	NN	O
large	JJ	O
enough	RB	O
to	TO	O
prevent	VB	O
uptake	NN	O
of	IN	O
the	DT	O
whole	JJ	O
segment	NN	O
of	IN	O
DNA	NNP	O
comprising	VBG	O
both	DT	O
repeats	NNS	O
in	IN	O
an	DT	O
adenovirus	NN	O
particle	NN	O
,	,	O
no	DT	O
problem	NN	O
is	VBZ	O
envisaged	VBN	O
.	.	O
Also	RB	O
when	WRB	O
the	DT	O
distance	NN	O
is	VBZ	O
such	JJ	O
that	IN	O
uptake	NN	O
of	IN	O
the	DT	O
fragment	NN	O
is	VBZ	O
possible	JJ	O
(	(	O
i.e.	JJ	O
,	,	O
10	CD	O
kb	NN	O
)	)	O
,	,	O
the	DT	O
duplication	NN	O
of	IN	O
the	DT	O
left	JJ	O
end	NN	O
resulting	VBG	O
from	IN	O
the	DT	O
inverted	JJ	O
repeat	NN	O
sequence	NN	O
gives	VBZ	O
a	DT	O
virus	NN	O
genome	NN	O
that	WDT	O
is	VBZ	O
too	RB	O
large	JJ	O
to	TO	O
be	VB	O
packaged	VBN	O
(	(	O
exemplified	VBN	O
in	IN	O
FIG	NNP	O
.	.	O
13	CD	O
)	)	O
.	.	O
The	DT	O
site	NN	O
of	IN	O
insertion	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
virus	NN	O
genome	NN	O
is	VBZ	O
important	JJ	O
for	IN	O
the	DT	O
final	JJ	O
total	NN	O
length	NN	O
of	IN	O
the	DT	O
HDEP	NNP	O
.	.	O
It	PRP	O
is	VBZ	O
obvious	JJ	O
that	IN	O
the	DT	O
chance	NN	O
that	IN	O
incorporation	NN	O
of	IN	O
an	DT	O
E1-containing	JJ	O
genomic	JJ	O
fragment	NN	O
results	NNS	O
in	IN	O
a	DT	O
packagable	JJ	O
genome	NN	O
increases	NNS	O
when	WRB	O
the	DT	O
insertion	NN	O
is	VBZ	O
more	RBR	O
to	TO	O
the	DT	O
left	JJ	O
end	NN	O
of	IN	O
the	DT	O
virus	NN	O
.	.	O
If	IN	O
the	DT	O
site	NN	O
of	IN	O
insertion	NN	O
is	VBZ	O
just	RB	O
3′	CD	O
from	IN	O
the	DT	O
minimal	JJ	O
packaging	NN	O
signal	NN	O
,	,	O
then	RB	O
the	DT	O
insert	NN	O
can	MD	O
be	VB	O
as	RB	O
large	JJ	O
as	IN	O
18.5	CD	O
kb	NNS	O
(	(	O
including	VBG	O
one	CD	O
copy	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
and	CC	O
an	DT	O
inverted	JJ	O
repeat	NN	O
sequence	NN	O
)	)	O
and	CC	O
still	RB	O
remain	VB	O
packagable	JJ	O
(	(	O
assuming	VBG	O
a	DT	O
left	NN	O
to	TO	O
right	JJ	O
end	NN	O
duplication	NN	O
including	VBG	O
350	CD	O
by	IN	O
ITR	NNP	O
and	CC	O
packaging	VBG	O
signal	NN	O
)	)	O
.	.	O
This	DT	O
does	VBZ	O
not	RB	O
mean	VB	O
that	IN	O
an	DT	O
insert	NN	O
of	IN	O
,	,	O
e.g.	UH	O
,	,	O
17	CD	O
kb	NN	O
will	MD	O
easily	RB	O
generate	VB	O
HDEPs	NNP	O
since	IN	O
the	DT	O
possible	JJ	O
sites	NNS	O
of	IN	O
integration	NN	O
of	IN	O
such	PDT	O
a	DT	O
fragment	NN	O
that	WDT	O
still	RB	O
results	NNS	O
in	IN	O
a	DT	O
virus	NN	O
of	IN	O
packagable	JJ	O
size	NN	O
is	VBZ	O
limited	VBN	O
to	TO	O
1.5	CD	O
kb	NN	O
just	RB	O
3′	CD	O
to	TO	O
the	DT	O
minimal	JJ	O
packaging	NN	O
sequence	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
frequency	NN	O
of	IN	O
generation	NN	O
of	IN	O
HDEP	NNP	O
will	MD	O
decrease	VB	O
with	IN	O
increasing	VBG	O
distance	NN	O
between	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
regions	NNS	O
and	CC	O
may	MD	O
very	RB	O
well	RB	O
still	RB	O
be	VB	O
below	IN	O
detection	NN	O
when	WRB	O
that	DT	O
distance	NN	O
is	VBZ	O
much	RB	O
smaller	JJR	O
than	IN	O
the	DT	O
mentioned	JJ	O
18.5	CD	O
kb	NN	O
.	.	O
The	DT	O
same	JJ	O
reasoning	NN	O
holds	VBZ	O
true	JJ	O
for	IN	O
direct	JJ	O
insertion	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
inverted	JJ	O
repeat	NN	O
sequences	NNS	O
.	.	O
In	IN	O
that	DT	O
case	NN	O
,	,	O
the	DT	O
total	JJ	O
insertion	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
can	MD	O
not	RB	O
be	VB	O
larger	JJR	O
than	IN	O
37.5	CD	O
kb	NNS	O
(	(	O
including	VBG	O
about	IN	O
3	CD	O
kb	NN	O
for	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
region	NN	O
)	)	O
,	,	O
but	CC	O
only	RB	O
when	WRB	O
it	PRP	O
inserts	VBZ	O
directly	RB	O
3′	CD	O
from	IN	O
the	DT	O
minimal	JJ	O
packaging	NN	O
signal	NN	O
.	.	O
Therefore	RB	O
,	,	O
when	WRB	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
,	,	O
insertion	NN	O
of	IN	O
both	DT	O
of	IN	O
these	DT	O
sequences	NNS	O
into	IN	O
a	DT	O
recombinant	JJ	O
adenovirus	NN	O
is	VBZ	O
prevented	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
whole	JJ	O
adenovirus	NN	O
genome	NN	O
should	MD	O
then	RB	O
be	VB	O
deleted	VBN	O
in	IN	O
a	DT	O
subsequent	JJ	O
step	NN	O
,	,	O
which	WDT	O
process	NN	O
may	MD	O
further	RB	O
be	VB	O
much	RB	O
less	RBR	O
efficient	JJ	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
inverted	JJ	O
repeat	NN	O
sequences	NNS	O
(	(	O
Steinwaerder	NNP	B
et	VBZ	I
al.	RB	I
,	,	I
1999	CD	I
)	)	O
.	.	O
In	IN	O
any	DT	O
case	NN	O
,	,	O
irrespective	NN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
inverted	JJ	O
E1	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
genome	NN	O
,	,	O
the	DT	O
chance	NN	O
of	IN	O
generating	VBG	O
particles	NNS	O
containing	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
is	VBZ	O
reduced	VBN	O
when	WRB	O
the	DT	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
further	JJ	O
apart	RB	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
Hence	NNP	O
,	,	O
in	IN	O
certain	JJ	O
embodiments	NNS	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
6	CD	O
kb	NN	O
,	,	O
8	CD	O
kb	NN	O
,	,	O
10	CD	O
kb	NN	O
,	,	O
12	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cells	NNS	O
according	VBG	O
to	TO	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
these	DT	O
embodiments	NNS	O
,	,	O
preferably	RB	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
15	CD	O
kb	NNS	O
and	CC	O
no	DT	O
inverted	JJ	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
present	JJ	O
,	,	O
which	WDT	O
will	MD	O
ensure	VB	O
that	IN	O
the	DT	O
theoretical	JJ	O
possibility	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
in	IN	O
such	JJ	O
a	DT	O
cell	NN	O
line	NN	O
by	IN	O
introduction	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cell	NN	O
line	NN	O
into	IN	O
an	DT	O
adenovirus	NN	O
is	VBZ	O
practically	RB	O
reduced	VBN	O
to	TO	O
zero	CD	O
(	(	O
see	VB	O
,	,	O
FIG	NNP	O
.	.	O
13	CD	O
)	)	O
.	.	O
In	IN	O
other	JJ	O
embodiments	NNS	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
18	CD	O
kb	NN	O
,	,	O
20	CD	O
kb	NN	O
,	,	O
25	CD	O
kb	NN	O
,	,	O
30	CD	O
kb	NN	O
.	.	O
Most	JJS	O
preferably	RB	O
,	,	O
the	DT	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
.	.	O
This	DT	O
will	MD	O
ensure	VB	O
that	IN	O
no	DT	O
single	JJ	O
integration	NN	O
of	IN	O
both	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
derived	VBD	O
from	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cell	NN	O
can	MD	O
result	VB	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
HDEP	NNP	O
.	.	O
Obviously	RB	O
,	,	O
as	IN	O
indicated	VBN	O
above	IN	O
,	,	O
in	IN	O
certain	JJ	O
equivalent	JJ	O
embodiments	NNS	O
,	,	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
are	VBP	O
present	JJ	O
on	IN	O
different	JJ	O
chromosomes	NNS	O
of	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cell	NN	O
.	.	O
Methods	NNS	O
for	IN	O
screening	VBG	O
generated	VBN	O
clones	NNS	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
of	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
and	CC	O
may	MD	O
include	VB	O
PCR	NNP	O
,	,	O
Southern	NNP	O
blotting	NN	O
,	,	O
restriction	NN	O
enzyme	NN	O
analysis	NN	O
,	,	O
Fiber-FISH	NNP	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Upon	IN	O
generating	VBG	O
cell	NN	O
clones	NNS	O
using	VBG	O
a	DT	O
plasmid	NN	O
containing	VBG	O
the	DT	O
E1	NNP	O
genes	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
pIG.E1A.E1B	NN	O
plasmid	NN	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
)	)	O
,	,	O
clones	NNS	O
can	MD	O
be	VB	O
first	RB	O
established	VBN	O
,	,	O
and	CC	O
in	IN	O
a	DT	O
screening	NN	O
round	NN	O
,	,	O
those	DT	O
clones	NNS	O
lacking	VBG	O
the	DT	O
inverted	JJ	O
repeat	NN	O
are	VBP	O
picked	VBN	O
for	IN	O
further	JJ	O
use	NN	O
.	.	O
The	DT	O
cells	NNS	O
from	IN	O
the	DT	O
picked	JJ	O
clones	NNS	O
can	MD	O
then	RB	O
be	VB	O
suitably	RB	O
used	VBN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
expected	VBN	O
that	IN	O
the	DT	O
frequency	NN	O
of	IN	O
generating	VBG	O
HDEP	NNP	O
on	IN	O
these	DT	O
cells	NNS	O
will	MD	O
be	VB	O
significantly	RB	O
lower	JJR	O
(	(	O
or	CC	O
even	RB	O
absent	NN	O
)	)	O
than	IN	O
in	IN	O
cells	NNS	O
that	WDT	O
do	VBP	O
contain	VB	O
the	DT	O
inverted	JJ	O
repeats	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
,	,	O
therefore	RB	O
,	,	O
another	DT	O
aspect	NN	O
hereof	NN	O
to	TO	O
provide	VB	O
a	DT	O
cell	NN	O
comprising	VBG	O
adenovirus	JJ	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
,	,	O
characterized	VBN	O
in	IN	O
that	DT	O
the	DT	O
E1	NNP	O
sequences	NNS	O
are	VBP	O
not	RB	O
present	JJ	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
For	IN	O
this	DT	O
aspect	JJ	O
hereof	NN	O
,	,	O
sequences	NNS	O
that	WDT	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
of	IN	O
non-E1	JJ	O
sequence	NN	O
are	VBP	O
not	RB	O
to	TO	O
be	VB	O
considered	VBN	O
as	IN	O
inverted	JJ	O
repeats	NNS	O
.	.	O
In	IN	O
a	DT	O
specific	JJ	O
aspect	NN	O
,	,	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
genome	NN	O
in	IN	O
at	IN	O
least	JJS	O
two	CD	O
copies	NNS	O
per	IN	O
genome	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
at	IN	O
least	JJS	O
two	CD	O
copies	NNS	O
comprise	VBP	O
at	IN	O
least	JJS	O
two	CD	O
copies	NNS	O
present	VBP	O
on	IN	O
one	CD	O
chromosome	NN	O
.	.	O
In	IN	O
another	DT	O
embodiment	NN	O
,	,	O
the	DT	O
cells	NNS	O
comprise	VBP	O
in	IN	O
their	PRP$	O
genome	NN	O
only	RB	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
E1	NNP	O
A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
regions	NNS	O
,	,	O
while	IN	O
lacking	VBG	O
sequences	NNS	O
encoding	VBG	O
adenovirus	NN	O
pIX	NN	O
.	.	O
Of	IN	O
course	NN	O
,	,	O
a	DT	O
cell	NN	O
comprising	VBG	O
only	RB	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
in	IN	O
its	PRP$	O
genome	NN	O
should	MD	O
be	VB	O
expected	VBN	O
to	TO	O
have	VB	O
a	DT	O
lower	JJR	O
frequency	NN	O
(	(	O
or	CC	O
even	RB	O
absence	NN	O
)	)	O
of	IN	O
HDEP	NNP	O
generation	NN	O
.	.	O
Use	NNP	O
of	IN	O
the	DT	O
Cells	NNP	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
provided	VBN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
generating	VBG	O
recombinant	JJ	O
adenovirus	NN	O
in	IN	O
the	DT	O
cells	NNS	O
hereof	NN	O
.	.	O
This	DT	O
will	MD	O
generate	VB	O
recombinant	JJ	O
adenovirus	NN	O
batches	NNS	O
having	VBG	O
a	DT	O
significantly	RB	O
reduced	JJ	O
frequency	NN	O
of	IN	O
HDEP	NNP	O
compared	VBN	O
to	TO	O
the	DT	O
batches	NNS	O
produced	VBN	O
on	IN	O
the	DT	O
systems	NNS	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
preferably	RB	O
no	DT	O
HDEP	NNP	O
at	IN	O
all	DT	O
.	.	O
In	IN	O
particularly	RB	O
preferred	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
vector	NN	O
and	CC	O
packaging	NN	O
cell	NN	O
used	VBN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
lack	VBP	O
substantial	JJ	O
sequence	NN	O
overlap	NN	O
(	(	O
i.e.	FW	O
,	,	O
preferably	RB	O
less	JJR	O
than	IN	O
10	CD	O
nt	JJ	O
,	,	O
or	CC	O
more	JJR	O
preferably	RB	O
,	,	O
no	DT	O
overlap	NN	O
at	IN	O
all	DT	O
)	)	O
,	,	O
and	CC	O
preferably	RB	O
have	VBP	O
no	DT	O
overlap	NN	O
,	,	O
thereby	RB	O
minimizing	VBG	O
the	DT	O
chance	NN	O
of	IN	O
homologous	JJ	O
recombination	NN	O
between	IN	O
vector	NN	O
and	CC	O
sequences	NNS	O
in	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
,	,	O
resulting	VBG	O
in	IN	O
virus	NN	O
batches	NNS	O
having	VBG	O
no	DT	O
E1-containing	JJ	O
particles	NNS	O
(	(	O
HDEP	NNP	O
,	,	O
RCA	NNP	O
)	)	O
.	.	O
It	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
noted	VBN	O
that	IN	O
the	DT	O
new	JJ	O
cells	NNS	O
provided	VBN	O
described	JJ	O
herein	NN	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
for	IN	O
the	DT	O
production	NN	O
of	IN	O
recombinant	JJ	O
proteins	NNS	O
as	IN	O
described	VBN	O
earlier	RBR	O
(	(	O
WO	NNP	O
00/63403	CD	O
)	)	O
and	CC	O
for	IN	O
producing	VBG	O
other	JJ	O
(	(	O
non-adenoviral	JJ	O
)	)	O
viruses	VBZ	O
as	IN	O
described	VBN	O
earlier	RBR	O
(	(	O
WO	NNP	O
01/38362	CD	O
)	)	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
clear	JJ	O
to	TO	O
the	DT	O
person	NN	O
skilled	VBD	O
in	IN	O
the	DT	O
art	NN	O
that	IN	O
the	DT	O
serotype	NN	O
or	CC	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
transgene	NN	O
is	VBZ	O
not	RB	O
critical	JJ	O
to	TO	O
the	DT	O
invention	NN	O
.	.	O
It	PRP	O
will	MD	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
be	VB	O
immediately	RB	O
clear	JJ	O
that	IN	O
the	DT	O
adenoviral	JJ	O
E1	NNP	O
coding	NN	O
sequences	NNS	O
that	WDT	O
are	VBP	O
used	VBN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
the	DT	O
cells	NNS	O
can	MD	O
be	VB	O
taken	VBN	O
from	IN	O
any	DT	O
convenient	JJ	O
serotype	NN	O
compatible	NN	O
with	IN	O
the	DT	O
adenovirus	NN	O
that	WDT	O
is	VBZ	O
to	TO	O
be	VB	O
propagated	VBN	O
on	IN	O
the	DT	O
cells	NNS	O
,	,	O
such	JJ	O
as	IN	O
Ad5	NNP	O
,	,	O
Ad35	NNP	O
,	,	O
Ad11	NNP	O
,	,	O
Ad16	NNP	O
,	,	O
Ad49	NNP	O
etc.	NN	O
,	,	O
or	CC	O
combinations	NNS	O
thereof	VBP	O
,	,	O
i.e.	FW	O
,	,	O
E1A	NNP	O
from	IN	O
one	CD	O
serotype	NN	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
from	IN	O
another	DT	O
serotype	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
WO	NNP	O
02/40665	CD	O
)	)	O
.	.	O
It	PRP	O
will	MD	O
also	RB	O
be	VB	O
clear	JJ	O
that	IN	O
in	IN	O
many	JJ	O
other	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
invention	NN	O
may	MD	O
be	VB	O
varied	VBN	O
without	IN	O
departing	VBG	O
from	IN	O
the	DT	O
scope	NN	O
or	CC	O
the	DT	O
spirit	NN	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
will	MD	O
now	RB	O
be	VB	O
illustrated	VBN	O
by	IN	O
the	DT	O
following	JJ	O
examples	NNS	O
,	,	O
which	WDT	O
should	MD	O
not	RB	O
be	VB	O
construed	VBN	O
to	TO	O
limit	VB	O
the	DT	O
scope	NN	O
thereof	NN	O
.	.	O
EXAMPLES	VB	O
The	DT	O
practice	NN	O
of	IN	O
this	DT	O
disclosure	NN	O
will	MD	O
typically	RB	O
employ	VB	O
,	,	O
unless	IN	O
otherwise	RB	O
indicated	VBN	O
,	,	O
conventional	JJ	O
techniques	NNS	O
of	IN	O
molecular	JJ	O
biology	NN	O
,	,	O
cell	NN	O
biology	NN	O
,	,	O
and	CC	O
recombinant	JJ	O
DNA	NNP	O
,	,	O
which	WDT	O
are	VBP	O
within	IN	O
the	DT	O
skill	NN	O
of	IN	O
the	DT	O
art	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Sambrook	NNP	B
,	,	I
Fritsch	NNP	I
and	CC	I
Maniatis	NNP	I
,	,	I
Molecular	NNP	I
Cloning	NNP	I
:	:	I
A	DT	I
Laboratory	NNP	I
Manual	NNP	I
,	,	I
2nd	CD	I
edition	NN	I
,	,	I
1989	CD	I
;	:	O
Current	NNP	B
Protocols	NNP	I
in	IN	I
Molecular	NNP	I
Biology	NNP	I
,	,	I
F.	NNP	I
M.	NNP	I
Ausubel	NNP	I
et	FW	I
al.	NN	I
,	,	I
eds.	NN	I
,	,	I
1987	CD	I
;	:	O
the	DT	O
series	NN	O
Methods	NNP	B
in	IN	I
Enzymology	NNP	I
(	(	I
Academic	NNP	I
Press	NNP	I
,	,	I
Inc.	NNP	I
)	)	I
;	:	O
PCR2	NNP	B
:	:	I
A	DT	I
Practical	NNP	I
Approach	NNP	I
,	,	I
M.	NNP	I
J.	NNP	I
MacPherson	NNP	I
,	,	I
B.	NNP	I
D.	NNP	I
Hams	NNP	I
,	,	I
G.	NNP	I
R.	NNP	I
Taylor	NNP	I
,	,	I
eds.	NN	I
,	,	I
1995	CD	I
.	.	O
Example	RB	O
1	CD	O
Generation	NNP	O
of	IN	O
Complementing	NNP	O
Cell	NNP	O
Lines	NNP	O
Using	NNP	O
Separate	NNP	O
Nucleic	NNP	O
Acids	NNP	O
Encoding	NNP	O
E1A	NNP	O
And	CC	O
E1B	NNP	O
Proteins	VBZ	O
The	DT	O
complete	JJ	O
morphological	JJ	O
transformation	NN	O
of	IN	O
primary	JJ	O
cells	NNS	O
by	IN	O
adenovirus	NN	O
E1	NNP	O
genes	NNS	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
the	DT	O
combined	JJ	O
activities	NNS	O
of	IN	O
the	DT	O
proteins	NNS	O
encoded	VBN	O
by	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
regions	NNS	O
.	.	O
The	DT	O
roles	NNS	O
of	IN	O
the	DT	O
different	JJ	O
E1	NNP	O
proteins	NNS	O
in	IN	O
lytic	JJ	O
infection	NN	O
and	CC	O
in	IN	O
transformation	NN	O
have	VBP	O
been	VBN	O
studied	VBN	O
extensively	RB	O
(	(	O
reviewed	VBN	O
in	IN	O
Zantema	NNP	B
and	CC	I
van	JJ	I
der	NN	I
Eb	NNP	I
,	,	I
1995	CD	I
;	:	O
White	NNP	B
,	,	I
1995	CD	I
,	,	I
1996	CD	I
)	)	O
.	.	O
The	DT	O
adenovirus	NN	O
E1A	NNP	O
proteins	NNS	O
are	VBP	O
essential	JJ	O
for	IN	O
transformation	NN	O
of	IN	O
primary	JJ	O
cells	NNS	O
.	.	O
The	DT	O
concomitant	JJ	O
induction	NN	O
of	IN	O
apoptosis	NN	O
is	VBZ	O
counteracted	VBN	O
by	IN	O
both	DT	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
,	,	O
although	IN	O
by	IN	O
different	JJ	O
mechanisms	NNS	O
.	.	O
Although	IN	O
the	DT	O
E1A	NNP	O
region	NN	O
encodes	VBZ	O
several	JJ	O
proteins	NNS	O
,	,	O
the	DT	O
whole	JJ	O
region	NN	O
is	VBZ	O
usually	RB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
“	NNP	O
E1A	NNP	O
coding	VBG	O
region	NN	O
”	NN	O
and	CC	O
in	IN	O
all	DT	O
embodiments	NNS	O
,	,	O
the	DT	O
“	NNP	O
E1A	NNP	O
coding	VBG	O
sequence	NN	O
”	NN	O
as	IN	O
used	VBN	O
herein	NN	O
refers	NNS	O
to	TO	O
the	DT	O
sequences	NNS	O
encoding	VBG	O
all	DT	O
E1	NNP	O
A	NNP	O
proteins	VBZ	O
.	.	O
In	IN	O
rodent	NN	O
cells	NNS	O
,	,	O
the	DT	O
activity	NN	O
of	IN	O
E1A	NNP	O
together	RB	O
with	IN	O
either	DT	O
E1B-19K	NNP	O
or	CC	O
55K	CD	O
is	VBZ	O
sufficient	JJ	O
for	IN	O
full	JJ	O
transformation	NN	O
,	,	O
although	IN	O
expression	NN	O
of	IN	O
both	DT	O
E1B	NNP	O
proteins	VBZ	O
together	RB	O
is	VBZ	O
twice	RB	O
as	RB	O
efficient	JJ	O
(	(	O
Gallimore	NNP	B
et	FW	I
al.	NN	I
,	,	I
1985	CD	I
;	:	O
Rao	NNP	B
et	FW	I
al.	NN	I
,	,	I
1992	CD	I
)	)	O
.	.	O
In	IN	O
human	JJ	O
cells	NNS	O
,	,	O
however	RB	O
,	,	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
E1B-55K	NNP	O
protein	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
more	RBR	O
important	JJ	O
,	,	O
given	VBN	O
the	DT	O
observation	NN	O
that	IN	O
E1B-55K	NNP	O
is	VBZ	O
indispensable	JJ	O
for	IN	O
the	DT	O
establishment	NN	O
of	IN	O
an	DT	O
immortal	NN	O
transformed	VBD	O
cell	NN	O
line	NN	O
(	(	O
Gallimore	NNP	B
et	FW	I
al.	NN	I
,	,	I
1986	CD	I
)	)	O
.	.	O
In	IN	O
adenovirus	JJ	O
infection	NN	O
and	CC	O
virus	NN	O
propagation	NN	O
,	,	O
the	DT	O
E1A	NNP	O
proteins	VBZ	O
function	NN	O
in	IN	O
activation	NN	O
of	IN	O
the	DT	O
adenovirus	NN	O
genes	NNS	O
,	,	O
including	VBG	O
E1B	NNP	O
and	CC	O
other	JJ	O
early	JJ	O
regions	NNS	O
,	,	O
probably	RB	O
via	IN	O
interaction	NN	O
with	IN	O
the	DT	O
TATA-binding	JJ	O
protein	NN	O
(	(	O
reviewed	VBN	O
in	IN	O
Zantema	NNP	B
and	CC	I
van	JJ	I
der	NN	I
Eb	NNP	I
,	,	I
1995	CD	I
)	)	O
.	.	O
E1B-55K	JJ	O
expression	NN	O
is	VBZ	O
important	JJ	O
in	IN	O
the	DT	O
late	JJ	O
phase	NN	O
of	IN	O
infection	NN	O
for	IN	O
shut-off	NN	O
of	IN	O
host	NN	O
protein	NN	O
synthesis	NN	O
and	CC	O
selective	JJ	O
transport	NN	O
from	IN	O
the	DT	O
nucleus	NN	O
to	TO	O
the	DT	O
cytoplasm	NN	O
of	IN	O
viral-encoded	JJ	O
proteins	NNS	O
(	(	O
Babiss	NNP	B
et	RB	I
al.	RB	I
,	,	I
1985	CD	I
;	:	O
Pilder	NNP	B
et	FW	I
al.	NN	I
,	,	I
1986	CD	I
)	)	O
.	.	O
Adenoviruses	NNS	O
that	WDT	O
are	VBP	O
deleted	VBN	O
for	IN	O
E1B-55K	NNP	O
show	NN	O
decreased	VBD	O
replication	NN	O
on	IN	O
non-complementing	JJ	O
human	NN	O
cell	NN	O
lines	NNS	O
(	(	O
Harada	NNP	B
and	CC	I
Berk	NNP	I
,	,	I
1999	CD	I
)	)	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
E1A-	NNP	O
and	CC	O
E1B-55K-encoded	JJ	O
proteins	NNS	O
are	VBP	O
necessary	JJ	O
for	IN	O
transformation	NN	O
of	IN	O
primary	JJ	O
human	JJ	O
cells	NNS	O
and	CC	O
for	IN	O
efficient	JJ	O
virus	NN	O
replication	NN	O
in	IN	O
human	JJ	O
cells	NNS	O
.	.	O
Non-homologous	JJ	O
recombination	NN	O
can	MD	O
result	VB	O
in	IN	O
incorporation	NN	O
of	IN	O
E1	NNP	O
sequences	NNS	O
from	IN	O
the	DT	O
cellular	JJ	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
into	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
.	.	O
The	DT	O
helper-dependent	JJ	O
E1-containing	JJ	O
particles	NNS	O
that	WDT	O
finally	RB	O
result	VBP	O
from	IN	O
the	DT	O
initial	JJ	O
recombined	JJ	O
adenovirus	NN	O
are	VBP	O
able	JJ	O
to	TO	O
complement	VB	O
replication	NN	O
of	IN	O
the	DT	O
replication-deficient	JJ	O
vector	NN	O
on	IN	O
non-complementing	JJ	O
(	(	O
human	JJ	O
)	)	O
cells	NNS	O
,	,	O
but	CC	O
are	VBP	O
incapable	JJ	O
of	IN	O
autonomous	JJ	O
replication	NN	O
.	.	O
This	DT	O
complementation	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
both	DT	O
E1A	NNP	O
and	CC	O
E1B-55K	NNP	O
and	CC	O
possibly	RB	O
E1B-19K	NNP	O
functions	NNS	O
.	.	O
Thus	RB	O
,	,	O
if	IN	O
the	DT	O
chance	NN	O
that	IN	O
both	DT	O
E1A	NNP	O
and	CC	O
E1B-55K	NNP	O
(	(	O
and	CC	O
preferably	RB	O
E1B-19K	NNP	O
)	)	O
functions	NNS	O
end	VBP	O
up	RP	O
in	IN	O
the	DT	O
adenoviral	JJ	O
vector	NN	O
is	VBZ	O
eliminated	VBN	O
or	CC	O
reduced	VBN	O
,	,	O
then	RB	O
the	DT	O
formation	NN	O
of	IN	O
HDEP	NNP	O
will	MD	O
be	VB	O
eliminated	VBN	O
or	CC	O
reduced	VBN	O
.	.	O
Here	RB	O
,	,	O
we	PRP	O
describe	VBP	O
examples	NNS	O
of	IN	O
functional	JJ	O
plasmids	NNS	O
expressing	VBG	O
either	CC	O
E1A	NNP	O
,	,	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
,	,	O
E1B	NNP	O
(	(	O
E1B-19K+E1B-55K	NNP	O
)	)	O
or	CC	O
E1B-55K	JJ	O
that	WDT	O
are	VBP	O
used	VBN	O
to	TO	O
generate	VB	O
adenoviral	JJ	O
packaging	NN	O
cell	NN	O
lines	NNS	O
with	IN	O
E1A	NNP	O
and	CC	O
E1B-55k	NNP	O
regions	NNS	O
separated	VBD	O
from	IN	O
each	DT	O
other	JJ	O
.	.	O
Construct	NN	O
pIG.E1A.E1B	NN	O
(	(	O
FIG	NNP	O
.	.	O
14	CD	O
;	:	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
of	IN	O
the	DT	O
accompanying	VBG	O
SEQUENCE	NNP	O
LISTING	NNP	O
,	,	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
)	)	O
containing	VBG	O
the	DT	O
Ad5-E1	JJ	O
region	NN	O
(	(	O
nucl	UH	O
.	.	O
459-3510	CD	O
of	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
(	(	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M73260	NNP	O
)	)	O
operatively	RB	O
linked	VBN	O
to	TO	O
the	DT	O
human	JJ	O
phosphoglycerate	NN	O
kinase	NN	O
(	(	O
PGK	NNP	O
)	)	O
promoter	NN	O
and	CC	O
hepatitis	NN	O
B	NNP	O
virus	NN	O
poly-adenylation	NN	O
sequence	NN	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
previously	RB	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,994,128	CD	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
Construct	NNP	O
pIG.E1A	FW	O
Construct	NNP	O
pIG.E1A	NN	O
was	VBD	O
made	VBN	O
by	IN	O
digestion	NN	O
of	IN	O
pIG.E1A.E1B	NN	O
with	IN	O
Hincll	NNP	O
followed	VBN	O
by	IN	O
purification	NN	O
of	IN	O
the	DT	O
resulting	VBG	O
5	CD	O
kb	JJ	O
fragment	NN	O
from	IN	O
gel	NN	O
using	VBG	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
.	.	O
Religation	NN	O
of	IN	O
the	DT	O
isolated	JJ	O
fragment	NN	O
and	CC	O
transformation	NN	O
into	IN	O
STBL2-competent	JJ	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
gave	VBD	O
pIG.E1A	NN	O
(	(	O
FIG	NNP	O
.	.	O
1	CD	O
)	)	O
.	.	O
This	DT	O
construct	NN	O
contains	VBZ	O
nt	JJ	O
.	.	O
459	CD	O
to	TO	O
1578	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
(	(	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M73260	NNP	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
Construct	NNP	O
pIG.E1AB21	FW	O
Construct	NNP	O
pIG.E1A	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
XbaI	NNP	O
and	CC	O
HpaI	NNP	O
and	CC	O
the	DT	O
resulting	VBG	O
4.8	CD	O
kb	JJ	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
as	IN	O
above	NN	O
.	.	O
Construct	NNP	O
pIG.E1A.E1B	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
BsrGI	NNP	O
and	CC	O
treated	VBN	O
with	IN	O
Klenow	NNP	O
enzyme	FW	O
(	(	O
New	NNP	O
England	NNP	O
Biolabs	NNP	O
)	)	O
to	TO	O
blunt	VB	O
the	DT	O
5′	CD	O
protruding	NN	O
ends	NNS	O
.	.	O
DNA	NN	O
was	VBD	O
then	RB	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
and	CC	O
subsequently	RB	O
digested	VBN	O
with	IN	O
XbaI	NNP	O
.	.	O
The	DT	O
resulting	VBG	O
913	CD	O
by	IN	O
fragment	NN	O
containing	VBG	O
the	DT	O
3′	CD	O
part	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
the	DT	O
E1B19K	NNP	O
coding	VBG	O
sequence	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
as	IN	O
described	NN	O
.	.	O
Ligation	NN	O
of	IN	O
the	DT	O
two	CD	O
isolated	JJ	O
fragments	NNS	O
and	CC	O
transformation	NN	O
into	IN	O
DH5α-T1r	NNP	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
gave	VBD	O
construct	NN	O
pIG.E1AB21	NN	O
(	(	O
FIG	NNP	O
.	.	O
2	CD	O
)	)	O
.	.	O
This	DT	O
construct	NN	O
thus	RB	O
contains	VBZ	O
nt	JJ	O
.	.	O
459	CD	O
to	TO	O
2253	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
(	(	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M73260	NNP	O
)	)	O
,	,	O
so	RB	O
that	IN	O
the	DT	O
E1A	NNP	O
sequence	NN	O
is	VBZ	O
driven	VBN	O
by	IN	O
the	DT	O
PGK	NNP	O
promoter	NN	O
and	CC	O
the	DT	O
E1B	NNP	O
promoter	NN	O
drives	VBZ	O
the	DT	O
E1B-19K	JJ	O
gene	NN	O
.	.	O
The	DT	O
Ad5	NNP	O
E1B-19K	NNP	O
gene	NN	O
is	VBZ	O
sometimes	RB	O
also	RB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
Ad5	NNP	O
E1B-21K	NNP	O
gene	NN	O
because	IN	O
the	DT	O
predicted	JJ	O
amino	NN	O
acid	JJ	O
sequence	NN	O
constitutes	VBZ	O
a	DT	O
20.6	CD	O
KD	NNP	O
protein	NN	O
(	(	O
for	IN	O
instance	NN	O
,	,	O
several	JJ	O
of	IN	O
the	DT	O
plasmids	NNS	O
and	CC	O
primers	NNS	O
in	IN	O
this	DT	O
application	NN	O
have	VBP	O
21K	CD	O
as	IN	O
part	NN	O
of	IN	O
their	PRP$	O
names	NNS	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
Construct	NNP	O
pCR5B	FW	O
A	NNP	O
construct	NN	O
containing	VBG	O
the	DT	O
Ad5-E1B	JJ	O
region	NN	O
was	VBD	O
then	RB	O
generated	VBN	O
as	IN	O
follows	VBZ	O
.	.	O
First	RB	O
,	,	O
a	DT	O
PCR	NNP	O
fragment	NN	O
was	VBD	O
generated	VBN	O
with	IN	O
primers	NNS	O
5E1Bfor-1	JJ	O
:	:	O
5′-CGG	JJ	O
AAT	NNP	O
TCG	NNP	O
GCG	NNP	O
TGT	NNP	O
TAA	NNP	O
ATG	NNP	O
GGG	NNP	O
CG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
)	)	O
and	CC	O
5E1B-rev	JJ	O
:	:	O
5′-TAG	JJ	O
CAG	NNP	O
GCG	NNP	O
ATT	NNP	O
CTT	NNP	O
GTG	NNP	O
TC-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:3	NNP	O
)	)	O
,	,	O
using	VBG	O
pIG.E1A.E1B	JJ	O
DNA	NNP	O
as	IN	O
template	NN	O
and	CC	O
Pwo	NNP	O
DNA	NNP	O
polymerase	NN	O
(	(	O
Roche	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
with	IN	O
DMSO	NNP	O
at	IN	O
3	CD	O
%	NN	O
final	JJ	O
concentration	NN	O
.	.	O
The	DT	O
amplification	NN	O
program	NN	O
was	VBD	O
94°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
followed	VBN	O
by	IN	O
30	CD	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
50°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
one	CD	O
minute	NN	O
)	)	O
and	CC	O
ended	VBN	O
by	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
ten	JJ	O
minutes	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
481	CD	O
by	IN	O
amplified	JJ	O
fragment	NN	O
was	VBD	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
and	CC	O
ligated	VBN	O
to	TO	O
the	DT	O
pCR-ScriptAmp	JJ	O
vector	NN	O
from	IN	O
the	DT	O
PCR	NNP	O
cloning	VBG	O
kit	NN	O
(	(	O
Stratagene	NNP	O
)	)	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
SrfI	NNP	O
enzyme	FW	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
.	.	O
The	DT	O
(	(	O
blunt	NN	O
)	)	O
ligation	NN	O
gave	VBD	O
two	CD	O
orientations	NNS	O
of	IN	O
the	DT	O
insert	NN	O
in	IN	O
the	DT	O
vector	NN	O
of	IN	O
which	WDT	O
the	DT	O
one	NN	O
with	IN	O
the	DT	O
largest	JJS	O
fragment	NN	O
between	IN	O
the	DT	O
EcoRI	NNP	O
site	NN	O
in	IN	O
the	DT	O
(	(	O
5′	CD	O
)	)	O
end	NN	O
of	IN	O
the	DT	O
insert	NN	O
and	CC	O
the	DT	O
EcoRI	NNP	O
site	NN	O
in	IN	O
the	DT	O
vector	NN	O
was	VBD	O
arbitrarily	RB	O
chosen	VBN	O
.	.	O
This	DT	O
resulted	VBD	O
in	IN	O
construct	NN	O
pCR5B	NN	O
.	.	O
Correct	JJ	O
amplification	NN	O
of	IN	O
the	DT	O
target	NN	O
sequence	NN	O
(	(	O
between	IN	O
KpnI	NNP	O
and	CC	O
EcoRI	NNP	O
sites	NNS	O
)	)	O
was	VBD	O
verified	VBN	O
by	IN	O
sequencing	VBG	O
.	.	O
Generation	NN	O
of	IN	O
Construct	NNP	O
pE1B	NN	O
pCR5B	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
KpnI	NNP	O
and	CC	O
EcoRI	NNP	O
and	CC	O
the	DT	O
415	CD	O
by	IN	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
using	VBG	O
the	DT	O
QIAquick	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
Construct	NNP	O
pIG.E1A.E1B	NN	O
was	VBD	O
then	RB	O
also	RB	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
KpnI	NNP	O
and	CC	O
the	DT	O
resulting	VBG	O
5.2	CD	O
kb	NN	O
vector	NN	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
as	IN	O
above	NN	O
.	.	O
Ligation	NN	O
of	IN	O
the	DT	O
isolated	JJ	O
fragments	NNS	O
and	CC	O
transformation	NN	O
into	IN	O
DH5α-T1r	NNP	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
resulted	VBD	O
in	IN	O
construct	NN	O
pE1B	NN	O
(	(	O
FIG	NNP	O
.	.	O
3	LS	O
)	)	O
.	.	O
The	DT	O
E1B	NNP	O
sequence	NN	O
in	IN	O
this	DT	O
construct	NN	O
constitutes	VBZ	O
nt	RB	O
.	.	O
1642	CD	O
to	TO	O
3510	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
.	.	O
The	DT	O
new	JJ	O
construct	NN	O
's	POS	O
transforming	NN	O
ability	NN	O
,	,	O
in	IN	O
comparison	NN	O
with	IN	O
the	DT	O
full	JJ	O
length	NN	O
Ad5E1	NNP	O
expression	NN	O
construct	NN	O
,	,	O
was	VBD	O
then	RB	O
tested	VBN	O
.	.	O
Hereto	NNP	O
,	,	O
primary	JJ	O
human	JJ	O
embryonic	JJ	O
retina	NN	O
(	(	O
HER	NNP	O
)	)	O
cells	NNS	O
were	VBD	O
isolated	VBN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Byrd	NNP	B
et	FW	I
al.	NN	I
,	,	I
1982	CD	I
,	,	I
1988	CD	I
)	)	O
and	CC	O
seeded	VBN	O
in	IN	O
6	CD	O
cm	NN	O
dishes	NNS	O
in	IN	O
DMEM	NNP	O
medium	NN	O
(	(	O
Gibco	NNP	O
BRL	NNP	O
)	)	O
,	,	O
supplemented	VBN	O
with	IN	O
10	CD	O
%	NN	O
heat-inactivated	JJ	O
Fetal	NNP	O
Bovine	NNP	O
Serum	NNP	O
(	(	O
FBS	NNP	O
,	,	O
Gibco	NNP	O
BRL	NNP	O
)	)	O
.	.	O
At	IN	O
60	CD	O
to	TO	O
70	CD	O
%	NN	O
confluency	NN	O
,	,	O
cells	NNS	O
were	VBD	O
transfected	VBN	O
with	IN	O
,	,	O
in	IN	O
total	JJ	O
,	,	O
20	CD	O
μg	JJ	O
DNA/dish	NNP	O
,	,	O
using	VBG	O
the	DT	O
CaPO4	NNP	O
co-precipitation	NN	O
kit	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
.	.	O
Two	CD	O
weeks	NNS	O
later	RB	O
,	,	O
transformed	VBD	O
clones	NNS	O
were	VBD	O
visible	JJ	O
as	IN	O
foci	NN	O
in	IN	O
a	DT	O
monolayer	NN	O
of	IN	O
primary	JJ	O
cells	NNS	O
.	.	O
Cells	NNS	O
in	IN	O
a	DT	O
focus	NN	O
showed	VBD	O
a	DT	O
clearly	RB	O
different	JJ	O
morphology	NN	O
compared	VBN	O
with	IN	O
the	DT	O
primary	JJ	O
cells	NNS	O
.	.	O
Table	NN	O
I	PRP	O
depicts	VBZ	O
the	DT	O
amounts	NNS	O
of	IN	O
transformed	JJ	O
clones	NNS	O
that	WDT	O
were	VBD	O
obtained	VBN	O
with	IN	O
each	DT	O
of	IN	O
the	DT	O
transfections	NNS	O
.	.	O
The	DT	O
results	NNS	O
confirm	VBP	O
previous	JJ	O
observations	NNS	O
that	WDT	O
primary	VBP	O
cells	NNS	O
can	MD	O
be	VB	O
transformed	VBN	O
with	IN	O
Ad5-E1A	NNP	O
and	CC	O
E1B19K	NNP	O
genes	NNS	O
(	(	O
pIG.E1AB21	NN	O
)	)	O
.	.	O
It	PRP	O
should	MD	O
be	VB	O
noted	VBN	O
that	IN	O
these	DT	O
foci	NNS	O
were	VBD	O
generally	RB	O
smaller	JJR	O
than	IN	O
the	DT	O
ones	NNS	O
obtained	VBN	O
with	IN	O
the	DT	O
transfection	NN	O
where	WRB	O
the	DT	O
complete	JJ	O
E1B	NNP	O
region	NN	O
was	VBD	O
present	JJ	O
.	.	O
Also	RB	O
,	,	O
after	IN	O
picking	VBG	O
the	DT	O
foci	NN	O
resulting	VBG	O
from	IN	O
transfections	NNS	O
with	IN	O
construct	NN	O
pIG.E1AB21	NN	O
and	CC	O
seeding	VBG	O
into	IN	O
96-well	NNP	O
plates	NNS	O
,	,	O
no	DT	O
sustained	VBN	O
cell	NN	O
growth	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
all	DT	O
cells	NNS	O
died	VBD	O
.	.	O
In	IN	O
all	DT	O
other	JJ	O
cases	NNS	O
,	,	O
most	JJS	O
of	IN	O
the	DT	O
picked	JJ	O
foci	NN	O
resulted	VBD	O
in	IN	O
viable	JJ	O
cell	NN	O
clones	NNS	O
.	.	O
Since	IN	O
transfection	NN	O
with	IN	O
pIG.E1AB21	NN	O
initially	RB	O
resulted	VBD	O
in	IN	O
transformed	JJ	O
cells	NNS	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
re-transfect	VB	O
the	DT	O
cells	NNS	O
with	IN	O
an	DT	O
E1B-55K	JJ	O
expression	NN	O
construct	NN	O
,	,	O
e.g	NN	O
.	.	O
five	CD	O
to	TO	O
ten	VB	O
days	NNS	O
following	VBG	O
the	DT	O
first	JJ	O
transfection	NN	O
.	.	O
This	DT	O
ensures	VBZ	O
that	IN	O
cells	NNS	O
are	VBP	O
obtained	VBN	O
that	IN	O
have	VBP	O
incorporated	VBN	O
both	DT	O
expression	NN	O
cassettes	VBZ	O
on	IN	O
different	JJ	O
loci	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
This	DT	O
experiment	NN	O
further	RB	O
confirms	VBZ	O
that	IN	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
generate	VB	O
and	CC	O
establish	VB	O
transformed	VBN	O
cell	NN	O
clones	NNS	O
by	IN	O
using	VBG	O
two	CD	O
separate	JJ	O
plasmids	NNS	O
for	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
genes	NNS	O
(	(	O
pIG.E1A+pE1B	NN	O
)	)	O
.	.	O
However	RB	O
,	,	O
because	IN	O
both	DT	O
plasmids	NNS	O
were	VBD	O
transfected	VBN	O
together	RB	O
and	CC	O
contain	VB	O
considerable	JJ	O
sequence	NN	O
overlap	NN	O
(	(	O
plasmid	JJ	O
backbone	NN	O
and	CC	O
promoter/polyA	NN	O
)	)	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
integration	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
took	VBD	O
place	NN	O
in	IN	O
the	DT	O
same	JJ	O
locus	NN	O
in	IN	O
the	DT	O
genome	NN	O
.	.	O
This	DT	O
may	MD	O
be	VB	O
avoided	VBN	O
using	VBG	O
fragments	NNS	O
with	IN	O
expression	NN	O
cassettes	NNS	O
only	RB	O
(	(	O
no	DT	O
vector	NN	O
sequences	NNS	O
)	)	O
and	CC	O
having	VBG	O
no	DT	O
sequence	NN	O
overlap	NN	O
.	.	O
The	DT	O
sequence	NN	O
overlap	NN	O
can	MD	O
be	VB	O
removed	VBN	O
from	IN	O
regulatory	JJ	O
elements	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
promoters	NNS	O
and	CC	O
polyadenylation	NN	O
(	(	O
polyA	NN	O
)	)	O
sequences	NNS	O
,	,	O
by	IN	O
using	VBG	O
different	JJ	O
regulatory	JJ	O
sequences	NNS	O
for	IN	O
the	DT	O
two	CD	O
expression	NN	O
constructs	NNS	O
with	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
.	.	O
Preferably	RB	O
,	,	O
these	DT	O
sequences	NNS	O
are	VBP	O
sufficiently	RB	O
divergent	JJ	O
to	TO	O
prevent	VB	O
overlap	NN	O
that	WDT	O
could	MD	O
lead	VB	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
paired	JJ	O
structures	NNS	O
found	VBN	O
during	IN	O
a	DT	O
homologous	JJ	O
recombination	NN	O
process	NN	O
.	.	O
Any	DT	O
promoter	NN	O
and	CC	O
polyA	JJ	O
sequence	NN	O
can	MD	O
be	VB	O
used	VBN	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
regulatory	JJ	O
sequences	NNS	O
are	VBP	O
different	JJ	O
from	IN	O
those	DT	O
from	IN	O
the	DT	O
transgenes	NNS	O
in	IN	O
the	DT	O
recombinant	JJ	O
adenovirus	NN	O
that	WDT	O
will	MD	O
be	VB	O
propagated	VBN	O
on	IN	O
these	DT	O
cells	NNS	O
.	.	O
Obviously	RB	O
,	,	O
this	DT	O
can	MD	O
only	RB	O
be	VB	O
determined	VBN	O
when	WRB	O
a	DT	O
given	VBN	O
recombinant	NN	O
adenovirus	NN	O
is	VBZ	O
propagated	VBN	O
on	IN	O
these	DT	O
cells	NNS	O
at	IN	O
a	DT	O
later	JJ	O
stage	NN	O
and	CC	O
will	MD	O
depend	VB	O
on	IN	O
the	DT	O
particular	JJ	O
recombinant	NN	O
adenovirus	NN	O
.	.	O
Hence	RB	O
,	,	O
it	PRP	O
is	VBZ	O
convenient	JJ	O
to	TO	O
choose	VB	O
the	DT	O
regulatory	JJ	O
sequence	NN	O
of	IN	O
such	JJ	O
transgenes	NNS	O
later	RB	O
,	,	O
such	JJ	O
that	IN	O
they	PRP	O
differ	VBP	O
from	IN	O
those	DT	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
in	IN	O
the	DT	O
cells	NNS	O
that	WDT	O
are	VBP	O
established	VBN	O
by	IN	O
the	DT	O
invention	NN	O
.	.	O
However	RB	O
,	,	O
since	IN	O
many	JJ	O
currently	RB	O
available	JJ	O
recombinant	JJ	O
adenovirus	NN	O
vectors	NNS	O
carry	VBP	O
transgenes	NNS	O
regulated	VBN	O
by	IN	O
a	DT	O
CMV	NNP	O
promoter	NN	O
and	CC	O
an	DT	O
SV40	NNP	O
polyA	NN	O
sequence	NN	O
,	,	O
the	DT	O
preferred	JJ	O
regulatory	JJ	O
sequences	NNS	O
for	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
constructs	NNS	O
as	IN	O
exemplified	JJ	O
herein	NN	O
are	VBP	O
different	JJ	O
from	IN	O
the	DT	O
CMV	NNP	O
promoter	NN	O
and	CC	O
the	DT	O
SV40	NNP	O
polyA	NN	O
sequence	NN	O
.	.	O
In	IN	O
view	NN	O
of	IN	O
regulatory	JJ	O
issues	NNS	O
,	,	O
these	DT	O
regulatory	JJ	O
sequences	NNS	O
are	VBP	O
preferably	RB	O
not	RB	O
of	IN	O
viral	JJ	O
origin	NN	O
.	.	O
To	TO	O
this	DT	O
end	NN	O
,	,	O
the	DT	O
plasmids	NNS	O
described	VBD	O
herein	NNS	O
are	VBP	O
further	RB	O
modified	VBN	O
as	IN	O
described	VBN	O
below	IN	O
.	.	O
Generation	NN	O
of	IN	O
Construct	NNP	O
pCC.E1A	NN	O
and	CC	O
pCC.E1AB21	VB	O
The	DT	O
E1A	NNP	O
sequence	NN	O
was	VBD	O
amplified	VBN	O
with	IN	O
the	DT	O
following	VBG	O
primers	NNS	O
:	:	O
5E1A-For	JJ	O
:	:	O
5′-CCG	JJ	O
AAT	NNP	O
TCG	NNP	O
ATC	NNP	O
GTG	NNP	O
TAG	NNP	O
TG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:4	NNP	O
)	)	O
and	CC	O
5E1A-rev	JJ	O
:	:	O
5′-CGG	JJ	O
GAT	NNP	O
CCA	NNP	O
TTT	NNP	O
AAC	NNP	O
ACG	NNP	O
CCA	NNP	O
TGC	NNP	O
AAG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:5	NNP	O
)	)	O
.	.	O
The	DT	O
reaction	NN	O
was	VBD	O
done	VBN	O
on	IN	O
pIG.E1A.E1B	NN	O
template	NN	O
DNA	NNP	O
using	VBG	O
Pwo	NNP	O
DNA	NNP	O
polymerase	NN	O
(	(	O
Roche	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
but	CC	O
with	IN	O
a	DT	O
final	JJ	O
concentration	NN	O
of	IN	O
3	CD	O
%	NN	O
DMSO	NNP	O
.	.	O
The	DT	O
PCR	NNP	O
program	NN	O
was	VBD	O
set	VBN	O
on	IN	O
94°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
followed	VBN	O
by	IN	O
30	CD	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
58°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
120	CD	O
seconds	NNS	O
)	)	O
and	CC	O
ended	VBN	O
by	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
eight	CD	O
minutes	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
1.2	CD	O
kb	JJ	O
fragment	NN	O
contains	VBZ	O
the	DT	O
E1A	NNP	O
sequence	NN	O
from	IN	O
Ad5	NNP	O
(	(	O
nucleotide	RB	O
459	CD	O
to	TO	O
1655	CD	O
as	IN	O
in	IN	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M73260	NNP	O
)	)	O
flanked	VBN	O
by	IN	O
EcoRI	NNP	O
(	(	O
5′	CD	O
)	)	O
and	CC	O
BamHI	NNP	O
(	(	O
3′	CD	O
)	)	O
sites	NNS	O
.	.	O
A	DT	O
second	JJ	O
PCR	NNP	O
fragment	NN	O
was	VBD	O
generated	VBN	O
using	VBG	O
primer	JJ	O
5E1A-For	JJ	O
with	IN	O
reverse	JJ	O
primer	NN	O
:	:	O
5E1AB21-rev	JJ	O
:	:	O
5′-CGG	JJ	O
GAT	NNP	O
CCT	NNP	O
CAT	NNP	O
TCC	NNP	O
CGA	NNP	O
GGG	NNP	O
TCC	NNP	O
AG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
)	)	O
,	,	O
using	VBG	O
the	DT	O
same	JJ	O
conditions	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
1.8	CD	O
kb	JJ	O
fragment	NN	O
contains	VBZ	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B-19K	NNP	O
sequence	NN	O
from	IN	O
Ad5	NNP	O
(	(	O
nucleotide	RB	O
459	CD	O
to	TO	O
2244	CD	O
as	IN	O
in	IN	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M73260	NNP	O
)	)	O
flanked	VBN	O
by	IN	O
EcoRI	NNP	O
(	(	O
5′	CD	O
)	)	O
and	CC	O
BamHI	NNP	O
(	(	O
3′	CD	O
)	)	O
sites	NNS	O
.	.	O
Both	DT	O
PCR	NNP	O
fragments	NNS	O
were	VBD	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NN	O
,	,	O
purified	VBN	O
with	IN	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
and	CC	O
cloned	VBN	O
in	IN	O
a	DT	O
PCR	NNP	O
cloning	NN	O
vector	NN	O
;	:	O
pCR-TOPOblunt	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
and	CC	O
the	DT	O
sequence	NN	O
was	VBD	O
verified	VBN	O
.	.	O
The	DT	O
constructs	NNS	O
were	VBD	O
then	RB	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
BamHI	NNP	O
and	CC	O
the	DT	O
insert	NN	O
fragments	NNS	O
were	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
using	VBG	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
as	IN	O
above	NN	O
.	.	O
Each	DT	O
of	IN	O
the	DT	O
isolated	JJ	O
fragments	NNS	O
was	VBD	O
then	RB	O
ligated	VBN	O
into	IN	O
vector	NN	O
pCC101	NN	O
(	(	O
see	VB	O
below	IN	O
)	)	O
that	WDT	O
was	VBD	O
first	RB	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
BamHI	NNP	O
and	CC	O
purified	VBN	O
from	IN	O
gel	NN	O
as	IN	O
above	NN	O
.	.	O
Transformation	NN	O
into	IN	O
electro-competent	JJ	O
DH10B	NNP	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
generated	VBD	O
constructs	NNS	O
pCC.E1A	FW	O
(	(	O
FIG	NNP	O
.	.	O
4	CD	O
)	)	O
and	CC	O
pCC.E1AB21	NN	O
(	(	O
FIG	NNP	O
.	.	O
5	CD	O
)	)	O
.	.	O
A	DT	O
synthetic	JJ	O
polyadenylation	NN	O
signal	NN	O
(	(	O
SPA	NNP	O
)	)	O
is	VBZ	O
present	JJ	O
in	IN	O
these	DT	O
plasmids	NNS	O
(	(	O
derived	VBN	O
from	IN	O
construct	NN	O
pCC271	NN	O
as	IN	O
described	VBN	O
in	IN	O
WO	NNP	O
02/40665	CD	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
pCC101	NN	O
pCC	NN	O
100	CD	O
(	(	O
see	VB	O
below	IN	O
)	)	O
was	VBD	O
digested	VBN	O
with	IN	O
XbaI	NNP	O
and	CC	O
the	DT	O
resulting	VBG	O
linear	JJ	O
fragment	NN	O
was	VBD	O
purified	VBN	O
from	IN	O
gel	NN	O
using	VBG	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
as	IN	O
above	NN	O
.	.	O
A	DT	O
linker	NN	O
was	VBD	O
prepared	VBN	O
by	IN	O
annealing	VBG	O
the	DT	O
oligonucleotides	JJ	O
X-SM-1	JJ	O
:	:	O
5′-CTAGGTCGACCAATTG-3′	JJ	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:7	NNP	O
)	)	O
with	IN	O
X-SM-2	JJ	O
:	:	O
5′-CTAGCAATTGGTCGAC-3′	JJ	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:8	NNP	O
)	)	O
.	.	O
Hereto	NNP	O
,	,	O
1	CD	O
μg	NN	O
of	IN	O
each	DT	O
oligonucleotide	NN	O
was	VBD	O
mixed	JJ	O
with	IN	O
2	CD	O
μl	NNS	O
10×NEB2	CD	O
buffer	NN	O
(	(	O
NEB	NNP	O
)	)	O
and	CC	O
milliQ	$	O
H2O	NNP	O
to	TO	O
a	DT	O
final	JJ	O
volume	NN	O
of	IN	O
20	CD	O
μl	NNS	O
.	.	O
The	DT	O
mixture	NN	O
was	VBD	O
placed	VBN	O
at	IN	O
98°	CD	O
C.	NNP	O
and	CC	O
slowly	RB	O
cooled	VBD	O
to	TO	O
4°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
PCR	NNP	O
machine	NN	O
(	(	O
cooling	VBG	O
rate	NN	O
of	IN	O
2°	CD	O
C./minute	NNP	O
)	)	O
.	.	O
The	DT	O
annealed	JJ	O
linker	NN	O
was	VBD	O
then	RB	O
ligated	VBN	O
to	TO	O
the	DT	O
isolated	JJ	O
XbaI-digested	JJ	O
fragment	NN	O
using	VBG	O
a	DT	O
4×	CD	O
molar	JJ	O
excess	NN	O
of	IN	O
linker	NN	O
over	IN	O
fragment	NN	O
.	.	O
The	DT	O
ligated	JJ	O
DNA	NNP	O
was	VBD	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
and	CC	O
digested	VBN	O
with	IN	O
XbaI	NNP	O
to	TO	O
remove	VB	O
self-ligated	JJ	O
vector	NN	O
DNA	NN	O
.	.	O
Following	VBG	O
heat-inactivation	NN	O
of	IN	O
the	DT	O
XbaI	NNP	O
enzyme	NN	O
,	,	O
the	DT	O
mixture	NN	O
was	VBD	O
then	RB	O
used	VBN	O
to	TO	O
transform	VB	O
DH5α-T1r-competent	NNP	O
cells	NNS	O
resulting	VBG	O
in	IN	O
pCC101	NN	O
(	(	O
FIG	NNP	O
.	.	O
6	CD	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
pCC100	JJ	O
Construct	NNP	O
pCC271	NN	O
(	(	O
described	VBN	O
in	IN	O
WO	NNP	O
02/40665	CD	O
)	)	O
was	VBD	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
PstI	NNP	O
and	CC	O
the	DT	O
3	CD	O
kb	NNS	O
vector	JJ	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
gel	NN	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
A	DT	O
linker	NN	O
was	VBD	O
prepared	VBN	O
by	IN	O
annealing	VBG	O
oligonucleotide	JJ	O
EcoPst-3	JJ	O
:	:	O
5′-AAT	JJ	O
TGA	NNP	O
TAT	NNP	O
CGA	NNP	O
ATT	NNP	O
CGC	NNP	O
CGA	NNP	O
GCT	NNP	O
CGT	NNP	O
AAG	NNP	O
CTT	NNP	O
GGA	NNP	O
TCC	NNP	O
CTG	NNP	O
CA-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:9	NNP	O
)	)	O
with	IN	O
oligonucleotide	JJ	O
EcoPst-4	JJ	O
:	:	O
5′-GGG	JJ	O
ATC	NNP	O
CAA	NNP	O
GCT	NNP	O
TAC	NNP	O
GAG	NNP	O
CTC	NNP	O
GGC	NNP	O
GAA	NNP	O
TFC	NNP	O
GAT	NNP	O
ATC-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:10	NNP	O
)	)	O
.	.	O
Hereto	NNP	O
,	,	O
oligonucleotides	NNS	O
were	VBD	O
mixed	JJ	O
as	IN	O
described	VBN	O
above	IN	O
and	CC	O
annealed	VBN	O
by	IN	O
incubation	NN	O
at	IN	O
98°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
,	,	O
65°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
minutes	NNS	O
and	CC	O
room	NN	O
temperature	NN	O
for	IN	O
two	CD	O
hours	NNS	O
.	.	O
The	DT	O
isolated	JJ	O
vector	NN	O
fragment	NN	O
was	VBD	O
then	RB	O
ligated	VBN	O
to	TO	O
excess	VB	O
annealed	JJ	O
oligo	NN	O
and	CC	O
transformed	VBD	O
into	IN	O
DH5α-T1′-competent	NNP	O
cells	NNS	O
resulting	VBG	O
in	IN	O
construct	NN	O
pCC100	NN	O
.	.	O
Generation	NN	O
of	IN	O
pCC200	NN	O
Plasmid	NNP	O
pBR322	NN	O
(	(	O
GenBank	NNP	O
J01749.1	NNP	O
)	)	O
was	VBD	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
then	RB	O
blunted	VBD	O
with	IN	O
Klenow	NNP	O
enzyme	NN	O
,	,	O
followed	VBN	O
by	IN	O
purification	NN	O
with	IN	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
After	IN	O
a	DT	O
second	JJ	O
digestion	NN	O
with	IN	O
NheI	NNP	O
,	,	O
the	DT	O
4150	CD	O
by	IN	O
vector	NN	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NNS	O
using	VBG	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
In	IN	O
parallel	JJ	O
,	,	O
construct	NN	O
pCC100	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
BsaAl	NNP	O
,	,	O
blunted	VBD	O
with	IN	O
Klenow	NNP	O
enzyme	NN	O
and	CC	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
a	DT	O
second	JJ	O
digestion	NN	O
with	IN	O
XbaI	NNP	O
and	CC	O
isolation	NN	O
of	IN	O
the	DT	O
350	CD	O
bp	NN	O
fragment	NN	O
from	IN	O
agarose	JJ	O
gel	NN	O
.	.	O
The	DT	O
fragments	NNS	O
were	VBD	O
then	RB	O
ligated	VBN	O
and	CC	O
transformed	VBN	O
into	IN	O
chemical-competent	JJ	O
STBL-2	JJ	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
,	,	O
resulting	VBG	O
in	IN	O
pCC200	NN	O
(	(	O
FIG	NNP	O
.	.	O
15	CD	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
pCC105	JJ	O
Construct	NNP	O
pCC105	NN	O
contains	VBZ	O
the	DT	O
human	JJ	O
PGK	NNP	O
promoter	NN	O
and	CC	O
a	DT	O
poly-adenylation	JJ	O
sequence	NN	O
derived	VBN	O
from	IN	O
the	DT	O
human	JJ	O
COL1A2	NNP	O
gene	NN	O
.	.	O
First	RB	O
,	,	O
the	DT	O
COL1A2	NNP	O
poly-adenylation	NN	O
sequence	NN	O
(	(	O
Natalizio	NNP	O
et	RB	O
al.	RB	O
,	,	O
2002	CD	O
)	)	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NNP	O
from	IN	O
human	JJ	O
genomic	JJ	O
DNA	NN	O
as	IN	O
described	VBN	O
by	IN	O
the	DT	O
authors	NNS	O
using	VBG	O
recombinant	JJ	O
Taq	NNP	O
polymerase	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
and	CC	O
primers	NNS	O
COL1A2F	NNP	O
:	:	O
5′-CAG	JJ	O
CTA	NNP	O
GCC	NNP	O
TGC	NNP	O
AGG	NNP	O
AAG	NNP	O
TAT	NNP	O
GCA	NNP	O
GAT	NNP	O
TAT	NNP	O
TTG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:11	NNP	O
)	)	O
and	CC	O
COL1A2R-sal	JJ	O
:	:	O
5′-ACA	JJ	O
CGT	NNP	O
CGA	NNP	O
CGG	NNP	O
CTG	NNP	O
GTA	NNP	O
GAG	NNP	O
ATG	NNP	O
C-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:12	NNP	O
)	)	O
.	.	O
Herewith	NNP	O
,	,	O
the	DT	O
published	VBN	O
sequence	NN	O
is	VBZ	O
extended	VBN	O
at	IN	O
the	DT	O
5′-end	JJ	O
by	IN	O
an	DT	O
SbfI	NNP	O
restriction	NN	O
sequence	NN	O
and	CC	O
at	IN	O
the	DT	O
3′-end	JJ	O
by	IN	O
an	DT	O
SalI	NNP	O
restriction	NN	O
sequence	NN	O
.	.	O
The	DT	O
resulting	VBG	O
PCR	NNP	O
fragment	NN	O
was	VBD	O
cloned	VBN	O
into	IN	O
pCR-TOPO-TA	JJ	O
using	VBG	O
the	DT	O
pCR-TOPO4	JJ	O
TA	NNP	O
cloning	VBG	O
kit	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
.	.	O
After	IN	O
verification	NN	O
of	IN	O
the	DT	O
insert	NN	O
by	IN	O
sequencing	VBG	O
,	,	O
the	DT	O
277	CD	O
bp	NN	O
insert	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
the	DT	O
TOPO	NNP	O
vector	NN	O
by	IN	O
digestion	NN	O
with	IN	O
SbfI	NNP	O
and	CC	O
SalI	NNP	O
,	,	O
and	CC	O
purified	VBD	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
In	IN	O
parallel	NN	O
,	,	O
the	DT	O
plasmid	NN	O
pCC101	NN	O
was	VBD	O
also	RB	O
digested	VBN	O
with	IN	O
SbfI	NNP	O
and	CC	O
SalI	NNP	O
,	,	O
followed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
The	DT	O
2965	CD	O
by	IN	O
vector	NN	O
fragment	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NNS	O
using	VBG	O
a	DT	O
GeneClean	JJ	O
Kit	NNP	O
(	(	O
Bio101	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
.	.	O
This	DT	O
vector	NN	O
fragment	NN	O
was	VBD	O
ligated	VBN	O
to	TO	O
the	DT	O
purified	VBN	O
COL1A2pA	NNP	O
fragment	NN	O
in	IN	O
equimolar	JJ	O
amounts	NNS	O
and	CC	O
transformed	VBN	O
to	TO	O
chemical-competent	JJ	O
STBL-2	JJ	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
.	.	O
This	DT	O
gave	VBD	O
plasmid	JJ	O
pCC105	NN	O
(	(	O
FIG	NNP	O
.	.	O
7	CD	O
)	)	O
.	.	O
Generation	NN	O
of	IN	O
pCC205	JJ	O
Construct	NNP	O
pCC205	NN	O
was	VBD	O
made	VBN	O
by	IN	O
digestion	NN	O
of	IN	O
pCC200	NN	O
with	IN	O
SalI	NNP	O
and	CC	O
EcoRI	NNP	O
,	,	O
followed	VBN	O
by	IN	O
purification	NN	O
of	IN	O
the	DT	O
4225	CD	O
nt	NN	O
vector	NN	O
fragment	NN	O
from	IN	O
agarose	JJ	O
gel	NN	O
,	,	O
using	VBG	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
In	IN	O
parallel	NN	O
,	,	O
the	DT	O
310	CD	O
nt	JJ	O
COL1A2	NNP	O
polyA	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
construct	NN	O
pCC105	NN	O
by	IN	O
digestion	NN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
SalI	NNP	O
,	,	O
followed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
and	CC	O
purification	NN	O
of	IN	O
the	DT	O
fragment	NN	O
using	VBG	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
.	.	O
The	DT	O
two	CD	O
fragments	NNS	O
were	VBD	O
then	RB	O
ligated	VBN	O
in	IN	O
equimolar	JJ	O
amounts	NNS	O
and	CC	O
transformed	VBN	O
to	TO	O
DH5α-T1r	NNP	O
,	,	O
resulting	VBG	O
in	IN	O
pCC205	NN	O
(	(	O
FIG	NNP	O
.	.	O
16	CD	O
)	)	O
.	.	O
Cloning	NN	O
of	IN	O
pCC.55Kcol	NN	O
Vector	NNP	O
pCC205	NN	O
is	VBZ	O
used	VBN	O
for	IN	O
the	DT	O
construction	NN	O
of	IN	O
a	DT	O
plasmid	NN	O
expressing	VBG	O
the	DT	O
Ad5	NNP	O
E1B-55k	NNP	O
protein	NN	O
.	.	O
Hereto	NNP	O
,	,	O
a	DT	O
PCR	NNP	O
product	NN	O
is	VBZ	O
generated	VBN	O
using	VBG	O
the	DT	O
following	JJ	O
primers	NNS	O
:	:	O
55KforE	CD	O
:	:	O
5′-GGA	JJ	O
ATT	NNP	O
CGC	NNP	O
CAC	NNP	O
CAT	NNP	O
GGA	NNP	O
GCG	NNP	O
AAG	NNP	O
AAA	NNP	O
CCC	NNP	O
ATC	NNP	O
TGA-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:13	NNP	O
)	)	O
and	CC	O
55KrevB	CD	O
:	:	O
5′-gga	JJ	O
tcc	NN	O
TCA	NNP	O
ATC	NNP	O
TGT	NNP	O
ATC	NNP	O
TTC	NNP	O
ATC	NNP	O
GCT	NNP	O
AGA	NNP	O
GCC-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:14	NNP	O
)	)	O
.	.	O
PCR	NNP	O
is	VBZ	O
performed	VBN	O
with	IN	O
Pwo	NNP	O
DNA	NNP	O
polymerase	NN	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
protocol	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
3	CD	O
%	NN	O
DMSO	NNP	O
.	.	O
The	DT	O
amplification	NN	O
is	VBZ	O
done	VBN	O
on	IN	O
pIG.E1A.E1B	NN	O
and	CC	O
the	DT	O
program	NN	O
is	VBZ	O
set	VBN	O
at	IN	O
94°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
followed	VBN	O
by	IN	O
30	CD	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
60°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
90	CD	O
seconds	NNS	O
)	)	O
and	CC	O
ended	VBN	O
by	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
eight	CD	O
minutes	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
1510	CD	O
by	IN	O
amplified	JJ	O
fragment	NN	O
contains	VBZ	O
the	DT	O
E1B-55K	JJ	O
sequence	NN	O
nt	NN	O
.	.	O
2019	CD	O
to	TO	O
3510	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
sequence	NN	O
.	.	O
The	DT	O
fragment	NN	O
is	VBZ	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
PCR	NNP	O
purification	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
,	,	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
BamHI	NNP	O
followed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
for	IN	O
the	DT	O
removal	NN	O
of	IN	O
the	DT	O
cleaved	JJ	O
ends	NNS	O
.	.	O
This	DT	O
fragment	NN	O
is	VBZ	O
then	RB	O
purified	VBN	O
from	IN	O
agarose	JJ	O
gel	NNS	O
using	VBG	O
the	DT	O
GeneCleanII	NNP	O
kit	NN	O
(	(	O
Bio101	NNP	O
)	)	O
and	CC	O
ligated	VBN	O
to	TO	O
pCC205	VB	O
,	,	O
which	WDT	O
is	VBZ	O
also	RB	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
BamHI	NNP	O
and	CC	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NNS	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
The	DT	O
ligation	NN	O
mixture	NN	O
is	VBZ	O
transformed	VBN	O
to	TO	O
chemical-competent	JJ	O
STBL2	NNP	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
resulting	VBG	O
in	IN	O
construct	NN	O
pCC.55Kcol	NN	O
(	(	O
FIG	NNP	O
.	.	O
8	CD	O
)	)	O
.	.	O
Cloning	VBG	O
ofpIG.E1B	RP	O
A	DT	O
PCR	NNP	O
fragment	NN	O
was	VBD	O
generated	VBN	O
with	IN	O
Pwo	NNP	O
DNA	NNP	O
polymerase	NN	O
(	(	O
Roche	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
3	CD	O
%	NN	O
DMSO	NNP	O
.	.	O
The	DT	O
following	JJ	O
primers	NNS	O
were	VBD	O
used	VBN	O
in	IN	O
the	DT	O
amplification	NN	O
reaction	NN	O
:	:	O
5E1Bstart	CD	O
:	:	O
5′-GGA	JJ	O
ATT	NNP	O
CCT	NNP	O
CAT	NNP	O
GGA	NNP	O
GGC	NNP	O
TTG	NNP	O
GG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:15	NNP	O
)	)	O
and	CC	O
5E1Brev2	CD	O
:	:	O
5′-GTG	JJ	O
TCT	NNP	O
CAC	NNP	O
AAC	NNP	O
CGC	NNP	O
TCT	NNP	O
C-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:16	NNP	O
)	)	O
.	.	O
The	DT	O
amplification	NN	O
was	VBD	O
done	VBN	O
on	IN	O
pIG.E1A.E1B	NN	O
and	CC	O
the	DT	O
program	NN	O
was	VBD	O
set	VBN	O
on	IN	O
94°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
followed	VBN	O
by	IN	O
five	CD	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
56°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
60	CD	O
seconds	NNS	O
)	)	O
these	DT	O
cycles	NNS	O
were	VBD	O
then	RB	O
followed	VBN	O
by	IN	O
another	DT	O
35	CD	O
cycles	NNS	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
60°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
60	CD	O
seconds	NNS	O
)	)	O
and	CC	O
ended	VBN	O
by	IN	O
68°	CD	O
C.	NNP	O
for	IN	O
eight	CD	O
minutes	NNS	O
.	.	O
The	DT	O
390	CD	O
nt	JJ	O
PCR	NNP	O
fragment	NN	O
was	VBD	O
then	RB	O
digested	VBN	O
with	IN	O
KpnI	NNP	O
and	CC	O
EcoRI	NNP	O
resulting	VBG	O
in	IN	O
a	DT	O
347	CD	O
nt	JJ	O
fragment	NN	O
that	WDT	O
was	VBD	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NNS	O
using	VBG	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
Gel	NNP	O
Extraction	NNP	O
Kit	NNP	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
This	DT	O
fragment	NN	O
was	VBD	O
then	RB	O
ligated	VBN	O
to	TO	O
the	DT	O
5713	CD	O
by	IN	O
pIG.E1A.E1B	NN	O
vector	NN	O
fragment	NN	O
resulting	VBG	O
from	IN	O
digestion	NN	O
with	IN	O
Kpnl	NNP	O
and	CC	O
partially	RB	O
with	IN	O
EcoRI	NNP	O
,	,	O
subsequent	JJ	O
isolation	NN	O
from	IN	O
gel	NN	O
and	CC	O
purified	VBN	O
with	IN	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
After	IN	O
ligation	NN	O
,	,	O
the	DT	O
mixture	NN	O
was	VBD	O
transformed	VBN	O
into	IN	O
chemically	RB	O
competent	JJ	O
STBL-2	NNP	O
cells	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
plasmid	NN	O
pIG.E1B	NN	O
(	(	O
FIG	NNP	O
.	.	O
9	CD	O
)	)	O
.	.	O
pIG.E1B	NN	O
contains	VBZ	O
nt	JJ	O
.	.	O
2019	CD	O
to	TO	O
3510	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
.	.	O
Cloning	NN	O
of	IN	O
pCC.E1Bcol	NN	O
For	IN	O
the	DT	O
construction	NN	O
of	IN	O
a	DT	O
plasmid	NN	O
carrying	VBG	O
both	CC	O
the	DT	O
19K	CD	O
and	CC	O
55K	CD	O
Ad5	NNP	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
,	,	O
the	DT	O
plasmid	NN	O
pCC.55Kcol	NN	O
is	VBZ	O
digested	VBN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
KpnI	NNP	O
.	.	O
The	DT	O
5970	CD	O
nt	NN	O
vector	NN	O
fragment	NN	O
is	VBZ	O
isolated	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
and	CC	O
purified	VBN	O
from	IN	O
agarose	JJ	O
gel	NN	O
with	IN	O
the	DT	O
GeneCleanII	NNP	O
kit	NN	O
(	(	O
Bio101	NNP	O
)	)	O
as	IN	O
above	NN	O
.	.	O
Construct	NNP	O
pIG.E1B	NN	O
is	VBZ	O
then	RB	O
also	RB	O
digested	VBN	O
with	IN	O
KpnI	NNP	O
and	CC	O
EcoRI	NNP	O
and	CC	O
the	DT	O
347	CD	O
nt	JJ	O
fragment	NN	O
is	VBZ	O
isolated	VBN	O
from	IN	O
gel	NN	O
and	CC	O
purified	VBN	O
with	IN	O
the	DT	O
QIAquick	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
Ligation	NN	O
of	IN	O
this	DT	O
insert	NN	O
and	CC	O
the	DT	O
isolated	JJ	O
pCC.55Kcol	NN	O
vector	NN	O
fragment	NN	O
and	CC	O
transformation	NN	O
into	IN	O
STBL2	NNP	O
cells	NNS	O
gives	VBZ	O
construct	NN	O
pCC.E1Bcol	NN	O
(	(	O
FIG	NNP	O
.	.	O
10	CD	O
)	)	O
.	.	O
This	DT	O
construct	NN	O
contains	VBZ	O
nt	JJ	O
.	.	O
1711	CD	O
to	TO	O
3510	CD	O
from	IN	O
the	DT	O
Ad5	NNP	O
genome	NN	O
sequence	NN	O
.	.	O
Cloning	NN	O
of	IN	O
pEC.E1B	NN	O
The	DT	O
Human	NNP	O
Elongation	NNP	O
Factor	NNP	O
1-α	JJ	O
promoter	NN	O
(	(	O
EF1-α	NNP	O
)	)	O
is	VBZ	O
isolated	VBN	O
from	IN	O
plasmid	JJ	O
pEF/myc/nuc	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
by	IN	O
digestion	NN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
Pmll	NNP	O
.	.	O
After	IN	O
digestion	NN	O
,	,	O
the	DT	O
fragment	NN	O
is	VBZ	O
blunted	VBN	O
with	IN	O
Klenow	NNP	O
enzyme	NN	O
and	CC	O
the	DT	O
1183	CD	O
nt	JJ	O
EF1-α	NNP	O
promoter	NN	O
fragment	NN	O
is	VBZ	O
then	RB	O
isolated	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
and	CC	O
purified	VBN	O
with	IN	O
the	DT	O
GeneCleanII	NNP	O
kit	NN	O
(	(	O
Bio101	NNP	O
)	)	O
.	.	O
In	IN	O
parallel	NN	O
,	,	O
the	DT	O
vector	NN	O
pCC.E1Bcol	NN	O
is	VBZ	O
digested	VBN	O
with	IN	O
BstXI	NNP	O
,	,	O
followed	VBN	O
by	IN	O
T4	NNP	O
DNA	NNP	O
polymerase	NN	O
treatment	NN	O
to	TO	O
make	VB	O
the	DT	O
ends	NNS	O
blunt	NN	O
and	CC	O
purified	VBD	O
over	IN	O
a	DT	O
PCR	NNP	O
purification	NN	O
column	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
Then	RB	O
,	,	O
a	DT	O
second	JJ	O
digestion	NN	O
is	VBZ	O
performed	VBN	O
with	IN	O
EcoRV	NNP	O
,	,	O
followed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
The	DT	O
5827	CD	O
nt	NN	O
vector	NN	O
fragment	NN	O
is	VBZ	O
then	RB	O
purified	VBN	O
with	IN	O
the	DT	O
GeneCleanII	NNP	O
kit	NN	O
(	(	O
Bio101	NNP	O
)	)	O
.	.	O
Both	DT	O
the	DT	O
EF1-α	NNP	O
fragment	NN	O
and	CC	O
vector	NN	O
fragment	NN	O
are	VBP	O
ligated	VBN	O
together	RB	O
in	IN	O
an	DT	O
equimolar	JJ	O
amount	NN	O
and	CC	O
transformed	VBN	O
to	TO	O
chemical-competent	JJ	O
STBL-2	JJ	O
cells	NNS	O
(	(	O
Invitrogen	NNP	O
)	)	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
the	DT	O
plasmid	NN	O
pEC.E1B	NN	O
(	(	O
FIG	NNP	O
.	.	O
11	CD	O
)	)	O
that	WDT	O
contains	VBZ	O
the	DT	O
same	JJ	O
Ad5-E1B	NNP	O
sequence	NN	O
as	IN	O
in	IN	O
plasmid	NN	O
pCC.E1Bcol	NN	O
.	.	O
Cloning	NN	O
of	IN	O
pSC.55K	NN	O
The	DT	O
SV40	NNP	O
promoter	NN	O
was	VBD	O
amplified	VBN	O
from	IN	O
pEF/myc/nuc	NN	O
plasmid	NN	O
DNA	NNP	O
(	(	O
Invitrogen	NNP	O
)	)	O
by	IN	O
using	VBG	O
recombinant	JJ	O
Taq	NNP	O
DNA	NNP	O
polymerase	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
and	CC	O
the	DT	O
following	JJ	O
primers	NNS	O
:	:	O
SV40.forS	NN	O
:	:	O
5′-CAA	JJ	O
CTA	NNP	O
GTA	NNP	O
CAT	NNP	O
GTG	NNP	O
GAA	NNP	O
TGT	NNP	O
GTG	NNP	O
TCA	NNP	O
GTT	NNP	O
AGG-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:17	NNP	O
)	)	O
and	CC	O
SV40.RevERI	NNP	O
:	:	O
5′-GGA	JJ	O
ATT	NNP	O
CAG	NNP	O
CTT	NNP	O
TTT	NNP	O
GCA	NNP	O
AAA	NNP	O
GCC	NNP	O
TAG	NNP	O
G-3′	NNP	O
(	(	O
SEQ	NNP	O
ID	NNP	O
NO:18	NNP	O
)	)	O
.	.	O
The	DT	O
amplification	NN	O
program	NN	O
was	VBD	O
set	VBN	O
at	IN	O
94°	CD	O
C.	NNP	O
for	IN	O
two	CD	O
minutes	NNS	O
followed	VBN	O
by	IN	O
five	CD	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
48°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
)	)	O
then	RB	O
25	CD	O
additional	JJ	O
cycles	NNS	O
of	IN	O
(	(	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
58°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds	NNS	O
)	)	O
and	CC	O
ended	VBN	O
by	IN	O
68°	CD	O
C.	NNP	O
for	IN	O
eight	CD	O
minutes	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
357	CD	O
by	IN	O
amplified	JJ	O
fragment	NN	O
(	(	O
nucleotide	RB	O
266	CD	O
to	TO	O
−71	VB	O
from	IN	O
SV40	NNP	O
sequence	NN	O
GenBank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
J02400	NNP	O
)	)	O
was	VBD	O
isolated	VBN	O
from	IN	O
agarose	JJ	O
gel	NN	O
with	IN	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
This	DT	O
fragment	NN	O
was	VBD	O
then	RB	O
cloned	VBN	O
into	IN	O
pCR-TOPO	NN	O
,	,	O
using	VBG	O
the	DT	O
PCR	NNP	O
TOPO4	NNP	O
blunt	NN	O
cloning	VBG	O
kit	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
.	.	O
After	IN	O
sequence	NN	O
verification	NN	O
,	,	O
the	DT	O
357	CD	O
by	IN	O
insert	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
the	DT	O
TOPO	NNP	O
vector	NN	O
by	IN	O
digestion	NN	O
with	IN	O
EcoRI	NNP	O
and	CC	O
SpeI	NNP	O
,	,	O
and	CC	O
isolated	VBD	O
from	IN	O
agarose	JJ	O
gel	NN	O
with	IN	O
the	DT	O
QIAEX	NNP	O
II	NNP	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
.	.	O
In	IN	O
parallel	NN	O
,	,	O
the	DT	O
plasmid	NN	O
pCC.55Kcol	NN	O
(	(	O
which	WDT	O
has	VBZ	O
a	DT	O
pBR322-backbone	NN	O
)	)	O
is	VBZ	O
digested	VBN	O
with	IN	O
AvrII	NNP	O
and	CC	O
EcoRI	NNP	O
followed	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
The	DT	O
5508	CD	O
nt	NN	O
vector	NN	O
fragment	NN	O
is	VBZ	O
isolated	VBN	O
from	IN	O
gel	NN	O
as	IN	O
described	VBN	O
above	IN	O
and	CC	O
ligated	VBN	O
in	IN	O
equimolar	JJ	O
amount	NN	O
to	TO	O
the	DT	O
digested	VBN	O
PCR	NNP	O
fragment	NN	O
.	.	O
The	DT	O
ligation	NN	O
mixture	NN	O
is	VBZ	O
transformed	VBN	O
into	IN	O
chemical-competent	JJ	O
STBL-2	NNP	O
cells	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
plasmid	NN	O
pSC.55K	NN	O
(	(	O
FIG	NNP	O
.	.	O
12	CD	O
)	)	O
that	WDT	O
contains	VBZ	O
the	DT	O
same	JJ	O
Ad5	NNP	O
E1B-55K	NNP	O
sequence	NN	O
as	IN	O
in	IN	O
pCC.55Kcol	NN	O
.	.	O
To	TO	O
generate	VB	O
transformed	JJ	O
clones	NNS	O
from	IN	O
primary	JJ	O
HER	NNP	O
cells	NNS	O
,	,	O
DNA	NNP	O
fragments	VBZ	O
containing	VBG	O
the	DT	O
appropriate	JJ	O
expression	NN	O
cassettes	NNS	O
are	VBP	O
isolated	VBN	O
from	IN	O
gel	NN	O
.	.	O
The	DT	O
elimination	NN	O
of	IN	O
(	(	O
overlapping	VBG	O
)	)	O
vector	NN	O
sequences	NNS	O
is	VBZ	O
believed	VBN	O
to	TO	O
reduce	VB	O
the	DT	O
chance	NN	O
of	IN	O
co-integration	NN	O
.	.	O
Hereto	NNP	O
,	,	O
pCC.E1A	NN	O
and	CC	O
pCC.E1AB21	NN	O
are	VBP	O
digested	VBN	O
with	IN	O
BsaAI	NNP	O
and	CC	O
AflIII	NNP	O
and	CC	O
the	DT	O
insert	NN	O
fragments	NNS	O
are	VBP	O
purified	VBN	O
from	IN	O
gel	NN	O
using	VBG	O
an	DT	O
ELU-Trap	JJ	O
apparatus	NN	O
(	(	O
Schleier	NNP	O
and	CC	O
Schuell	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
instructions	NNS	O
.	.	O
This	DT	O
apparatus	NN	O
enables	VBZ	O
isolation	NN	O
of	IN	O
large	JJ	O
amounts	NNS	O
of	IN	O
DNA	NN	O
fragments	NNS	O
.	.	O
Constructs	NNS	O
pEC.E1B	NN	O
and	CC	O
pSC.55K	NN	O
are	VBP	O
digested	VBN	O
with	IN	O
AflIII/HincII	NNP	O
and	CC	O
AflIII/HincII	NNP	O
,	,	O
respectively	RB	O
,	,	O
and	CC	O
insert	JJ	O
fragments	NNS	O
are	VBP	O
isolated	VBN	O
as	IN	O
above	NN	O
.	.	O
Primary	NNP	O
HER	NNP	O
cells	NNS	O
are	VBP	O
cultured	VBN	O
and	CC	O
transfected	VBN	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
Fragments	NNS	O
isolated	VBN	O
from	IN	O
pCC.E1A	NN	O
and	CC	O
pEC.E1B	NN	O
are	VBP	O
combined	VBN	O
for	IN	O
transfection	NN	O
.	.	O
The	DT	O
DNA	NN	O
fragments	NNS	O
isolated	VBN	O
from	IN	O
pCC.E1AB21	NN	O
are	VBP	O
combined	VBN	O
with	IN	O
pSC.55K	NN	O
or	CC	O
transfected	VBN	O
alone	RB	O
.	.	O
The	DT	O
latter	JJ	O
cultures	NNS	O
are	VBP	O
then	RB	O
retransfected	VBN	O
with	IN	O
the	DT	O
DNA	NNP	O
fragment	NN	O
isolated	VBD	O
from	IN	O
pSC.55K	JJ	O
seven	CD	O
to	TO	O
ten	VB	O
days	NNS	O
following	VBG	O
the	DT	O
first	JJ	O
transfection	NN	O
,	,	O
depending	VBG	O
on	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
observed	JJ	O
clones	NNS	O
.	.	O
One	CD	O
day	NN	O
before	IN	O
transfection	NN	O
,	,	O
half	NN	O
of	IN	O
the	DT	O
dishes	NNS	O
transfected	VBD	O
with	IN	O
E1AB21	NNP	O
alone	RB	O
is	VBZ	O
passed	VBN	O
to	TO	O
10	CD	O
cm	NN	O
dishes	NNS	O
and	CC	O
then	RB	O
re-transfected	JJ	O
,	,	O
the	DT	O
other	JJ	O
half	NN	O
of	IN	O
the	DT	O
dishes	NNS	O
is	VBZ	O
re-transfected	JJ	O
without	IN	O
prior	JJ	O
passage	NN	O
.	.	O
The	DT	O
transformed	JJ	O
clones	NNS	O
that	WDT	O
result	VBP	O
from	IN	O
these	DT	O
transfections	NNS	O
are	VBP	O
picked	VBN	O
and	CC	O
further	RBR	O
expanded	VBN	O
in	IN	O
96-well	CD	O
plates	NNS	O
and	CC	O
subsequent	JJ	O
larger	JJR	O
formats	NNS	O
.	.	O
The	DT	O
integration	NN	O
site	NN	O
and	CC	O
copy	JJ	O
number	NN	O
of	IN	O
the	DT	O
fragments	NNS	O
is	VBZ	O
investigated	VBN	O
with	IN	O
Southern	NNP	O
blots	NNS	O
and	CC	O
by	IN	O
PCR	NNP	O
to	TO	O
reveal	VB	O
whether	IN	O
insertions	NNS	O
occurred	VBD	O
in	IN	O
close	JJ	O
vicinity	NN	O
.	.	O
Clones	NNS	O
where	WRB	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
55K	CD	O
are	VBP	O
present	JJ	O
in	IN	O
single	JJ	O
copy	NN	O
,	,	O
or	CC	O
present	JJ	O
in	IN	O
more	JJR	O
than	IN	O
one	CD	O
copy	NN	O
but	CC	O
without	IN	O
inverted	JJ	O
repeat	NN	O
conformation	NN	O
of	IN	O
these	DT	O
sequences	NNS	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
transfected	JJ	O
cells	NNS	O
,	,	O
or	CC	O
wherein	VB	O
E1A	NNP	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
(	(	O
in	IN	O
this	DT	O
case	NN	O
E1B-55K	NNP	O
)	)	O
are	VBP	O
separated	VBN	O
by	IN	O
at	IN	O
least	JJS	O
4	CD	O
kb	NN	O
,	,	O
preferably	RB	O
by	IN	O
at	IN	O
least	JJS	O
10	CD	O
kb	NN	O
,	,	O
more	JJR	O
preferably	RB	O
by	IN	O
at	IN	O
least	JJS	O
34.5	CD	O
kb	NN	O
,	,	O
are	VBP	O
preferably	RB	O
used	VBN	O
further	RB	O
.	.	O
Example	RB	O
2	CD	O
Generation	NNP	O
of	IN	O
Complementing	NNP	O
Cell	NNP	O
Lines	NNP	O
Using	NNP	O
Nucleic	NNP	O
Acids	NNP	O
that	WDT	O
have	VBP	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
Regions	NNP	O
Separated	VBN	O
by	IN	O
Large	NNP	O
Spacer	NNP	O
Sequences	NNP	O
As	IN	O
described	VBN	O
in	IN	O
the	DT	O
previous	JJ	O
example	NN	O
,	,	O
it	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
generate	VB	O
stably	RB	O
transformed	VBN	O
cell	NN	O
clones	NNS	O
from	IN	O
primary	JJ	O
cells	NNS	O
using	VBG	O
separate	JJ	O
plasmids	NNS	O
for	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
.	.	O
However	RB	O
,	,	O
when	WRB	O
DNA	NN	O
fragments	NNS	O
are	VBP	O
transfected	VBN	O
together	RB	O
,	,	O
there	EX	O
is	VBZ	O
still	RB	O
a	DT	O
chance	NN	O
that	IN	O
the	DT	O
transfected	JJ	O
fragments	NNS	O
end	VBP	O
up	RP	O
in	IN	O
near	JJ	O
proximity	NN	O
of	IN	O
each	DT	O
other	JJ	O
,	,	O
although	IN	O
this	DT	O
chance	NN	O
is	VBZ	O
reduced	VBN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
considerable	JJ	O
sequence	NN	O
overlap	NN	O
.	.	O
The	DT	O
possibility	NN	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
expression	NN	O
cassette	NN	O
integration	NN	O
with	IN	O
less	JJR	O
than	IN	O
30	CD	O
kb	JJ	O
non-E1	JJ	O
sequence	NN	O
in	IN	O
between	IN	O
in	IN	O
the	DT	O
chromosome	NN	O
can	MD	O
be	VB	O
avoided	VBN	O
by	IN	O
flanking	VBG	O
the	DT	O
different	JJ	O
E1	NNP	O
expression	NN	O
cassettes	VBZ	O
with	IN	O
large	JJ	O
pieces	NNS	O
of	IN	O
non-	JJ	O
(	(	O
E1-	NNP	O
)	)	O
coding	VBG	O
DNA	NN	O
sequences	NNS	O
(	(	O
so	RB	O
called	VBN	O
“	NN	O
spacer	NN	O
”	NNP	O
fragments	NNS	O
)	)	O
.	.	O
If	IN	O
an	DT	O
E1A-carrying	JJ	O
fragment	NN	O
integrates	NNS	O
next	IN	O
to	TO	O
an	DT	O
E1B-containing	JJ	O
fragment	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
generated	JJ	O
packaging	NN	O
cell	NN	O
,	,	O
the	DT	O
large	JJ	O
flanking	NN	O
sequences	NNS	O
should	MD	O
create	VB	O
enough	JJ	O
distance	NN	O
to	TO	O
eliminate	VB	O
the	DT	O
chance	NN	O
that	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
encoding	VBG	O
sequences	NNS	O
recombine	VBP	O
into	IN	O
the	DT	O
same	JJ	O
recombinant	JJ	O
vector	NN	O
molecule	NN	O
upon	IN	O
propagation	NN	O
of	IN	O
a	DT	O
recombinant	JJ	O
adenoviral	JJ	O
vector	NN	O
in	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
.	.	O
Non-limiting	JJ	O
examples	NNS	O
of	IN	O
large	JJ	O
spacer	NN	O
DNA	NN	O
fragments	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
are	VBP	O
large	JJ	O
sequences	NNS	O
derived	VBN	O
from	IN	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
human	JJ	O
dystrophin	JJ	O
gene	NN	O
or	CC	O
the	DT	O
human	JJ	O
Apo-E1	NNP	O
gene	NN	O
.	.	O
Other	JJ	O
spacing	VBG	O
molecules	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
,	,	O
even	RB	O
from	IN	O
non-human	JJ	O
sources	NNS	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
flanking	NN	O
sequences	NNS	O
do	VBP	O
not	RB	O
contain	VB	O
coding	VBG	O
regions	NNS	O
for	IN	O
functional	JJ	O
proteins	NNS	O
and	CC	O
can	MD	O
thus	RB	O
be	VB	O
derived	VBN	O
from	IN	O
intron	NN	O
sequences	NNS	O
.	.	O
Also	RB	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
do	VBP	O
not	RB	O
need	VB	O
to	TO	O
be	VB	O
on	IN	O
different	JJ	O
molecules	NNS	O
but	CC	O
may	MD	O
be	VB	O
situated	VBN	O
on	IN	O
the	DT	O
same	JJ	O
large	JJ	O
molecule	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
cosmid	NN	O
.	.	O
Examples	NNS	O
of	IN	O
these	DT	O
E1A-	NNP	O
and	CC	O
E1B-carrying	NNP	O
molecules	NNS	O
are	VBP	O
given	VBN	O
in	IN	O
FIG	NNP	O
.	.	O
13	CD	O
.	.	O
In	IN	O
preferred	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
distance	NN	O
between	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
regions	NNS	O
is	VBZ	O
>	JJ	O
34.5	CD	O
kb	NN	O
because	IN	O
then	RB	O
co-insertion	NN	O
of	IN	O
the	DT	O
two	CD	O
regions	NNS	O
into	IN	O
a	DT	O
virus	NN	O
results	NNS	O
in	IN	O
a	DT	O
genome	NN	O
that	WDT	O
is	VBZ	O
too	RB	O
large	JJ	O
to	TO	O
be	VB	O
packaged	VBN	O
.	.	O
This	DT	O
situation	NN	O
will	MD	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
be	VB	O
reached	VBN	O
when	WRB	O
two	CD	O
separate	JJ	O
cosmid	NN	O
fragments	NNS	O
of	IN	O
approximately	RB	O
40	CD	O
kb	NNS	O
having	VBG	O
the	DT	O
expression	NN	O
cassettes	VBZ	O
roughly	RB	O
in	IN	O
the	DT	O
middle	NN	O
are	VBP	O
used	VBN	O
.	.	O
However	RB	O
,	,	O
assuming	VBG	O
that	IN	O
E1	NNP	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
inverted	JJ	O
repeat	NN	O
structures	NNS	O
contributes	VBZ	O
to	TO	O
the	DT	O
frequency	NN	O
of	IN	O
HDEP	NNP	O
generation	NN	O
,	,	O
then	RB	O
a	DT	O
construct	NN	O
where	WRB	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
cassettes	NNS	O
are	VBP	O
located	VBN	O
on	IN	O
a	DT	O
single	JJ	O
cosmid	NN	O
fragment	NN	O
of	IN	O
a	DT	O
total	JJ	O
length	NN	O
of	IN	O
approximately	RB	O
22	CD	O
kb	NNS	O
(	(	O
like	IN	O
in	IN	O
FIG	NNP	O
.	.	O
13	CD	O
,	,	O
Panel	NNP	O
I	PRP	O
)	)	O
suffices	NNS	O
even	RB	O
when	WRB	O
a	DT	O
second	JJ	O
copy	NN	O
would	MD	O
become	VB	O
located	VBN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cell	NN	O
in	IN	O
inverted	JJ	O
orientation	NN	O
next	IN	O
to	TO	O
the	DT	O
first	JJ	O
.	.	O
Full	NNP	O
integration	NN	O
of	IN	O
the	DT	O
mirror-imaged	JJ	O
structure	NN	O
would	MD	O
then	RB	O
also	RB	O
involve	VBP	O
a	DT	O
fragment	NN	O
of	IN	O
>	$	O
38	CD	O
kb	NN	O
.	.	O
Also	RB	O
,	,	O
if	IN	O
the	DT	O
presence	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
increases	VBZ	O
the	DT	O
frequency	NN	O
of	IN	O
HDEP	NNP	O
formation	NN	O
,	,	O
then	RB	O
a	DT	O
situation	NN	O
where	WRB	O
multiple	JJ	O
copies	NNS	O
are	VBP	O
integrated	VBN	O
as	IN	O
direct	JJ	O
repeats	NN	O
is	VBZ	O
considered	VBN	O
less	JJR	O
of	IN	O
a	DT	O
problem	NN	O
even	RB	O
when	WRB	O
the	DT	O
DNA	NNP	O
fragment	NN	O
that	WDT	O
includes	VBZ	O
two	CD	O
full	JJ	O
copies	NNS	O
of	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
has	VBZ	O
a	DT	O
length	NN	O
of	IN	O
<	$	O
20	CD	O
kb	NN	O
.	.	O
In	IN	O
the	DT	O
absence	NN	O
of	IN	O
inverted	JJ	O
repeats	NNS	O
,	,	O
integration	NN	O
of	IN	O
any	DT	O
E1-containing	JJ	O
fragment	NN	O
larger	JJR	O
than	IN	O
the	DT	O
space	NN	O
left	VBD	O
in	IN	O
the	DT	O
recombinant	JJ	O
virus	NN	O
(	(	O
i.e.	JJ	O
,	,	O
38	CD	O
kb	NN	O
minus	CC	O
actual	JJ	O
genome	NN	O
length	NN	O
of	IN	O
recombinant	JJ	O
virus	NN	O
)	)	O
into	IN	O
the	DT	O
recombinant	JJ	O
virus	NN	O
forces	NNS	O
it	PRP	O
to	TO	O
delete	VB	O
parts	NNS	O
of	IN	O
the	DT	O
essential	JJ	O
viral	JJ	O
sequences	NNS	O
as	IN	O
a	DT	O
sequential	JJ	O
step	NN	O
to	TO	O
ensure	VB	O
packaging	NN	O
and	CC	O
thus	RB	O
propagation	NN	O
.	.	O
Analysis	NN	O
of	IN	O
the	DT	O
first	JJ	O
HDEP	NNP	O
genome	NN	O
that	WDT	O
arose	VBD	O
via	IN	O
homologous	JJ	O
recombination	NN	O
(	(	O
Murakami	NNP	B
et	RB	I
al.	RB	I
,	,	I
2002	CD	I
)	)	O
showed	VBD	O
that	IN	O
deletion	NN	O
of	IN	O
viral	JJ	O
sequences	NNS	O
is	VBZ	O
possible	JJ	O
.	.	O
DNA	NN	O
sequences	NNS	O
that	WDT	O
integrate	VBP	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
a	DT	O
cell	NN	O
are	VBP	O
not	RB	O
always	RB	O
accessible	JJ	O
for	IN	O
activating	VBG	O
transcription	NN	O
factors	NNS	O
due	JJ	O
to	TO	O
chromatin-associated	JJ	O
repression	NN	O
.	.	O
Especially	RB	O
when	WRB	O
large	JJ	O
fragments	NNS	O
of	IN	O
intron	NN	O
DNA	NN	O
are	VBP	O
used	VBN	O
that	IN	O
originate	NN	O
from	IN	O
genomic	JJ	O
regions	NNS	O
that	WDT	O
are	VBP	O
normally	RB	O
not	RB	O
active	JJ	O
in	IN	O
the	DT	O
cell	NN	O
that	WDT	O
will	MD	O
be	VB	O
transduced	VBN	O
with	IN	O
these	DT	O
sequences	NNS	O
,	,	O
gene	NN	O
expression	NN	O
may	MD	O
be	VB	O
shut-off	JJ	O
due	JJ	O
to	TO	O
inactive	JJ	O
chromatin	NN	O
.	.	O
Recently	RB	O
,	,	O
sequences	NNS	O
were	VBD	O
identified	VBN	O
that	IN	O
can	MD	O
inhibit	VB	O
this	DT	O
repression	NN	O
.	.	O
Examples	NNS	O
are	VBP	O
the	DT	O
chicken	JJ	O
β-globin	JJ	O
HS4	NNP	O
element	NN	O
(	(	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,610,053	CD	O
)	)	O
that	WDT	O
functions	VBZ	O
as	IN	O
an	DT	O
insulator	NN	O
sequence	NN	O
,	,	O
a	DT	O
Drosophila	NNP	O
scs	NN	O
or	CC	O
scs′	JJ	O
element	NN	O
(	(	O
Kellum	NNP	B
et	RB	I
al.	RB	I
,	,	I
1991	CD	I
;	:	O
Farkas	NNP	B
et	FW	I
al.	NN	I
,	,	I
1992	CD	I
)	)	O
,	,	O
and	CC	O
a	DT	O
series	NN	O
of	IN	O
sequences	NNS	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
(	(	O
so-called	JJ	O
anti-repressor	NN	O
elements	NNS	O
or	CC	O
STAR	NNP	O
elements	NNS	O
)	)	O
identified	VBN	O
by	IN	O
a	DT	O
specific	JJ	O
screen	NN	O
for	IN	O
anti-repressor	JJ	O
elements	NNS	O
(	(	O
Kwaks	NNP	B
et	RB	I
al.	RB	I
,	,	I
2003	CD	I
;	:	O
WO	NNP	O
03/004704	CD	O
)	)	O
.	.	O
Incorporation	NN	O
of	IN	O
such	JJ	O
sequences	NNS	O
in	IN	O
the	DT	O
E1	NNP	O
A	NNP	O
and	CC	O
E1B	NNP	O
expression	NN	O
constructs	NNS	O
,	,	O
which	WDT	O
sequences	VBZ	O
prevent	JJ	O
positional	JJ	O
silencing	NN	O
of	IN	O
the	DT	O
E1A	NNP	O
and/or	NN	O
E1B	NNP	O
genes	NNS	O
,	,	O
also	RB	O
enhances	VBZ	O
the	DT	O
amount	NN	O
of	IN	O
immortalized	JJ	O
clones	NNS	O
.	.	O
Therefore	RB	O
,	,	O
in	IN	O
certain	JJ	O
embodiments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
one	CD	O
or	CC	O
more	JJR	O
STAR-elements	NNS	O
,	,	O
for	IN	O
instance	NN	O
,	,	O
STAR	NNP	O
7	CD	O
(	(	O
Genbank	NNP	O
accession	NN	O
number	NN	O
AY190751	NNP	O
)	)	O
or	CC	O
STAR	$	O
40	CD	O
(	(	O
Genbank	NNP	O
accession	NN	O
number	NN	O
AY190756	NNP	O
)	)	O
,	,	O
are	VBP	O
present	JJ	O
in	IN	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
E1A	NNP	O
and/or	NN	O
E1B	NNP	O
expression	NN	O
constructs	NNS	O
.	.	O
The	DT	O
elements	NNS	O
may	MD	O
flanking	VB	O
both	DT	O
sides	NNS	O
of	IN	O
the	DT	O
E1A	NNP	O
and/or	NN	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
i.e.	NN	O
,	,	O
the	DT	O
expression	NN	O
constructs	NNS	O
may	MD	O
comprise	VB	O
from	IN	O
5′	CD	O
to	TO	O
3′	CD	O
:	:	O
STAR	NN	O
element—expression	NN	O
regulatory	JJ	O
sequence	NN	O
(	(	O
e.g.	JJ	O
,	,	O
promoter	NN	O
)	)	O
—E1A	VBZ	O
coding	VBG	O
sequence	NN	O
;	:	O
or	CC	O
E1A+	VB	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
;	:	O
or	CC	O
one	CD	O
E1B	NNP	O
coding	VBG	O
sequence	NN	O
;	:	O
or	CC	O
both	DT	O
E1B	NNP	O
coding	VBG	O
sequences—polyadenylation	NN	O
sequence—STAR	NN	O
element	NN	O
.	.	O
Example	RB	O
3	CD	O
Generation	NNP	O
of	IN	O
Cell	NNP	O
Lines	NNP	O
with	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
on	IN	O
Separate	NNP	O
Constructs	NNP	O
and	CC	O
Flanked	VBN	O
by	IN	O
Stuffer	NNP	O
DNA	NNP	O
This	DT	O
example	NN	O
describes	VBZ	O
the	DT	O
generation	NN	O
of	IN	O
new	JJ	O
cell	NN	O
lines	NNS	O
described	VBN	O
herein	RB	O
by	IN	O
co-transfection	NN	O
of	IN	O
a	DT	O
first	JJ	O
DNA	NNP	O
fragment	NN	O
having	VBG	O
an	DT	O
E1A	NNP	O
expression	NN	O
cassette	NN	O
flanked	VBN	O
by	IN	O
large	JJ	O
stuffer	NN	O
DNA	NN	O
and	CC	O
a	DT	O
second	JJ	O
DNA	NNP	O
fragment	NN	O
having	VBG	O
an	DT	O
E1B	NNP	O
expression	NN	O
cassette	NN	O
flanked	VBN	O
by	IN	O
plasmid	JJ	O
DNA	NNP	O
.	.	O
The	DT	O
human	JJ	O
dystrophin	NN	O
intron	NN	O
44	CD	O
sequence	NN	O
(	(	O
Genbank	NNP	O
Acc	NNP	O
.	.	O
No	DT	O
.	.	O
M86524	NNP	O
)	)	O
cloned	VBD	O
in	IN	O
a	DT	O
cosmid	NN	O
vector	NN	O
backbone	NN	O
(	(	O
pdys44	NN	O
;	:	O
FIG	NNP	O
.	.	O
17	CD	O
)	)	O
was	VBD	O
taken	VBN	O
in	IN	O
this	DT	O
example	NN	O
as	IN	O
a	DT	O
stuffer	NN	O
DNA	NN	O
surrounding	VBG	O
the	DT	O
E1A	NNP	O
expression	NN	O
plasmid	NN	O
.	.	O
Construct	NN	O
pCC.E1A	NN	O
(	(	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
;	:	O
FIG	NNP	O
.	.	O
4	CD	O
)	)	O
was	VBD	O
digested	VBN	O
with	IN	O
AflIII	NNP	O
and	CC	O
AvrII	NNP	O
(	(	O
New	NNP	O
England	NNP	O
Biolabs	NNP	O
)	)	O
and	CC	O
protruding	VBG	O
ends	NNS	O
were	VBD	O
made	VBN	O
blunt	NN	O
with	IN	O
Klenow	NNP	O
enzyme	FW	O
(	(	O
New	NNP	O
England	NNP	O
Biolabs	NNP	O
)	)	O
.	.	O
Digested	VBN	O
fragments	NNS	O
were	VBD	O
separated	VBN	O
on	IN	O
a	DT	O
0.5	CD	O
%	NN	O
TAE	NNP	O
agarose	JJ	O
gel	NN	O
and	CC	O
the	DT	O
2	CD	O
kb	NN	O
fragment	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
PGK-E1A	NNP	O
expression	NN	O
cassette	NN	O
was	VBD	O
purified	VBN	O
using	VBG	O
the	DT	O
gel	NN	O
extraction	NN	O
kit	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
according	VBG	O
to	TO	O
the	DT	O
manufacturer	NN	O
's	POS	O
description	NN	O
.	.	O
The	DT	O
construct	NN	O
pdys44	NN	O
(	(	O
FIG	NNP	O
.	.	O
17	CD	O
)	)	O
was	VBD	O
digested	VBN	O
with	IN	O
BglII	NNP	O
(	(	O
New	NNP	O
England	NNP	O
Biolabs	NNP	O
)	)	O
and	CC	O
protruding	VBG	O
ends	NNS	O
were	VBD	O
made	VBN	O
blunt	NN	O
with	IN	O
Klenow	NNP	O
enzyme	NN	O
.	.	O
Fragments	NNS	O
were	VBD	O
separated	VBN	O
on	IN	O
a	DT	O
0.5	CD	O
%	NN	O
TAE	NNP	O
agarose	JJ	O
gel	NN	O
and	CC	O
the	DT	O
27	CD	O
kb	NN	O
fragment	NN	O
containing	VBG	O
the	DT	O
backbone	NN	O
plasmid	NN	O
and	CC	O
part	NN	O
of	IN	O
the	DT	O
dystrophin	JJ	O
intron	NN	O
was	VBD	O
excised	VBN	O
.	.	O
The	DT	O
gel	NN	O
slice	NN	O
was	VBD	O
then	RB	O
put	VBN	O
in	IN	O
a	DT	O
syringe	NN	O
containing	VBG	O
a	DT	O
bit	NN	O
of	IN	O
glass	NN	O
wool	NN	O
and	CC	O
,	,	O
using	VBG	O
the	DT	O
plunger	NN	O
,	,	O
the	DT	O
buffer	NN	O
containing	VBG	O
DNA	NNP	O
was	VBD	O
pushed	VBN	O
in	IN	O
an	DT	O
Eppendorf	NNP	O
tube	NN	O
.	.	O
The	DT	O
thus	RB	O
obtained	VBN	O
DNA	NNP	O
solution	NN	O
contained	VBD	O
approximately	RB	O
5	CD	O
ng/μl	NNS	O
and	CC	O
was	VBD	O
used	VBN	O
directly	RB	O
in	IN	O
the	DT	O
ligation	NN	O
reaction	NN	O
with	IN	O
the	DT	O
purified	JJ	O
2	CD	O
kb	JJ	O
PGK-E1A	JJ	O
fragment	NN	O
.	.	O
Transformation	NN	O
into	IN	O
DH5αT1-competent	NNP	O
cells	NNS	O
resulted	VBD	O
in	IN	O
construct	NN	O
p44-1.ccE1A	NN	O
(	(	O
FIG	NNP	O
.	.	O
18	CD	O
)	)	O
.	.	O
The	DT	O
construct	NN	O
contains	VBZ	O
E1A	NNP	O
under	IN	O
control	NN	O
of	IN	O
the	DT	O
human	JJ	O
PGK	NNP	O
promoter	NN	O
and	CC	O
a	DT	O
synthetic	JJ	O
polyA	NN	O
signal	NN	O
.	.	O
Construct	NN	O
pE1B	NN	O
(	(	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
;	:	O
FIG	NNP	O
.	.	O
3	LS	O
)	)	O
was	VBD	O
used	VBN	O
in	IN	O
this	DT	O
example	NN	O
as	IN	O
the	DT	O
E1B	NNP	O
expression	NN	O
plasmid	NN	O
.	.	O
The	DT	O
plasmid	NN	O
contains	VBZ	O
E1B	NNP	O
under	IN	O
control	NN	O
of	IN	O
its	PRP$	O
own	JJ	O
promoter	NN	O
and	CC	O
a	DT	O
hepatitis	NN	O
B	NNP	O
virus	NN	O
(	(	O
HBV	NNP	O
)	)	O
polyA	VBP	O
signal	NN	O
.	.	O
Construct	NNP	O
p44-1.ccE1A	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
XhoI	NNP	O
and	CC	O
PmeI	NNP	O
and	CC	O
digested	VBD	O
DNA	NNP	O
was	VBD	O
purified	VBN	O
by	IN	O
phenol/chloroform	NN	O
(	(	O
1:1	CD	O
)	)	O
extraction	NN	O
followed	VBN	O
by	IN	O
Ethanol	NNP	O
precipitation	NN	O
(	(	O
resulting	VBG	O
in	IN	O
E1A	NNP	O
coding	VBG	O
sequences	NNS	O
flanked	VBN	O
by	IN	O
a	DT	O
stuffer	NN	O
of	IN	O
about	IN	O
11.6	CD	O
kb	NNS	O
upstream	RB	O
(	(	O
including	VBG	O
the	DT	O
PGK	NNP	O
promoter	NN	O
)	)	O
and	CC	O
about	IN	O
6.5	CD	O
kb	NNS	O
downstream	NN	O
(	(	O
including	VBG	O
the	DT	O
synthetic	JJ	O
polyA	NN	O
signal	NN	O
)	)	O
of	IN	O
the	DT	O
E1A	NNP	O
coding	NN	O
sequences	NNS	O
)	)	O
.	.	O
DNA	NN	O
was	VBD	O
then	RB	O
pelleted	VBN	O
,	,	O
washed	VBN	O
with	IN	O
70	CD	O
%	NN	O
ethanol	NN	O
and	CC	O
aseptically	RB	O
dissolved	VBN	O
in	IN	O
sterile	JJ	O
endotoxin-free	JJ	O
TE	NNP	O
.	.	O
Plasmid	NNP	O
pE1B	NN	O
was	VBD	O
digested	VBN	O
with	IN	O
ScaI	NNP	O
and	CC	O
purified	VBD	O
as	IN	O
above	IN	O
(	(	O
resulting	VBG	O
in	IN	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
flanked	VBN	O
by	IN	O
a	DT	O
stuffer	NN	O
of	IN	O
about	IN	O
1.4	CD	O
kb	NNS	O
upstream	RB	O
and	CC	O
more	JJR	O
than	IN	O
2.3	CD	O
kb	JJ	O
downstream	NN	O
of	IN	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
the	DT	O
downstream	NN	O
stuffer	NN	O
including	VBG	O
the	DT	O
HBV	NNP	O
polyA	NN	O
sequence	NN	O
)	)	O
.	.	O
Primary	JJ	O
human	VBD	O
HER	NNP	O
cells	NNS	O
were	VBD	O
cultured	VBN	O
and	CC	O
transfected	VBN	O
on	IN	O
passage	NN	O
number	NN	O
6	CD	O
(	(	O
PN6	NNP	O
)	)	O
in	IN	O
one	CD	O
series	NN	O
of	IN	O
transfections	NNS	O
and	CC	O
on	IN	O
PN9	NNP	O
in	IN	O
a	DT	O
second	JJ	O
series	NN	O
of	IN	O
transfections	NNS	O
.	.	O
HER	PRP$	O
cell	NN	O
culture	NN	O
and	CC	O
transfections	NNS	O
were	VBD	O
done	VBN	O
according	VBG	O
to	TO	O
the	DT	O
method	NN	O
described	VBN	O
in	IN	O
Example	NNP	O
1	CD	O
.	.	O
The	DT	O
E1A-	NNP	O
and	CC	O
E1B-containing	NNP	O
DNAs	NNP	O
prepared	VBD	O
above	IN	O
were	VBD	O
mixed	JJ	O
in	IN	O
different	JJ	O
proportions	NNS	O
in	IN	O
separate	JJ	O
transfections	NNS	O
(	(	O
both	DT	O
fragments	NNS	O
lack	VBP	O
significant	JJ	O
overlap	NN	O
with	IN	O
respect	NN	O
to	TO	O
each	DT	O
other	JJ	O
)	)	O
,	,	O
derived	VBN	O
from	IN	O
vector	NN	O
sequences	NNS	O
or	CC	O
regulatory	JJ	O
sequences	NNS	O
,	,	O
thereby	RB	O
reducing	VBG	O
the	DT	O
chances	NNS	O
of	IN	O
homologous	JJ	O
recombination	NN	O
between	IN	O
the	DT	O
two	CD	O
fragments	NNS	O
.	.	O
If	IN	O
both	DT	O
fragments	NNS	O
would	MD	O
form	VB	O
a	DT	O
single	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
(	(	O
e.g.	NN	O
,	,	O
by	IN	O
end-to-end	JJ	O
joining	NN	O
or	CC	O
ligation	NN	O
,	,	O
a	DT	O
theoretical	JJ	O
possibility	NN	O
)	)	O
and	CC	O
subsequently	RB	O
integrate	VB	O
into	IN	O
the	DT	O
genome	NN	O
as	IN	O
a	DT	O
single	JJ	O
unit	NN	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	VBG	O
sequences	NNS	O
in	IN	O
the	DT	O
resulting	JJ	O
cells	NNS	O
would	MD	O
be	VB	O
separated	VBN	O
by	IN	O
more	JJR	O
than	IN	O
4	CD	O
kb	NN	O
of	IN	O
stuffer	NN	O
sequences	NNS	O
(	(	O
at	IN	O
least	JJS	O
6.5	CD	O
kb	NN	O
(	(	O
downstream	JJ	O
E1A	NNP	O
)	)	O
+1.4	VBP	O
kb	NN	O
(	(	O
upstream	JJ	O
E1B	NNP	O
)	)	O
=	VBP	O
at	IN	O
least	JJS	O
7.9	CD	O
kb	NN	O
between	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
,	,	O
in	IN	O
theory	NN	O
)	)	O
.	.	O
A	DT	O
total	NN	O
of	IN	O
eight	CD	O
dishes	NNS	O
were	VBD	O
transfected	VBN	O
with	IN	O
approximate	JJ	O
equimolar	JJ	O
ratios	NNS	O
of	IN	O
both	DT	O
constructs	NNS	O
(	(	O
17	CD	O
μg	NNP	O
E1A	NNP	O
and	CC	O
3	CD	O
μg	NN	O
E1B	NNP	O
plasmid	NN	O
)	)	O
and	CC	O
three	CD	O
dishes	NNS	O
were	VBD	O
transfected	VBN	O
with	IN	O
10	CD	O
μg	NNS	O
of	IN	O
each	DT	O
fragment	NN	O
.	.	O
Foci	NNP	O
were	VBD	O
observed	VBN	O
in	IN	O
both	DT	O
series	NN	O
of	IN	O
transfections	NNS	O
but	CC	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
10	CD	O
μg	NNS	O
of	IN	O
each	DT	O
construct	NN	O
,	,	O
relatively	RB	O
more	RBR	O
foci	NNS	O
were	VBD	O
obtained	VBN	O
.	.	O
Construct	NNP	O
pIG.E1A.E1B	NN	O
digested	VBD	O
with	IN	O
Asel	NNP	O
and	CC	O
BglI	NNP	O
was	VBD	O
used	VBN	O
as	IN	O
a	DT	O
positive	JJ	O
control	NN	O
(	(	O
20	CD	O
μg	NNP	O
DNA/dish	NNP	O
)	)	O
on	IN	O
separate	JJ	O
dishes	NNS	O
.	.	O
As	IN	O
expected	VBN	O
,	,	O
the	DT	O
efficiency	NN	O
of	IN	O
foci	JJ	O
formation	NN	O
was	VBD	O
higher	RBR	O
with	IN	O
the	DT	O
(	(	O
single	JJ	O
)	)	O
positive	JJ	O
control	NN	O
plasmid	NN	O
than	IN	O
with	IN	O
the	DT	O
two	CD	O
separate	JJ	O
fragments	NNS	O
(	(	O
from	IN	O
p44-1.ccE1A	NN	O
and	CC	O
pE1B	NN	O
)	)	O
.	.	O
The	DT	O
pIG.E1A.E1B	NN	O
plasmid	NN	O
was	VBD	O
approximately	RB	O
ten	JJ	O
times	NNS	O
more	RBR	O
efficient	JJ	O
.	.	O
Still	RB	O
,	,	O
both	DT	O
with	IN	O
the	DT	O
positive	JJ	O
control	NN	O
plasmid	NN	O
and	CC	O
with	IN	O
the	DT	O
two-fragment	JJ	O
transfection	NN	O
,	,	O
about	RB	O
80	CD	O
to	TO	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
transformed	VBN	O
cell	NN	O
clones	NNS	O
that	WDT	O
were	VBD	O
picked	VBN	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
viable	JJ	O
and	CC	O
established	VBN	O
as	IN	O
a	DT	O
cell	NN	O
line	NN	O
.	.	O
These	DT	O
experiments	NNS	O
clearly	RB	O
show	VBP	O
that	IN	O
it	PRP	O
is	VBZ	O
feasible	JJ	O
to	TO	O
transform	VB	O
primary	JJ	O
cells	NNS	O
by	IN	O
co-transfection	NN	O
with	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
genes	NNS	O
on	IN	O
separate	JJ	O
DNA	NN	O
fragments	NNS	O
and	CC	O
flanked	VBN	O
by	IN	O
(	(	O
non-overlapping	JJ	O
)	)	O
stuffer	NN	O
DNA	NN	O
.	.	O
A	DT	O
total	NN	O
of	IN	O
six	CD	O
clones	NNS	O
,	,	O
HER01-B-71	NNP	O
(	(	O
deposited	VBN	O
on	IN	O
1	CD	O
Oct.	NNP	O
2004	CD	O
at	IN	O
the	DT	O
European	JJ	O
Collection	NNP	O
of	IN	O
Cell	NNP	O
Cultures	NNP	O
(	(	O
ECACC	NNP	O
)	)	O
under	IN	O
number	NN	O
04100101	CD	O
)	)	O
,	,	O
HER01-H-87	NNP	O
(	(	O
deposited	VBN	O
on	IN	O
1	CD	O
Oct.	NNP	O
2004	CD	O
at	IN	O
the	DT	O
ECACC	NNP	O
under	IN	O
number	NN	O
04100102	CD	O
)	)	O
,	,	O
HER01-H-86	NNP	O
,	,	O
HER01-H-88	NNP	O
,	,	O
HER01-H-89	NNP	O
and	CC	O
HER01-B-90	NNP	O
,	,	O
were	VBD	O
analyzed	VBN	O
further	RB	O
.	.	O
Expression	NN	O
of	IN	O
the	DT	O
E1	NNP	O
genes	NNS	O
was	VBD	O
analyzed	VBN	O
using	VBG	O
specific	JJ	O
antibodies	NNS	O
for	IN	O
the	DT	O
E1	NNP	O
proteins	VBZ	O
on	IN	O
Western	JJ	O
Blots	NNP	O
.	.	O
A	DT	O
total	JJ	O
amount	NN	O
of	IN	O
10	CD	O
μg	NNS	O
protein	RB	O
from	IN	O
a	DT	O
lysate	NN	O
of	IN	O
the	DT	O
generated	VBN	O
cell	NN	O
clones	NNS	O
was	VBD	O
used	VBN	O
in	IN	O
the	DT	O
Western	JJ	O
blot	NN	O
assay	NN	O
.	.	O
The	DT	O
samples	NNS	O
were	VBD	O
denatured	VBN	O
for	IN	O
15	CD	O
minutes	NNS	O
at	IN	O
70°	CD	O
C.	NNP	O
after	IN	O
addition	NN	O
of	IN	O
¼	JJ	O
volume	NN	O
NuPage	NNP	O
sample	NN	O
buffer	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
.	.	O
As	IN	O
a	DT	O
positive	JJ	O
control	NN	O
,	,	O
PER.C6®	NNP	O
cell	NN	O
lysate	NN	O
was	VBD	O
used	VBN	O
.	.	O
Untransfected	JJ	O
primary	NN	O
HER	NNP	O
cell	NN	O
lysate	NN	O
(	(	O
passage	JJ	O
number	NN	O
6	CD	O
)	)	O
served	VBD	O
as	IN	O
a	DT	O
negative	JJ	O
control	NN	O
.	.	O
The	DT	O
samples	NNS	O
were	VBD	O
run	VBN	O
on	IN	O
a	DT	O
10	CD	O
%	NN	O
BisTris	NNP	O
SDS	NNP	O
page	NN	O
gel	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
,	,	O
alongside	RB	O
a	DT	O
Seeblue	NNP	O
plus2	NN	O
prestained	VBD	O
marker	NN	O
(	(	O
Invitrogen	NNP	O
)	)	O
.	.	O
A	DT	O
Western	JJ	O
blot	NN	O
was	VBD	O
prepared	VBN	O
from	IN	O
the	DT	O
gel	NN	O
.	.	O
The	DT	O
following	JJ	O
antibodies	NNS	O
were	VBD	O
used	VBN	O
:	:	O
either	DT	O
1	CD	O
)	)	O
E1A	NN	O
:	:	O
mouse	NN	O
anti-human	JJ	O
Ad2.E1A	NNP	O
(	(	O
1:400	CD	O
,	,	O
Santa	NNP	O
Cruz	NNP	O
)	)	O
,	,	O
or	CC	O
2	CD	O
)	)	O
E1B.19K	NN	O
:	:	O
rat	NN	O
anti-human	JJ	O
E1B	NNP	O
21K	CD	O
monoclonal	NN	O
(	(	O
1:500	CD	O
,	,	O
Oncogene	NNP	O
)	)	O
,	,	O
or	CC	O
3	CD	O
)	)	O
E1B.55K	NN	O
:	:	O
mouse	NN	O
anti-human	JJ	O
55	CD	O
Kda	NNP	O
(	(	O
harvested	VBN	O
from	IN	O
hybridoma	NN	O
cell	NN	O
line	NN	O
C9A1C6	NNP	O
,	,	O
obtained	VBN	O
from	IN	O
Dr.	NNP	O
R.	NNP	O
Hoeben	NNP	O
,	,	O
LUMC	NNP	O
,	,	O
Leiden	NNP	O
)	)	O
.	.	O
The	DT	O
following	JJ	O
antibodies	NNS	O
were	VBD	O
used	VBN	O
as	IN	O
a	DT	O
second	JJ	O
antibody	NN	O
:	:	O
1	CD	O
)	)	O
E1A	NN	O
:	:	O
Goat-anti	JJ	O
mouse	NN	O
IgG-HRP	NNP	O
(	(	O
Biorad	NNP	O
)	)	O
,	,	O
2	CD	O
)	)	O
E1B.19K	NN	O
:	:	O
Goat-anti	JJ	O
rat	NN	O
IgG-HRP	NNP	O
(	(	O
Epcam	NNP	O
)	)	O
,	,	O
3	CD	O
)	)	O
E1B.55K	NN	O
:	:	O
μl	JJ	O
Goat-anti	NNP	O
mouse	NN	O
IgG-HRP	NNP	O
(	(	O
Biorad	NNP	O
)	)	O
.	.	O
The	DT	O
proteins	NNS	O
were	VBD	O
visualized	VBN	O
by	IN	O
the	DT	O
use	NN	O
of	IN	O
an	DT	O
ECL+assay	NNP	O
(	(	O
Amersham	NNP	O
)	)	O
.	.	O
From	IN	O
these	DT	O
experiments	NNS	O
,	,	O
it	PRP	O
is	VBZ	O
clear	JJ	O
that	IN	O
all	DT	O
tested	VBN	O
clones	NNS	O
express	RBR	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
proteins	NNS	O
and	CC	O
that	IN	O
the	DT	O
levels	NNS	O
are	VBP	O
comparable	JJ	O
to	TO	O
those	DT	O
in	IN	O
PER.C6®	NNP	O
cells	NNS	O
(	(	O
FIG	NNP	O
.	.	O
19	CD	O
)	)	O
.	.	O
This	DT	O
confirms	VBZ	O
that	IN	O
the	DT	O
transformation	NN	O
of	IN	O
the	DT	O
primary	JJ	O
cells	NNS	O
is	VBZ	O
indeed	RB	O
induced	VBN	O
by	IN	O
Ad5	NNP	O
E1	NNP	O
expression	NN	O
and	CC	O
not	RB	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
spontaneous	JJ	O
event	NN	O
.	.	O
Functional	JJ	O
expression	NN	O
of	IN	O
Ad5	NNP	O
E1	NNP	O
genes	NNS	O
in	IN	O
these	DT	O
cell	NN	O
lines	NNS	O
can	MD	O
also	RB	O
be	VB	O
tested	VBN	O
by	IN	O
showing	VBG	O
that	IN	O
the	DT	O
cells	NNS	O
are	VBP	O
able	JJ	O
to	TO	O
complement	VB	O
E1-deleted	JJ	O
Ad5	NNP	O
viruses	NNS	O
.	.	O
Therefore	RB	O
,	,	O
the	DT	O
six	CD	O
different	JJ	O
cell	NN	O
clones	NNS	O
were	VBD	O
tested	VBN	O
for	IN	O
replication	NN	O
of	IN	O
an	DT	O
Ad5.eGFP	NNP	O
vector	NN	O
,	,	O
an	DT	O
E1-deleted	JJ	O
(	(	O
deletion	NN	O
of	IN	O
nt	NN	O
.	.	O
455-3510	CD	O
of	IN	O
the	DT	O
Ad5	NNP	O
sequence	NN	O
)	)	O
Ad5-based	JJ	O
adenovirus	NN	O
vector	NN	O
expressing	VBG	O
Green	JJ	O
Fluorescent	NNP	O
Protein	NNP	O
.	.	O
Hereto	NNP	O
,	,	O
cells	NNS	O
were	VBD	O
seeded	VBN	O
at	IN	O
a	DT	O
density	NN	O
of	IN	O
1×106	CD	O
cells/well	NN	O
and	CC	O
infected	VBD	O
the	DT	O
day	NN	O
after	IN	O
with	IN	O
a	DT	O
multiplicity	NN	O
of	IN	O
infection	NN	O
(	(	O
MOI	NNP	O
)	)	O
of	IN	O
five	CD	O
virus	NNS	O
particles	NNS	O
(	(	O
VP	NNP	O
)	)	O
/cell	NN	O
.	.	O
As	IN	O
a	DT	O
positive	JJ	O
control	NN	O
,	,	O
PER.C6®	NNP	O
cells	NNS	O
were	VBD	O
also	RB	O
seeded	VBN	O
and	CC	O
infected	VBN	O
with	IN	O
an	DT	O
MOI	NNP	O
of	IN	O
5	CD	O
.	.	O
Five	CD	O
days	NNS	O
later	RB	O
,	,	O
full	JJ	O
cytopathogenic	NN	O
effect	NN	O
(	(	O
CPE	NNP	O
)	)	O
was	VBD	O
seen	VBN	O
in	IN	O
all	DT	O
wells	NNS	O
.	.	O
Cells	NNS	O
and	CC	O
medium	NN	O
were	VBD	O
harvested	VBN	O
,	,	O
freeze/thawed	VBD	O
three	CD	O
times	NNS	O
and	CC	O
centrifuged	VBD	O
to	TO	O
remove	VB	O
cell	NN	O
debris	NN	O
.	.	O
Supernatants	NNS	O
(	(	O
crude	VB	O
lysates	NNS	O
)	)	O
were	VBD	O
then	RB	O
used	VBN	O
to	TO	O
infect	VB	O
A549	NNP	O
cells	NNS	O
.	.	O
Hereto	NNP	O
,	,	O
5×105	CD	O
A549	NNP	O
cells	NNS	O
were	VBD	O
seeded	VBN	O
in	IN	O
24-well	JJ	O
plates	NNS	O
and	CC	O
one	CD	O
day	NN	O
later	RB	O
infected	VBN	O
with	IN	O
50	CD	O
μl	NNS	O
of	IN	O
the	DT	O
crude	NN	O
lysates	VBZ	O
.	.	O
Two	CD	O
days	NNS	O
later	RB	O
,	,	O
A549	NNP	O
cells	NNS	O
were	VBD	O
harvested	VBN	O
and	CC	O
analyzed	VBN	O
for	IN	O
GFP	NNP	O
expression	NN	O
by	IN	O
FACS	NNP	O
.	.	O
Results	NNS	O
show	VBP	O
that	IN	O
all	DT	O
clones	NNS	O
are	VBP	O
able	JJ	O
to	TO	O
complement	VB	O
an	DT	O
Ad5.eGFP	NNP	O
vector	NN	O
(	(	O
FIG	NNP	O
.	.	O
20	CD	O
)	)	O
.	.	O
Notably	RB	O
,	,	O
the	DT	O
adenovirus	NN	O
vector	NN	O
(	(	O
E1-deleted	JJ	O
,	,	O
lacks	VBZ	O
nt	JJ	O
455-3510	NN	O
)	)	O
has	VBZ	O
no	DT	O
overlap	NN	O
with	IN	O
the	DT	O
E1	NNP	O
sequences	NNS	O
present	NN	O
in	IN	O
the	DT	O
cell	NN	O
line	NN	O
(	(	O
Ad5	NNP	O
nt	RB	O
459-3510	JJ	O
)	)	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
the	DT	O
combination	NN	O
of	IN	O
adenovirus	JJ	O
vector	NN	O
with	IN	O
the	DT	O
new	JJ	O
cell	NN	O
lines	NNS	O
in	IN	O
this	DT	O
example	NN	O
amounts	VBZ	O
to	TO	O
a	DT	O
packaging	NN	O
system	NN	O
described	VBD	O
herein	RB	O
,	,	O
and	CC	O
the	DT	O
generation	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
in	IN	O
this	DT	O
example	NN	O
amounts	VBZ	O
to	TO	O
a	DT	O
method	NN	O
of	IN	O
generating	VBG	O
a	DT	O
batch	NN	O
of	IN	O
recombinant	JJ	O
adenovirus	NN	O
described	VBD	O
herein	NN	O
.	.	O
Genomic	NNP	O
DNA	NN	O
from	IN	O
the	DT	O
generated	VBN	O
cell	NN	O
lines	NNS	O
is	VBZ	O
tested	VBN	O
on	IN	O
Southern	NNP	O
blots	NNS	O
,	,	O
using	VBG	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
probes	NNS	O
,	,	O
to	TO	O
demonstrate	VB	O
that	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
are	VBP	O
separated	VBN	O
by	IN	O
more	JJR	O
than	IN	O
4	CD	O
kb	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
cells	NNS	O
.	.	O
Hereto	NNP	O
,	,	O
the	DT	O
genomic	JJ	O
DNA	NN	O
is	VBZ	O
digested	VBN	O
with	IN	O
the	DT	O
restriction	NN	O
endonucleases	VBZ	O
EcoRV	NNP	O
and	CC	O
BglII	NNP	O
(	(	O
FIG	NNP	O
.	.	O
21	CD	O
)	)	O
.	.	O
The	DT	O
digested	JJ	O
DNA	NNP	O
is	VBZ	O
size	NN	O
separated	VBN	O
by	IN	O
gel	JJ	O
electrophoresis	NN	O
(	(	O
e.g.	NN	O
,	,	O
using	VBG	O
field-inversed	JJ	O
gel	NN	O
electrophoresis	NN	O
,	,	O
FIGE	NNP	O
,	,	O
to	TO	O
enable	VB	O
separation	NN	O
of	IN	O
large	JJ	O
DNA	NNP	O
fragments	NNS	O
)	)	O
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
a	DT	O
nylon	NN	O
membrane	NN	O
by	IN	O
capillary	JJ	O
blotting	NN	O
.	.	O
Three	CD	O
different	JJ	O
probes	NNS	O
are	VBP	O
radioactively	RB	O
labeled	VBN	O
for	IN	O
hybridization	NN	O
of	IN	O
the	DT	O
blots	NNS	O
.	.	O
One	CD	O
Ad5.E1A	NNP	O
probe	NN	O
is	VBZ	O
generated	VBN	O
from	IN	O
an	DT	O
EcoRV-SalI	JJ	O
restriction	NN	O
fragment	NN	O
(	(	O
1330	CD	O
bp	NN	O
;	:	O
see	VB	O
FIG	NNP	O
.	.	O
21	CD	O
)	)	O
located	VBD	O
3′	CD	O
from	IN	O
the	DT	O
EcoRV	NNP	O
site	NN	O
in	IN	O
the	DT	O
Ad5.E1A	NNP	O
gene	NN	O
.	.	O
Two	CD	O
Ad5.E1B	NNP	O
probes	NNS	O
are	VBP	O
generated	VBN	O
:	:	O
Ad5.E1B	NNP	O
(	(	O
5′	CD	O
)	)	O
,	,	O
from	IN	O
a	DT	O
BssHII-BglII	JJ	O
fragment	NN	O
(	(	O
1354	CD	O
bp	NN	O
)	)	O
,	,	O
and	CC	O
Ad5.E1B	NNP	O
(	(	O
3′	CD	O
)	)	O
,	,	O
from	IN	O
a	DT	O
BglII-BsrGI	JJ	O
fragment	NN	O
(	(	O
652	CD	O
bp	NN	O
)	)	O
,	,	O
which	WDT	O
are	VBP	O
located	VBN	O
at	IN	O
the	DT	O
5′	CD	O
side	NN	O
and	CC	O
the	DT	O
3′	CD	O
side	NN	O
of	IN	O
the	DT	O
BglII	NNP	O
site	NN	O
in	IN	O
the	DT	O
Ad5.E1B	NNP	O
gene	NN	O
,	,	O
respectively	RB	O
.	.	O
Identical	JJ	O
blots	NNS	O
containing	VBG	O
the	DT	O
digested	JJ	O
genomic	JJ	O
DNA	NN	O
of	IN	O
the	DT	O
generated	VBN	O
cell	NN	O
lines	NNS	O
are	VBP	O
prepared	JJ	O
or	CC	O
,	,	O
alternatively	RB	O
,	,	O
the	DT	O
blot	NN	O
is	VBZ	O
stripped	VBN	O
after	IN	O
hybridization	NN	O
of	IN	O
the	DT	O
first	JJ	O
probe	NN	O
and	CC	O
then	RB	O
hybridized	VBD	O
to	TO	O
a	DT	O
second	JJ	O
.	.	O
Either	DT	O
method	NN	O
should	MD	O
allow	VB	O
overlay	NN	O
of	IN	O
the	DT	O
signals	NNS	O
obtained	VBN	O
with	IN	O
E1A	NNP	O
and	CC	O
the	DT	O
E1B	NNP	O
probes	NNS	O
.	.	O
If	IN	O
,	,	O
following	VBG	O
transfection	NN	O
and	CC	O
integration	NN	O
during	IN	O
generation	NN	O
of	IN	O
the	DT	O
transformed	VBN	O
cell	NN	O
line	NN	O
,	,	O
the	DT	O
E1A	NNP	O
fragment	NN	O
becomes	RB	O
integrated	JJ	O
next	JJ	O
to	TO	O
an	DT	O
E1B-containing	JJ	O
fragment	NN	O
,	,	O
the	DT	O
probes	NNS	O
for	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
detect	VBP	O
the	DT	O
same	JJ	O
bands	NNS	O
on	IN	O
the	DT	O
blots	NNS	O
,	,	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
band	NN	O
identifying	VBG	O
the	DT	O
distance	NN	O
between	IN	O
the	DT	O
two	CD	O
genes	NNS	O
.	.	O
Since	IN	O
the	DT	O
orientation	NN	O
of	IN	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
fragment	JJ	O
relative	NN	O
to	TO	O
each	DT	O
other	JJ	O
is	VBZ	O
not	RB	O
known	VBN	O
,	,	O
the	DT	O
two	CD	O
E1B	NNP	O
probes	NNS	O
are	VBP	O
used	VBN	O
separately	RB	O
,	,	O
enabling	VBG	O
hybridization	NN	O
either	DT	O
to	TO	O
the	DT	O
fragment	JJ	O
5′	CD	O
or	CC	O
3′	CD	O
of	IN	O
the	DT	O
BglII	NNP	O
restriction	NN	O
site	NN	O
.	.	O
If	IN	O
an	DT	O
E1A	NNP	O
fragment	NN	O
becomes	RB	O
integrated	JJ	O
next	JJ	O
to	TO	O
another	DT	O
E1A	NNP	O
fragment	NN	O
,	,	O
then	RB	O
the	DT	O
band	NN	O
resulting	VBG	O
from	IN	O
EcoRV	NNP	O
digestion	NN	O
will	MD	O
not	RB	O
be	VB	O
recognized	VBN	O
by	IN	O
the	DT	O
E1B	NNP	O
probe	NN	O
.	.	O
Also	RB	O
,	,	O
single	JJ	O
integrants	NNS	O
or	CC	O
end	NN	O
fragments	NNS	O
will	MD	O
generate	VB	O
bands	NNS	O
that	WDT	O
are	VBP	O
not	RB	O
recognized	VBN	O
by	IN	O
both	DT	O
probes	NNS	O
.	.	O
Altogether	RB	O
,	,	O
the	DT	O
experiments	NNS	O
in	IN	O
this	DT	O
example	NN	O
clearly	RB	O
show	VBP	O
that	IN	O
co-transfection	NN	O
of	IN	O
primary	JJ	O
human	JJ	O
cells	NNS	O
with	IN	O
separate	JJ	O
plasmids	NNS	O
,	,	O
one	CD	O
containing	VBG	O
E1A	NNP	O
flanked	VBN	O
by	IN	O
a	DT	O
large	JJ	O
stuffer	NN	O
region	NN	O
and	CC	O
one	CD	O
containing	NN	O
E1B	NNP	O
flanked	VBN	O
by	IN	O
backbone	NN	O
sequences	NNS	O
,	,	O
results	NNS	O
in	IN	O
transformed	JJ	O
cell	NN	O
lines	NNS	O
.	.	O
Furthermore	RB	O
,	,	O
these	DT	O
cell	NN	O
lines	NNS	O
express	RB	O
E1	NNP	O
proteins	NNS	O
in	IN	O
quantities	NNS	O
sufficient	JJ	O
for	IN	O
efficient	JJ	O
complementation	NN	O
of	IN	O
E1-deleted	JJ	O
Ad5	NNP	O
vectors	NNS	O
.	.	O
In	IN	O
an	DT	O
alternative	JJ	O
embodiment	NN	O
,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
sequences	NNS	O
are	VBP	O
cloned	VBN	O
into	IN	O
a	DT	O
single	JJ	O
construct	NN	O
,	,	O
with	IN	O
a	DT	O
stuffer	NN	O
fragment	NN	O
between	IN	O
these	DT	O
sequences	NNS	O
,	,	O
after	IN	O
which	WDT	O
cell	NN	O
lines	NNS	O
are	VBP	O
created	VBN	O
using	VBG	O
the	DT	O
single	JJ	O
construct	NN	O
.	.	O
Clearly	RB	O
,	,	O
if	IN	O
larger	JJR	O
distances	NNS	O
between	IN	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
are	VBP	O
desired	VBN	O
,	,	O
the	DT	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
may	MD	O
also	RB	O
be	VB	O
flanked	VBN	O
by	IN	O
a	DT	O
longer	JJR	O
stuffer	NN	O
nucleic	JJ	O
acid	NN	O
,	,	O
and/or	VBP	O
the	DT	O
length	NN	O
of	IN	O
the	DT	O
stuffers	NNS	O
flanking	VBG	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
could	MD	O
be	VB	O
increased	VBN	O
,	,	O
by	IN	O
standard	JJ	O
routine	NN	O
molecular	JJ	O
biology	NN	O
techniques	NNS	O
,	,	O
following	VBG	O
the	DT	O
teachings	NNS	O
of	IN	O
the	DT	O
present	JJ	O
disclosure	NN	O
.	.	O
Clearly	RB	O
,	,	O
therefore	RB	O
,	,	O
this	DT	O
example	NN	O
should	MD	O
not	RB	O
be	VB	O
construed	VBN	O
to	TO	O
limit	VB	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
actually	RB	O
performed	VBN	O
experiments	NNS	O
,	,	O
but	CC	O
rather	RB	O
as	IN	O
an	DT	O
exemplification	NN	O
of	IN	O
the	DT	O
concepts	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
REFERENCES	NN	O
Claims	NNP	O
(	(	O
7	CD	O
)	)	O
Priority	NN	O
Applications	NNP	O
(	(	O
6	CD	O
)	)	O
Applications	NNPS	O
Claiming	NNP	O
Priority	NNP	O
(	(	O
1	CD	O
)	)	O
Related	VBN	O
Parent	NN	O
Applications	NNP	O
(	(	O
1	CD	O
)	)	O
Publications	NNPS	O
(	(	O
2	CD	O
)	)	O
Family	RB	O
ID=34400432	NNP	O
Family	NNP	O
Applications	NNP	O
(	(	O
2	CD	O
)	)	O
Family	NNP	O
Applications	NNP	O
Before	NNP	O
(	(	O
1	CD	O
)	)	O
Country	NN	O
Status	NNP	O
(	(	O
8	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
1	CD	O
)	)	O
Families	NNPS	O
Citing	VBG	O
this	DT	O
family	NN	O
(	(	O
6	CD	O
)	)	O
Citations	NNPS	O
(	(	O
16	CD	O
)	)	O
Patent	NN	O
Citations	NNP	O
(	(	O
20	CD	O
)	)	O
Non-Patent	JJ	O
Citations	NNP	O
(	(	O
10	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
1	CD	O
)	)	O
Also	RB	O
Published	VBN	O
As	IN	O
Similar	JJ	O
Documents	NNP	O
Legal	NNP	O
Events	NNP	O
Owner	NNP	O
name	NN	O
:	:	O
CRUCELL	NNP	O
HOLLAND	NNP	O
B.V.	NNP	O
,	,	O
NETHERLANDS	NNP	O
Free	NNP	O
format	NN	O
text	NN	O
:	:	O
ASSIGNMENT	NNP	O
OF	IN	O
ASSIGNORS	NNP	O
INTEREST	NNP	O
;	:	O
ASSIGNORS	NNP	O
:	:	O
VOGELS	NNP	O
,	,	O
RONALD	NNP	O
;	:	O
HAVENGA	NNP	O
,	,	O
MENZO	NNP	O
J.	NNP	O
E.	NNP	O
;	:	O
ZUIJDGEEST	NNP	O
,	,	O
DAVID	NNP	O
A.T.	NNP	O
M.	NNP	O
;	:	O
REEL/FRAME:024768/0159	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20041004	CD	O
Year	NN	O
of	IN	O
fee	JJ	O
payment	NN	O
:	:	O
4	CD	O
